P. 1
washingtonblade.com - vol. 41, issue 48 - november 26, 2010

washingtonblade.com - vol. 41, issue 48 - november 26, 2010

|Views: 101|Likes:
DADT, Clay Aiken, Holiday Gift Guide, Gay News, Gay Entertainment, Gay Nightlife
DADT, Clay Aiken, Holiday Gift Guide, Gay News, Gay Entertainment, Gay Nightlife

More info:

Published by: Washington Blade Newspaper on Dec 02, 2010
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

11/24/2013

pdf

text

original

local

news
Clark Ray won’t seek
interim appointment
to Council seat vacated
by Kwame Brown.
PAGE 4
social
agenda
Local TV personality
Paul Wharton to host
Whitman-Walker
beneft at Urbana.
PAGE 41
doubling our
pleasure
Tony Award-winning
Levi Kreis joins fellow
gay singer Eric Himan
for Jammin’ Java show.
PAGE 37
the lgbtq community news source
washingtonblade.com • vol. 41, issue 48 • november 26, 2010 • Still sharp after 40 years
New optimism as Reid commits to vote,
but hearings and debate loom
By CHRIS JOHNSON
cjohnson@washblade.com
Supporters of “Don’t Ask, Don’t Tell” repeal continue to fret
about having enough time to pass a measure to overturn the
military’s gay ban before year’s end even as Senate leader-
ship has committed to a vote on the issue during the lame
duck session of Congress.
An announcement last week from Senate Majority Leader
Harry Reid (D-Nev.) that he would bring major defense legis-
lation with repeal language to a vote bolstered the confdence
of supporters as they acknowledge signifcant hurdles remain
in reaching the fnish line.
Aubrey Sarvis, executive director of the Servicemembers
Legal Defense Network, said he’s “hopeful” that Congress will
be able to enact repeal, but acknowledged that “the clock is
our enemy.”
“I’m fearful of time running out on the bill before it’s fnished
or the prospects of strong opposition from a core group of
senators who don’t want to see anything happen in the lame
duck,” Sarvis said.
Debate on the defense authorization bill traditionally takes
‘Idol’ speaks out
Will time run out for ‘Don’t Ask’ repeal?
artbriefs
Jim Carrey plays gay in long-delayed ‘I Love You, Phillip Morris.’
PAGE 43
Continues on page 15
Continues on page 21
giftguide
Part two of our holiday gift guide features season’s hottest electronics.
PAGE 33
Aubrey Sarvis, executive director of the Servicemembers Legal Defense Network, said he’s ‘hopeful’ that Congress will
enact repeal of the military’s gay ban, but acknowledged that ‘the clock is our enemy.’
Washington Blade fle photo by Michael Key
Aiken joins lawmakers to push anti-bullying bills
By LOU CHIBBARO JR.
lchibbaro@washblade.com
“American Idol” singer Clay Aiken and two mothers whose sons committed suicide because of anti-
gay bullying at their schools appeared at a Capitol Hill briefng last week to urge Congress to pass two
bills that would require schools to address bullying and harassment targeting LGBT students.
The Gay, Lesbian and Straight Education Network (GLSEN) organized the briefng as a means of
drawing public attention to the two pending bills, the Safe Schools Improvement Act and the Student
Non-Discrimination Act.
“Like many kids now in middle schools and high schools, I was bullied,” said Aiken, who came out
as gay in 2008 after winning the runner-up title on the hit TV show “American Idol.”
“I was picked on, I was called gay, I was called fag, I was called sissy, you name it,” he said. “For-
tunately, I was able to overcome it and live through it because of a number of friends who were sup-
portive of me.”
N.J. passes sweeping anti-bullying measure, PAge 11
Nuns denounce bishops over recent suicides, PAge 12
LOCALNEWS
2 washingtonblade.com • november 26, 2010
‘Rubber Revolution’ condom
campaign targets gay men

The D.C. Department of Health launched a new
condom awareness campaign last week called “Rub-
ber Revolution,” which includes ads in gay publications
urging men who have sex with men to use condoms
“every time” to prevent the spread of HIV.
AIDS activists have expressed concern that the city’s
existing condom distribution and awareness campaigns
didn’t go far enough to attract the attention of high risk
groups, including black men and women and gay men.
In a statement released on Nov. 18, DOH Director Dr.
Pierre Vigilance pointed to the new campaign’s more
blunt and explicit messages.
“Big Enuf 4 U,” “A condom Fits Any Head,” and “Get
Wrapped Up for the Moment,” are among slogans the
“Rubber Revolution” condom campaign will use in its
literature and on its newly launched website, Rubber-
RevolutionDC.com.
“The Rubber Revolution aims to encourage sexu-
ally active people to always use condoms and engage
community and business partners to support condom
use,” said Mayor Adrian Fenty in a statement. “The Dis-
trict is proud of its aggressive approach to address this
issue, and we hope to build on our success as one of
the only two cities in the country with a public sector
condom distribution program that has provided more
than 3.5 million free condoms last year,” Fenty said.
DOH said in its statement that it developed the cam-
paign in response to studies showing that between 40
percent and 70 percent of all D.C. adults and adoles-
cents are not regularly using condoms
The city will continue to fund a separate condom distri-
bution campaign organized by gay D.C. physician Terry
Gerace with the involvement of the Whitman-Walker Clin-
ic and the D.C. LGBT Community Center called “FUK!T.”
That campaign has already distributed thousands of
packets containing condoms and lube to the city’s gay
establishments. Volunteers assemble the packets each
week, according to AIDS activist and D.C. medical stu-
dent Daniel O’Neill, who is involved with the project.
“It’s a step in the right direction,” O’Neill said of the
‘Rubber Revolution’ campaign. “It can’t be as provoca-
tive as the ‘FUK!T’ campaign. But this could be helpful
with certain groups.”
LOU CHIBBARO JR.
Gay couple participates
in D.C. Adoption Day

A judge signed the offcial papers for a gay male
couple to adopt a 2-year-old girl they have raised since
infancy on Saturday during the 24th Annual Adoption
Day ceremony at the D.C. Superior Court.
District residents John Coon, 43, and Josh Tuerk,
42, who have been a couple for 18 years, were among
the parents of more than 20 kids whose adoptions were
fnalized at the ceremony. Their adopted daughter, Ga-
briella “Ella” Logan, who attended the event, was de-
scribed by an announcer as having a “captivating and
vivacious personality.”
Court offcials and the D.C. Child and Family Servic-
es Agency said in a statement that the Adoption Day
event is intended to “celebrate the joy of adoption and
encourage area residents to consider adopting or fos-
tering a child” through the city’s child welfare system.
Same-sex couples have been adopting children in
the city since 1994, when the D.C. Court of Appeals is-
sued a ruling clearing the way for such adoptions. Local
gay rights attorney Michelle Zavos, who specializes in
gay family law, said the city’s child welfare and adoption
offce is fully supportive of gay adoptions. She noted
that qualifcations and background checks used in the
adoption approval process are the same for same-sex
and opposite-sex couples.
“We adopted two boys 10 years ago — Noah and
Marcus. They’re both 10,” Coon told the Blade. “And
Ella — we decided it was time to add a little princess to
join our all-male household.”
Coon, an interior decorator, and Tuerk, who owns and
operates a D.C.-based pet care business, live with their
children in the city’s Wesley Heights section. They recently
bought a farmhouse and farm outside Charlestown, W.Va.,
where they plan to spend the Thanksgiving holiday.
“All the grandparents will be with us,” Coon said.
LOU CHIBBARO JR.

Anti-gay lawmaker
ousted in Maryland
LGBT advocates in Maryland are celebrating the de-
feat of Republican State Senator Alex X. Mooney in the
recent elections. Mooney conceded the contest to Ron
Young a few days after most of the absentee ballots
were counted. He lost by fewer than 1,000 votes and
had represented the 3rd District that includes Frederick
and Washington counties.
Since taking offce in January 1999, Mooney, 39,
was a vocal opponent of LGBT rights. He frequently de-
nounced the LGBT community.
Mooney once said “Homosexual activists have man-
aged to gain legal recognition as a minority, based
solely on their lifestyle choices, through so-called ‘hate
crimes’ and domestic partnership laws.”
Mooney had been a member of the Senate Judicial
Proceedings Committee, which consistently blocked
movement on marriage equality and gender identity
protection bills.
In each of the three previous races for Senate,
Mooney’s margin of victory declined — a trend that
speaks to the changing demographics in Frederick.
But the election may have also turned on the work
of Equality Maryland, SEIU and a host of volunteers.
Equality Maryland’s Field Organizer Aimee Martin was in
charge of GOTV (Get Out the Vote) support in Frederick
County. She turned out approximately two-dozen Equal-
ity Maryland supporters to work in the Frederick area
each weekend during October through the election.
According to Lisa Polyak, PAC Director for Equal-
ity Maryland, the organization provided ground sup-
port, such as literature drops, door knocking and phone
banks on behalf of all the LGBT-supportive candidates,
including Ron Young, Candy Greenway and Ryan Trout
in the Frederick area. During the summer, Equality Mary-
land collected signed statements from 1,200 residents
who support LGBT equality in Frederick County. In addi-
tion, the PAC contributed $3,000 to Young’s campaign.
Equality Maryland also collected signatures in support
of gender identity anti-discrimination and marriage equal-
ity at two dozen polling places in Anne Arundel, Baltimore,
Howard, Montgomery and Prince Georges counties on
Election Day. This resulted in identifcation of 3,278 voters
who were willing to sign their names in support of LGBT
equality, including 588 new supporters in the home district
of Senate President Mike Miller (District 27).
STEVE CHARING/BALTIMORE OUTLoud
Orange Crush wins
football championship
Last Sunday, the D.C. Gay Flag Football League
(DCGFFL) held its inaugural league championships.
Orange Crush was 0-3 after the frst two weeks of the
season and then went undefeated for the next fve
weeks to make it to the championships.
The team lived up to their name and crushed Gang
Green by a score of 34-20. The teams started the cham-
pionship game by trading touchdowns. As Gang Green
was driving to score again, Kevin Smith intercepted a
pass and it was all Orange Crush for the rest of the game.
Quarterback Brian Moll was voted MVP for the Or-
ange Crush and Brian Sparrow, utility player, was voted
MVP for Gang Green.
In the consolation brackets, Rug Burn defeated
Golden Wave 14-13 for 3rd place and Blue Ballers
topped Hell Marys 40-14 for ffth place. Complete de-
tails can be found at dcgff.org.
KEVIN MAJOROS
The D.C. Department of Health launched a new condom
awareness campaign last week.
Photo courtesy of D.C.DOH
PHOTO: condom ad, sent in email
CAPTION: (Image courtesy of D.C. DOH)

Orange Crush and its MVP quarterback Brian Moll won the D.C. Gay Flag Football League championship on Sunday.
Washington Blade photo by Kevin Majoros
november 26, 2010 • washingtonblade.com 3
LOCALNEWS
4 washingtonblade.com • november 26, 2010
Ray stays out of
interim Council race
12 seek temporary appointment to Kwame Brown’s seat
By LOU CHIBBARO JR.
lchibbaro@washblade.com
Clark Ray, the gay candidate who lost his race for an at-large D.C. Council seat
in the September primary, has chosen not to enter a preliminary contest for another
at-large seat that will become vacant on Jan. 1.
The 60-member D.C. Democratic State Committee is scheduled to vote Jan. 6
to appoint an interim replacement for Council member Kwame Brown (D-At-Large),
who won election Nov. 2 as Council chairman.
Ray did not fle as a candidate for the State Committee appointment process by
the Nov. 6 deadline. He did not immediately return a call seeking comment.
Some political observers say the winner of the State Committee appointment for
interim Council member will have the advantage of incumbency and greater name
recognition in a special citywide election expected to take place in spring of 2011.
Twelve candidates fled papers to compete for the interim appointment, including
former Ward 5 Council member Vincent Orange, who is considered the frontrunner.
Earlier this year Ray said he would consider running for Brown’s seat in the
2011 special election if he lost his race in September for the seat held by Council
member Phil Mendelson.
Mendelson, who has a strong pro-LGBT record, won the primary with 63 percent
of the vote, beating Ray in precincts with high concentrations of gay voters. D.C.
Shadow Sen. Michael D. Brown came in second, with 27 percent of the vote. Ray
fnished third with 9 percent of the vote, losing in every precinct.
Gay Democratic activist Peter Rosenstein, who served as a Ray campaign ad-
viser, said Ray would have a decent chance of winning in the special election
despite his poor showing in the September primary. Rosenstein noted that special
elections are known for yielding a low voter turnout. He said Ray could win with
10,000 votes — which he received in the primary — in a multi-candidate contest.
“He could pull this off if the gay vote unifes behind him, which I think it will,” said
Rosenstein.
At least two other candidates said to be considering entering the race for the
special election have strong pro-gay records and could take LGBT votes away
from Ray. Adam Clampitt received gay support as an at-large candidate in the
2008 Democratic primary before withdrawing from the race and backing Michael
A. Brown, who won the primary and general election.
Republican Patrick Mara, an early supporter of same-sex marriage, stunned
the political establishment when he defeated longtime Council member Carol
Schwartz in the 2008 GOP primary. Mara lost in the general election to Michael A.
Brown but came back to win a seat on the D.C. school board in Ward 1 earlier this
month. Mara is said to be weighing whether to run in the special election for the
at-large Council seat.
“Clark spent over $200,000, ran for two years, knocked on doors throughout the
city, hung signs everywhere and got less than 10 percent of the vote,” said gay ac-
tivist Bob Summersgill, who campaigned for Mendelson in the September primary.
Summersgill noted that Ray and several candidates competing for the interim
appointment for the vacant at-large seat, who also ran and lost in Council races
this year, “need to explain why we should give them any consideration in the spe-
cial election.”
Clark Ray, a gay candidate who lost his race for City Council in September, declined to seek an
interim appointment to the seat vacated by Kwame Brown, but could still enter the race for the
special election later this year.
Washington Blade fle photo by Michael Key
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 101022 SALES REPRESENTATIVE: Brian Pitts (bpitts@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
The time to start planning
your fnancial future is today

• IndependentFinancialPlanning&AdvisoryServices
• InvestmentManagement
• Life,Disability,Long-TermCareInsurances
• PlanningStrategiesforBusiness&BusinessOwners
Contact:tagardemal@potomacfm.com
Phone:301-840-0770 x 110
www.potomacfm.com
Securities, fnancial planning and advisory services offered through LPL Financial, Member FINRA/SIPC.
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 2 ISSUE DATE: 100402 SALES REP: JP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
dcagenda
the lgbtq community’s news source
703 D St NW
Washington, DC
202-628-1288
1221 Mass Ave NW*
Washington, DC
202-628-7979
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF 1 ISSUE DATE: 11-05-10 SALES REPRESENTATIVE: BRIAN PITTS (bpitts@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
november 26, 2010 • washingtonblade.com 5
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: BRIAN PITTS (bpitts@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Sunday, December 12, 2010
5:00-8:00pm
Four Seasons Hotel, Washington, DC
2800 Pennsylvania Avenue, NW
A holiday event to beneft the Pediatric Bone Marrow Transplant
Program and Childhood Cancer Survivorship Program at the
Georgetown Lombardi Comprehensive Cancer Center
Pamala Stanley
Event Highlights
Designer Trees and Holiday Vignettes
DC Magazine Sports Lounge
CVS/Pharmacy Children’s Workshop
Holiday Tastings
Silent Auction
2011 Toyota Venza Raffe
Entertainment featuring
Pamala Stanley
Visit www.georgetownjingle.com
for more information or to purchase tickets.
6 washingtonblade.com • november 26, 2010
Job number: 697US09AB07051 Trim size 9.75" x 10.5 No BLEED Pub:
To learn more, visit
www.ATRIPLA.com
“My entire HIV regimen
in one pill daily.
For me, that’s great.”
on ATRIPLA for 2 years
Phil lip
© 2010 Bristol-Myers Squibb & Gilead Sciences, LLC. All rights reserved. ATRIPLA is a
trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, VIREAD, and
TRUVADA are trademarks of Gilead Sciences, Inc. SUSTIVA and REYATAZ are registered
trademarks of Bristol-Myers Squibb. All other trademarks are owned by third parties.
INDICATION
ATRIPLA
®
(efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil
fumarate [DF] 300 mg) is a prescription medication used alone as a
complete regimen or with other medicines to treat HIV-1 infection in adults.
ATRIPLA does not cure HIV-1 and has not been shown to prevent
passing HIV-1 to others. The long-term effects of ATRIPLA are not known
at this time. People taking ATRIPLA may still get infections that develop
because the immune system is weak or other conditions that happen with
HIV-1 infection.
Do not stop taking ATRIPLA unless directed by your healthcare
provider. See your healthcare provider regularly.
IMPORTANT SAFETY INFORMATION
Contact your healthcare provider right away if you get the following
side effects or conditions associated with ATRIPLA:
• Nausea, vomiting, unusual muscle pain, and/or weakness. These
may be signs of a buildup of acid in the blood (lactic acidosis),
which is a serious medical condition.
• Light-colored stools, dark-colored urine, and/or if your skin or the
whites of your eyes turn yellow. These may be signs of serious
liver problems.
• If you have HIV-1 and hepatitis B virus (HBV), your liver disease
may suddenly get worse if you stop taking ATRIPLA.
Do not take ATRIPLA if you are taking the following medicines
because serious and life-threatening side effects may occur when
taken together: Vascor
®
(bepridil), Propulsid
®
(cisapride),
Versed
®
(midazolam), Orap
®
(pimozide), Halcion
®
(triazolam),
or ergot medications (for example, Wigraine
®
and Cafergot
®
).
In addition, ATRIPLA should not be taken with:
Combivir
®
(lamivudine/zidovudine), EMTRIVA
®
(emtricitabine), Epivir
®
or Epivir-HBV
®
(lamivudine), Epzicom
®
(abacavir sulfate/lamivudine),
SUSTIVA
®
(efavirenz), Trizivir
®
(abacavir sulfate/lamivudine/zidovudine),
TRUVADA
®
(emtricitabine/tenofovir DF), or VIREAD
®
(tenofovir DF),
because they contain the same or similar active ingredients as ATRIPLA.
ATRIPLA should not be used with HEPSERA
®
(adefovir dipivoxil).
Vfend
®
(voriconazole) or REYATAZ
®
(atazanavir sulfate) with or without
Norvir
®
(ritonavir) should not be taken with ATRIPLA since they may
lose their effect and may also increase the chance of having side effects
from ATRIPLA. Fortovase
®
or Invirase
®
(saquinavir) should not be used
as the only protease inhibitor in combination with ATRIPLA.
Taking ATRIPLA with St. John’s wort or products containing St. John’s wort
is not recommended as it may cause decreased levels of ATRIPLA,
increased viral load, and possible resistance to ATRIPLA or
cross-resistance to other anti-HIV drugs.
This list of medicines is not complete. Discuss with your healthcare
provider all prescription and nonprescription medicines, vitamins,
or herbal supplements you are taking or plan to take.
Tell your healthcare provider if you:
• Are pregnant: Women should not become pregnant while taking
ATRIPLA and for 12 weeks after stopping ATRIPLA. Serious birth defects
have been seen in children of women treated during pregnancy with
one of the medicines in ATRIPLA. Women must use a reliable form of
barrier contraception, such as a condom or diaphragm, even if they also
use other methods of birth control, while on ATRIPLA and for 12 weeks
after stopping ATRIPLA.
• Are breastfeeding: Women with HIV should not breastfeed
because they can pass HIV through their milk to the baby. Also,
ATRIPLA may pass through breast milk and cause serious harm
to the baby.
• Have liver problems, including hepatitis B or C virus infection.

• Have ever had seizures: Seizures have occurred in patients taking a
component of ATRIPLA, usually in those with a history of seizures. If you
have ever had seizures, or take medicine for seizures, your healthcare
provider may want to switch you to another medicine or monitor you.
• Have ever had mental illness or use drugs or alcohol.
Contact your healthcare provider right away if you experience any
of the following serious or common side effects:
Serious side effects associated with ATRIPLA:
• Severe depression, strange thoughts, or angry behavior have been
reported by a small number of patients. Some patients have had thoughts
of suicide, and a few have actually committed suicide. These problems
may occur more often in patients who have had mental illness.
• Kidney problems (including decline or failure of kidney function).
If you have had kidney problems, or take other medicines that may
cause kidney problems, your healthcare provider should do regular
blood tests. Symptoms that may be related to kidney problems include
a high volume of urine, thirst, muscle pain, and muscle weakness.
• Other serious liver problems. Some patients have experienced
serious liver problems, including liver failure resulting in transplantation
or death. Most of these serious side effects occurred in patients with a
chronic liver disease such as hepatitis infection, but there have also
been a few reports in patients without any existing liver disease.
• Bone changes. Lab tests show changes in the bones of patients treated
with tenofovir DF, a component of ATRIPLA. Some HIV patients treated
with tenofovir DF developed thinning of the bones (osteopenia), which
could lead to fractures. Also, bone pain and softening of the bone
(which may lead to fractures) may occur as a consequence of kidney
problems. If you have had bone problems in the past, your healthcare
provider may want to check your bones.
Common side effects:
• Dizziness, headache, trouble sleeping, drowsiness, trouble
concentrating, and/or unusual dreams. These side effects tend to
go away after taking ATRIPLA for a few weeks. These symptoms may
be more severe with the use of alcohol and/or mood-altering (street)
drugs. If you are dizzy, have trouble concentrating, and/or are drowsy,
avoid activities that may be dangerous, such as driving or operating
machinery.
• Rash is a common side effect that usually goes away without any
change in treatment, but may be serious in a small number of patients.
• Other common side effects include: tiredness, upset stomach, vomiting,
gas, and diarrhea.
Other possible side effects:
• Changes in body fat have been seen in some people taking anti-HIV-1
medicines. The cause and long-term health effects are not known.
• Skin discoloration (small spots or freckles) may also happen.
• If you notice any symptoms of infection, contact your healthcare
provider right away.
• Additional side effects are inflammation of the pancreas, allergic
reaction (including swelling of the face, lips, tongue, or throat),
shortness of breath, pain, stomach pain, weakness, and indigestion.
You should take ATRIPLA once daily on an empty stomach. Taking
ATRIPLA at bedtime may make some side effects less bothersome.
ATRIPLA is one of several treatment options your doctor may consider.
You are encouraged to report negative side effects
of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
697US09AB07051/TR7171 10/10
ATRIPLA Important Safety Information and Indication
*
Synovate Healthcare Data; US HIV Monitor, Q1 2010.
Patient model. Individual results may vary.
Your doctor may prescribe ATRIPLA alone
or with other HIV medications.
Talk to your doctor to see if ATRIPLA is right for you.
Please see Patient Information on the following pages.

Defined as a viral load of less than 400 copies/mL.

Average increase of 312 cells/mm
3
.
§
In this study, 227 patients took the meds in ATRIPLA.
ATRIPLA is the #1 prescribed HIV regimen.
*
About ATRIPLA:
•Only ATRIPLA combines 3 HIV medications in 1 pill daily.
• Proven to lower viral load to undetectable

in approximately
7 out of 10 patients new to therapy, and also raise T-cell

(CD4+)
count to help control HIV through 3 years of a clinical study.
§
•ATRIPLA does not cure HIV-1 and has not been shown to prevent
passing HIV-1 to others.
Selected Important Safety Information:
Some people who have taken medicine like ATRIPLA have developed
the following: a serious condition of acid buildup in the blood (lactic
acidosis), and serious liver problems (hepatotoxicity). For patients
with both HIV-1 and hepatitis B virus (HBV), hepatitis may suddenly
worsen if ATRIPLA is discontinued.
Please see detailed and additional Important Safety Information,
including the bolded information to the left.
697US09AB07051_9.75x11.5_. 10/15/10 5:13 PM Page 1
november 26, 2010 • washingtonblade.com 7
Job number: 697US09AB07051 Trim size 9.75" x 10.5 No BLEED Pub:
To learn more, visit
www.ATRIPLA.com
“My entire HIV regimen
in one pill daily.
For me, that’s great.”
on ATRIPLA for 2 years
Phil lip
© 2010 Bristol-Myers Squibb & Gilead Sciences, LLC. All rights reserved. ATRIPLA is a
trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, VIREAD, and
TRUVADA are trademarks of Gilead Sciences, Inc. SUSTIVA and REYATAZ are registered
trademarks of Bristol-Myers Squibb. All other trademarks are owned by third parties.
INDICATION
ATRIPLA
®
(efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil
fumarate [DF] 300 mg) is a prescription medication used alone as a
complete regimen or with other medicines to treat HIV-1 infection in adults.
ATRIPLA does not cure HIV-1 and has not been shown to prevent
passing HIV-1 to others. The long-term effects of ATRIPLA are not known
at this time. People taking ATRIPLA may still get infections that develop
because the immune system is weak or other conditions that happen with
HIV-1 infection.
Do not stop taking ATRIPLA unless directed by your healthcare
provider. See your healthcare provider regularly.
IMPORTANT SAFETY INFORMATION
Contact your healthcare provider right away if you get the following
side effects or conditions associated with ATRIPLA:
• Nausea, vomiting, unusual muscle pain, and/or weakness. These
may be signs of a buildup of acid in the blood (lactic acidosis),
which is a serious medical condition.
• Light-colored stools, dark-colored urine, and/or if your skin or the
whites of your eyes turn yellow. These may be signs of serious
liver problems.
• If you have HIV-1 and hepatitis B virus (HBV), your liver disease
may suddenly get worse if you stop taking ATRIPLA.
Do not take ATRIPLA if you are taking the following medicines
because serious and life-threatening side effects may occur when
taken together: Vascor
®
(bepridil), Propulsid
®
(cisapride),
Versed
®
(midazolam), Orap
®
(pimozide), Halcion
®
(triazolam),
or ergot medications (for example, Wigraine
®
and Cafergot
®
).
In addition, ATRIPLA should not be taken with:
Combivir
®
(lamivudine/zidovudine), EMTRIVA
®
(emtricitabine), Epivir
®
or Epivir-HBV
®
(lamivudine), Epzicom
®
(abacavir sulfate/lamivudine),
SUSTIVA
®
(efavirenz), Trizivir
®
(abacavir sulfate/lamivudine/zidovudine),
TRUVADA
®
(emtricitabine/tenofovir DF), or VIREAD
®
(tenofovir DF),
because they contain the same or similar active ingredients as ATRIPLA.
ATRIPLA should not be used with HEPSERA
®
(adefovir dipivoxil).
Vfend
®
(voriconazole) or REYATAZ
®
(atazanavir sulfate) with or without
Norvir
®
(ritonavir) should not be taken with ATRIPLA since they may
lose their effect and may also increase the chance of having side effects
from ATRIPLA. Fortovase
®
or Invirase
®
(saquinavir) should not be used
as the only protease inhibitor in combination with ATRIPLA.
Taking ATRIPLA with St. John’s wort or products containing St. John’s wort
is not recommended as it may cause decreased levels of ATRIPLA,
increased viral load, and possible resistance to ATRIPLA or
cross-resistance to other anti-HIV drugs.
This list of medicines is not complete. Discuss with your healthcare
provider all prescription and nonprescription medicines, vitamins,
or herbal supplements you are taking or plan to take.
Tell your healthcare provider if you:
• Are pregnant: Women should not become pregnant while taking
ATRIPLA and for 12 weeks after stopping ATRIPLA. Serious birth defects
have been seen in children of women treated during pregnancy with
one of the medicines in ATRIPLA. Women must use a reliable form of
barrier contraception, such as a condom or diaphragm, even if they also
use other methods of birth control, while on ATRIPLA and for 12 weeks
after stopping ATRIPLA.
• Are breastfeeding: Women with HIV should not breastfeed
because they can pass HIV through their milk to the baby. Also,
ATRIPLA may pass through breast milk and cause serious harm
to the baby.
• Have liver problems, including hepatitis B or C virus infection.

• Have ever had seizures: Seizures have occurred in patients taking a
component of ATRIPLA, usually in those with a history of seizures. If you
have ever had seizures, or take medicine for seizures, your healthcare
provider may want to switch you to another medicine or monitor you.
• Have ever had mental illness or use drugs or alcohol.
Contact your healthcare provider right away if you experience any
of the following serious or common side effects:
Serious side effects associated with ATRIPLA:
• Severe depression, strange thoughts, or angry behavior have been
reported by a small number of patients. Some patients have had thoughts
of suicide, and a few have actually committed suicide. These problems
may occur more often in patients who have had mental illness.
• Kidney problems (including decline or failure of kidney function).
If you have had kidney problems, or take other medicines that may
cause kidney problems, your healthcare provider should do regular
blood tests. Symptoms that may be related to kidney problems include
a high volume of urine, thirst, muscle pain, and muscle weakness.
• Other serious liver problems. Some patients have experienced
serious liver problems, including liver failure resulting in transplantation
or death. Most of these serious side effects occurred in patients with a
chronic liver disease such as hepatitis infection, but there have also
been a few reports in patients without any existing liver disease.
• Bone changes. Lab tests show changes in the bones of patients treated
with tenofovir DF, a component of ATRIPLA. Some HIV patients treated
with tenofovir DF developed thinning of the bones (osteopenia), which
could lead to fractures. Also, bone pain and softening of the bone
(which may lead to fractures) may occur as a consequence of kidney
problems. If you have had bone problems in the past, your healthcare
provider may want to check your bones.
Common side effects:
• Dizziness, headache, trouble sleeping, drowsiness, trouble
concentrating, and/or unusual dreams. These side effects tend to
go away after taking ATRIPLA for a few weeks. These symptoms may
be more severe with the use of alcohol and/or mood-altering (street)
drugs. If you are dizzy, have trouble concentrating, and/or are drowsy,
avoid activities that may be dangerous, such as driving or operating
machinery.
• Rash is a common side effect that usually goes away without any
change in treatment, but may be serious in a small number of patients.
• Other common side effects include: tiredness, upset stomach, vomiting,
gas, and diarrhea.
Other possible side effects:
• Changes in body fat have been seen in some people taking anti-HIV-1
medicines. The cause and long-term health effects are not known.
• Skin discoloration (small spots or freckles) may also happen.
• If you notice any symptoms of infection, contact your healthcare
provider right away.
• Additional side effects are inflammation of the pancreas, allergic
reaction (including swelling of the face, lips, tongue, or throat),
shortness of breath, pain, stomach pain, weakness, and indigestion.
You should take ATRIPLA once daily on an empty stomach. Taking
ATRIPLA at bedtime may make some side effects less bothersome.
ATRIPLA is one of several treatment options your doctor may consider.
You are encouraged to report negative side effects
of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
697US09AB07051/TR7171 10/10
ATRIPLA Important Safety Information and Indication
*
Synovate Healthcare Data; US HIV Monitor, Q1 2010.
Patient model. Individual results may vary.
Your doctor may prescribe ATRIPLA alone
or with other HIV medications.
Talk to your doctor to see if ATRIPLA is right for you.
Please see Patient Information on the following pages.

Defined as a viral load of less than 400 copies/mL.

Average increase of 312 cells/mm
3
.
§
In this study, 227 patients took the meds in ATRIPLA.
ATRIPLA is the #1 prescribed HIV regimen.
*
About ATRIPLA:
•Only ATRIPLA combines 3 HIV medications in 1 pill daily.
• Proven to lower viral load to undetectable

in approximately
7 out of 10 patients new to therapy, and also raise T-cell

(CD4+)
count to help control HIV through 3 years of a clinical study.
§
•ATRIPLA does not cure HIV-1 and has not been shown to prevent
passing HIV-1 to others.
Selected Important Safety Information:
Some people who have taken medicine like ATRIPLA have developed
the following: a serious condition of acid buildup in the blood (lactic
acidosis), and serious liver problems (hepatotoxicity). For patients
with both HIV-1 and hepatitis B virus (HBV), hepatitis may suddenly
worsen if ATRIPLA is discontinued.
Please see detailed and additional Important Safety Information,
including the bolded information to the left.
697US09AB07051_9.75x11.5_. 10/15/10 5:13 PM Page 1
8 washingtonblade.com • november 26, 2010
FDA-Approved Patient Labeling
Patient Information
ATRIPLA
®
(uh TRIP luh) Tablets
ALERT: Find out about medicines that should NOT be taken with ATRIPLA.
Please also read the section “MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA.”
Generic name: efavirenz, emtricitabine and tenofovir disoproxil fumarate (eh FAH vih renz, em tri SIT
uh bean and te NOE’ fo veer dye soe PROX il FYOU mar ate)
Read the Patient Information that comes with ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil
fumarate) before you start taking it and each time you get a refill since there may be new
information. This information does not take the place of talking to your healthcare provider about
your medical condition or treatment. You should stay under a healthcare provider’s care when taking
ATRIPLA. Do not change or stop your medicine without first talking with your healthcare
provider. Talk to your healthcare provider or pharmacist if you have any questions about ATRIPLA.
What is the most important information I should know about ATRIPLA?
• Some people who have taken medicine like ATRIPLA (which contains nucleoside
analogs) have developed a serious condition called lactic acidosis (buildup of an acid
in the blood). Lactic acidosis can be a medical emergency and may need to be treated in the
hospital. Call your healthcare provider right away if you get the following signs or
symptoms of lactic acidosis:
• You feel very weak or tired.
• You have unusual (not normal) muscle pain.
• You have trouble breathing.
• You have stomach pain with nausea and vomiting.
• You feel cold, especially in your arms and legs.
• You feel dizzy or lightheaded.
• You have a fast or irregular heartbeat.
• Some people who have taken medicines like ATRIPLA have developed serious liver
problems called hepatotoxicity, with liver enlargement (hepatomegaly) and fat in the liver
(steatosis). Call your healthcare provider right away if you get the following signs or
symptoms of liver problems:
• Your skin or the white part of your eyes turns yellow (jaundice).
• Your urine turns dark.
• Your bowel movements (stools) turn light in color.
• You don’t feel like eating food for several days or longer.
• You feel sick to your stomach (nausea).
• You have lower stomach area (abdominal) pain.
• You may be more likely to get lactic acidosis or liver problems if you are female, very
overweight (obese), or have been taking nucleoside analog-containing medicines, like
ATRIPLA, for a long time.
• If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you
may get a “flare-up” of your hepatitis. A “flare-up” is when the disease suddenly
returns in a worse way than before. Patients with HBV who stop taking ATRIPLA need close
medical follow-up for several months, including medical exams and blood tests to check for
hepatitis that could be getting worse. ATRIPLA is not approved for the treatment of HBV, so
you must discuss your HBV therapy with your healthcare provider.
What is ATRIPLA?
ATRIPLA contains 3 medicines, SUSTIVA
®
(efavirenz), EMTRIVA
®
(emtricitabine) and VIREAD
®
(tenofovir disoproxil fumarate also called tenofovir DF) combined in one pill. EMTRIVA and VIREAD
are HIV-1 (human immunodeficiency virus) nucleoside analog reverse transcriptase inhibitors
(NRTIs) and SUSTIVA is an HIV-1 non-nucleoside analog reverse transcriptase inhibitor (NNRTI).
VIREAD and EMTRIVA are the components of TRUVADA
®
. ATRIPLA can be used alone as a complete
regimen, or in combination with other anti-HIV-1 medicines to treat people with HIV-1 infection.
ATRIPLA is for adults age 18 and over. ATRIPLA has not been studied in children under age 18 or
adults over age 65.
HIV infection destroys CD4
+
T cells, which are important to the immune system. The immune system
helps fight infection. After a large number of T cells are destroyed, acquired immune deficiency
syndrome (AIDS) develops.
ATRIPLA helps block HIV-1 reverse transcriptase, a viral chemical in your body (enzyme) that is
needed for HIV-1 to multiply. ATRIPLA lowers the amount of HIV-1 in the blood (viral load). ATRIPLA
may also help to increase the number of T cells (CD4
+
cells), allowing your immune system to
improve. Lowering the amount of HIV-1 in the blood lowers the chance of death or infections that
happen when your immune system is weak (opportunistic infections).
Does ATRIPLA cure HIV-1 or AIDS?
ATRIPLA does not cure HIV-1 infection or AIDS. The long-term effects of ATRIPLA are not known
at this time. People taking ATRIPLA may still get opportunistic infections or other conditions that
happen with HIV-1 infection. Opportunistic infections are infections that develop because the
immune system is weak. Some of these conditions are pneumonia, herpes virus infections, and
Mycobacterium avium complex (MAC) infection. It is very important that you see your healthcare
provider regularly while taking ATRIPLA.
Does ATRIPLA reduce the risk of passing HIV-1 to others?
ATRIPLA has not been shown to lower your chance of passing HIV-1 to other people through
sexual contact, sharing needles, or being exposed to your blood.
• Do not share needles or other injection equipment.
• Do not share personal items that can have blood or body fluids on them, like
toothbrushes or razor blades.
• Do not have any kind of sex without protection. Always practice safer sex by using a latex
or polyurethane condom or other barrier to reduce the chance of sexual contact with semen,
vaginal secretions, or blood.
Who should not take ATRIPLA?
Together with your healthcare provider, you need to decide whether ATRIPLA is right for you.
Do not take ATRIPLA if you are allergic to ATRIPLA or any of its ingredients. The active ingredients
of ATRIPLA are efavirenz, emtricitabine, and tenofovir DF. See the end of this leaflet for a complete
list of ingredients.
What should I tell my healthcare provider before taking ATRIPLA? Tell your healthcare
provider if you:
• Are pregnant or planning to become pregnant (see “What should I avoid while taking
ATRIPLA?”).
• Are breast-feeding (see “What should I avoid while taking ATRIPLA?”).
• Have kidney problems or are undergoing kidney dialysis treatment.
• Have bone problems.
• Have liver problems, including hepatitis B virus infection. Your healthcare provider may
want to do tests to check your liver while you take ATRIPLA.
• Have ever had mental illness or are using drugs or alcohol.
• Have ever had seizures or are taking medicine for seizures.
What important information should I know about taking other medicines with ATRIPLA?
ATRIPLA may change the effect of other medicines, including the ones for HIV-1, and may
cause serious side effects. Your healthcare provider may change your other medicines or change
their doses. Other medicines, including herbal products, may affect ATRIPLA. For this reason, it is
very important to let all your healthcare providers and pharmacists know what medications, herbal
supplements, or vitamins you are taking.
MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA
• The following medicines may cause serious and life-threatening side effects when taken
with ATRIPLA. You should not take any of these medicines while taking ATRIPLA: Vascor
(bepridil), Propulsid (cisapride), Versed (midazolam), Orap (pimozide), Halcion (triazolam),
ergot medications (for example, Wigraine and Cafergot).
• ATRIPLA also should not be used with Combivir (lamivudine/zidovudine), EMTRIVA, Epivir,
Epivir-HBV (lamivudine), Epzicom (abacavir sulfate/lamivudine), Trizivir (abacavir
sulfate/lamivudine/zidovudine), SUSTIVA, TRUVADA, or VIREAD.
• Vfend (voriconazole) should not be taken with ATRIPLA since it may lose its effect or may
increase the chance of having side effects from ATRIPLA.
• Do not take St. John’s wort (Hypericum perforatum), or products containing St. John’s
wort with ATRIPLA. St. John’s wort is an herbal product sold as a dietary supplement. Talk
with your healthcare provider if you are taking or are planning to take St. John’s wort. Taking
St. John’s wort may decrease ATRIPLA levels and lead to increased viral load and possible
resistance to ATRIPLA or cross-resistance to other anti-HIV-1 drugs.
• ATRIPLA should not be used with HEPSERA
®
(adefovir dipivoxil).
It is also important to tell your healthcare provider if you are taking any of the following:
• Fortovase, Invirase (saquinavir), Biaxin (clarithromycin), Noxafil (posaconazole), or
Sporanox (itraconazole); these medicines may need to be replaced with another
medicine when taken with ATRIPLA.
• Calcium channel blockers such as Cardizem or Tiazac (diltiazem), Covera HS or Isoptin
(verapamil) and others; Crixivan (indinavir), Selzentry (maraviroc); the immunosuppressant
medicines cyclosporine (Gengraf, Neoral, Sandimmune, and others), Prograf (tacrolimus), or
Rapamune (sirolimus); Methadone; Mycobutin (rifabutin); Rifampin; cholesterol-lowering
medicines such as Lipitor (atorvastatin), Pravachol (pravastatin sodium), and Zocor
(simvastatin); or Zoloft (sertraline); these medicines may need to have their dose
changed when taken with ATRIPLA.
• Videx, Videx EC (didanosine); tenofovir DF (a component of ATRIPLA) may increase the
amount of didanosine in your blood, which could result in more side effects. You may need
to be monitored more carefully if you are taking ATRIPLA and didanosine together. Also, the
dose of didanosine may need to be changed.
• Reyataz (atazanavir sulfate) or Kaletra (lopinavir/ritonavir); these medicines may increase the
amount of tenofovir DF (a component of ATRIPLA) in your blood, which could result in more
side effects. Reyataz is not recommended with ATRIPLA. You may need to be monitored
more carefully if you are taking ATRIPLA and Kaletra together. Also, the dose of Kaletra may
need to be changed.
• Medicine for seizures [for example, Dilantin (phenytoin), Tegretol (carbamazepine), or
phenobarbital]; your healthcare provider may want to switch you to another medicine or
check drug levels in your blood from time to time.
These are not all the medicines that may cause problems if you take ATRIPLA. Be sure to tell
your healthcare provider about all medicines that you take.
Keep a complete list of all the prescription and nonprescription medicines as well as any herbal
remedies that you are taking, how much you take, and how often you take them. Make a new list
when medicines or herbal remedies are added or stopped, or if the dose changes. Give copies of
this list to all of your healthcare providers and pharmacists every time you visit your healthcare
provider or fill a prescription. This will give your healthcare provider a complete picture of the
medicines you use. Then he or she can decide the best approach for your situation.
ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate)
How should I take ATRIPLA?
• Take the exact amount of ATRIPLA your healthcare provider prescribes. Never change the
dose on your own. Do not stop this medicine unless your healthcare provider tells you to stop.
• You should take ATRIPLA on an empty stomach.
• Swallow ATRIPLA with water.
• Taking ATRIPLA at bedtime may make some side effects less bothersome.
• Do not miss a dose of ATRIPLA. If you forget to take ATRIPLA, take the missed dose right
away, unless it is almost time for your next dose. Do not double the next dose. Carry on with
your regular dosing schedule. If you need help in planning the best times to take your
medicine, ask your healthcare provider or pharmacist.
• If you believe you took more than the prescribed amount of ATRIPLA, contact your local
poison control center or emergency room right away.
• Tell your healthcare provider if you start any new medicine or change how you take old ones.
Your doses may need adjustment.
• When your ATRIPLA supply starts to run low, get more from your healthcare provider or
pharmacy. This is very important because the amount of virus in your blood may increase if
the medicine is stopped for even a short time. The virus may develop resistance to ATRIPLA
and become harder to treat.
• Your healthcare provider may want to do blood tests to check for certain side effects while
you take ATRIPLA.
What should I avoid while taking ATRIPLA?
• Women should not become pregnant while taking ATRIPLA and for 12 weeks after
stopping it. Serious birth defects have been seen in the babies of animals and women
treated with efavirenz (a component of ATRIPLA) during pregnancy. It is not known whether
efavirenz caused these defects. Tell your healthcare provider right away if you are
pregnant. Also talk with your healthcare provider if you want to become pregnant.
• Women should not rely only on hormone-based birth control, such as pills, injections, or
implants, because ATRIPLA may make these contraceptives ineffective. Women must use a
reliable form of barrier contraception, such as a condom or diaphragm, even if they also use
other methods of birth control. Efavirenz, a component of ATRIPLA, may remain in your blood
for a time after therapy is stopped. Therefore, you should continue to use contraceptive
measures for 12 weeks after you stop taking ATRIPLA.
• Do not breast-feed if you are taking ATRIPLA. The Centers for Disease Control and
Prevention recommend that mothers with HIV not breast-feed because they can pass the HIV
through their milk to the baby. Also, ATRIPLA may pass through breast milk and cause serious
harm to the baby. Talk with your healthcare provider if you are breast-feeding. You should
stop breast-feeding or may need to use a different medicine.
• Taking ATRIPLA with alcohol or other medicines causing similar side effects as ATRIPLA, such
as drowsiness, may increase those side effects.
• Do not take any other medicines, including prescription and nonprescription medicines and
herbal products, without checking with your healthcare provider.
• Avoid doing things that can spread HIV-1 infection since ATRIPLA does not stop you from
passing the HIV-1 infection to others.
What are the possible side effects of ATRIPLA?
ATRIPLA may cause the following serious side effects:
• Lactic acidosis (buildup of an acid in the blood). Lactic acidosis can be a medical emergency
and may need to be treated in the hospital. Call your healthcare provider right away if you
get signs of lactic acidosis. (See “What is the most important information I should know
about ATRIPLA?”)
• Serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly) and fat in
the liver (steatosis). Call your healthcare provider right away if you get any signs of liver
problems. (See “What is the most important information I should know about ATRIPLA?”)
• “Flare-ups” of hepatitis B virus (HBV) infection, in which the disease suddenly returns in
a worse way than before, can occur if you have HBV and you stop taking ATRIPLA. Your
healthcare provider will monitor your condition for several months after stopping ATRIPLA if
you have both HIV-1 and HBV infection and may recommend treatment for your HBV. ATRIPLA
is not approved for the treatment of hepatitis B virus infection. If you have advanced liver
disease and stop treatment with ATRIPLA, the “flare-up” of hepatitis B may cause your liver
function to decline.
• Serious psychiatric problems. A small number of patients may experience severe
depression, strange thoughts, or angry behavior while taking ATRIPLA. Some patients have
thoughts of suicide and a few have actually committed suicide. These problems may occur
more often in patients who have had mental illness. Contact your healthcare provider right
away if you think you are having these psychiatric symptoms, so your healthcare provider
can decide if you should continue to take ATRIPLA.
• Kidney problems (including decline or failure of kidney function). If you have had kidney
problems in the past or take other medicines that can cause kidney problems, your
healthcare provider should do regular blood tests to check your kidneys. Symptoms that may
be related to kidney problems include a high volume of urine, thirst, muscle pain, and muscle
weakness.
• Other serious liver problems. Some patients have experienced serious liver problems
including liver failure resulting in transplantation or death. Most of these serious side effects
occurred in patients with a chronic liver disease such as hepatitis infection, but there have
also been a few reports in patients without any existing liver disease.
• Changes in bone mineral density (thinning bones). Laboratory tests show changes in the
bones of patients treated with tenofovir DF, a component of ATRIPLA. Some HIV patients
treated with tenofovir DF developed thinning of the bones (osteopenia) which could lead to
fractures. If you have had bone problems in the past, your healthcare provider may need to
do tests to check your bone mineral density or may prescribe medicines to help your bone
mineral density. Additionally, bone pain and softening of the bone (which may contribute to
fractures) may occur as a consequence of kidney problems.
Common side effects:
Patients may have dizziness, headache, trouble sleeping, drowsiness, trouble concentrating, and/or
unusual dreams during treatment with ATRIPLA. These side effects may be reduced if you take
ATRIPLA at bedtime on an empty stomach. They also tend to go away after you have taken the
medicine for a few weeks. If you have these common side effects, such as dizziness, it does not
mean that you will also have serious psychiatric problems, such as severe depression, strange
thoughts, or angry behavior. Tell your healthcare provider right away if any of these side effects
continue or if they bother you. It is possible that these symptoms may be more severe if ATRIPLA is
used with alcohol or mood altering (street) drugs.
If you are dizzy, have trouble concentrating, or are drowsy, avoid activities that may be dangerous,
such as driving or operating machinery.
Rash may be common. Rashes usually go away without any change in treatment. In a small number
of patients, rash may be serious. If you develop a rash, call your healthcare provider right away.
Other common side effects include tiredness, upset stomach, vomiting, gas, and diarrhea.
Other possible side effects with ATRIPLA:
• Changes in body fat. Changes in body fat develop in some patients taking anti-HIV-1
medicine. These changes may include an increased amount of fat in the upper back and neck
(“buffalo hump”), in the breasts, and around the trunk. Loss of fat from the legs, arms, and
face may also happen. The cause and long-term health effects of these fat changes are not
known.
• Skin discoloration (small spots or freckles) may also happen with ATRIPLA.
• In some patients with advanced HIV infection (AIDS), signs and symptoms of inflammation
from previous infections may occur soon after anti-HIV treatment is started. It is believed that
these symptoms are due to an improvement in the body’s immune response, enabling the
body to fight infections that may have been present with no obvious symptoms. If you notice
any symptoms of infection, please inform your doctor immediately.
• Additional side effects are inflammation of the pancreas, allergic reaction (including swelling
of the face, lips, tongue, or throat), shortness of breath, pain, stomach pain, weakness and
indigestion.
Tell your healthcare provider or pharmacist if you notice any side effects while taking ATRIPLA.
Contact your healthcare provider before stopping ATRIPLA because of side effects or for any other
reason.
This is not a complete list of side effects possible with ATRIPLA. Ask your healthcare provider or
pharmacist for a more complete list of side effects of ATRIPLA and all the medicines you will take.
How do I store ATRIPLA?
• Keep ATRIPLA and all other medicines out of reach of children.
• Store ATRIPLA at room temperature 77 °F (25 °C).
• Keep ATRIPLA in its original container and keep the container tightly closed.
• Do not keep medicine that is out of date or that you no longer need. If you throw any
medicines away make sure that children will not find them.
General information about ATRIPLA:
Medicines are sometimes prescribed for conditions that are not mentioned in patient information
leaflets. Do not use ATRIPLA for a condition for which it was not prescribed. Do not give ATRIPLA to
other people, even if they have the same symptoms you have. It may harm them.
This leaflet summarizes the most important information about ATRIPLA. If you would like more
information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist
for information about ATRIPLA that is written for health professionals.
Do not use ATRIPLA if the seal over bottle opening is broken or missing.
What are the ingredients of ATRIPLA?
Active Ingredients: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
Inactive Ingredients: croscarmellose sodium, hydroxypropyl cellulose, microcrystalline cellulose,
magnesium stearate, sodium lauryl sulfate. The film coating contains black iron oxide, polyethylene
glycol, polyvinyl alcohol, red iron oxide, talc, and titanium dioxide.
May 2010
ATRIPLA is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, TRUVADA,
HEPSERA and VIREAD are trademarks of Gilead Sciences, Inc. SUSTIVA is a trademark
of Bristol-Myers Squibb Pharma Company. Reyataz and Videx are trademarks of
Bristol-Myers Squibb Company. Pravachol is a trademark of ER Squibb & Sons, LLC. Other
brands listed are the trademarks of their respective owners.
SF-B0001B1-05-10 21-937-GS-007 TR5827 May 2010
ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate) ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate)
Job number: 697US09AB07051 Trim size 9.75" x 10.5 No BLEED Pub:
697US09AB07051_9.75x11.5_. 10/15/10 5:13 PM Page 3
november 26, 2010 • washingtonblade.com 9
FDA-Approved Patient Labeling
Patient Information
ATRIPLA
®
(uh TRIP luh) Tablets
ALERT: Find out about medicines that should NOT be taken with ATRIPLA.
Please also read the section “MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA.”
Generic name: efavirenz, emtricitabine and tenofovir disoproxil fumarate (eh FAH vih renz, em tri SIT
uh bean and te NOE’ fo veer dye soe PROX il FYOU mar ate)
Read the Patient Information that comes with ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil
fumarate) before you start taking it and each time you get a refill since there may be new
information. This information does not take the place of talking to your healthcare provider about
your medical condition or treatment. You should stay under a healthcare provider’s care when taking
ATRIPLA. Do not change or stop your medicine without first talking with your healthcare
provider. Talk to your healthcare provider or pharmacist if you have any questions about ATRIPLA.
What is the most important information I should know about ATRIPLA?
• Some people who have taken medicine like ATRIPLA (which contains nucleoside
analogs) have developed a serious condition called lactic acidosis (buildup of an acid
in the blood). Lactic acidosis can be a medical emergency and may need to be treated in the
hospital. Call your healthcare provider right away if you get the following signs or
symptoms of lactic acidosis:
• You feel very weak or tired.
• You have unusual (not normal) muscle pain.
• You have trouble breathing.
• You have stomach pain with nausea and vomiting.
• You feel cold, especially in your arms and legs.
• You feel dizzy or lightheaded.
• You have a fast or irregular heartbeat.
• Some people who have taken medicines like ATRIPLA have developed serious liver
problems called hepatotoxicity, with liver enlargement (hepatomegaly) and fat in the liver
(steatosis). Call your healthcare provider right away if you get the following signs or
symptoms of liver problems:
• Your skin or the white part of your eyes turns yellow (jaundice).
• Your urine turns dark.
• Your bowel movements (stools) turn light in color.
• You don’t feel like eating food for several days or longer.
• You feel sick to your stomach (nausea).
• You have lower stomach area (abdominal) pain.
• You may be more likely to get lactic acidosis or liver problems if you are female, very
overweight (obese), or have been taking nucleoside analog-containing medicines, like
ATRIPLA, for a long time.
• If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, you
may get a “flare-up” of your hepatitis. A “flare-up” is when the disease suddenly
returns in a worse way than before. Patients with HBV who stop taking ATRIPLA need close
medical follow-up for several months, including medical exams and blood tests to check for
hepatitis that could be getting worse. ATRIPLA is not approved for the treatment of HBV, so
you must discuss your HBV therapy with your healthcare provider.
What is ATRIPLA?
ATRIPLA contains 3 medicines, SUSTIVA
®
(efavirenz), EMTRIVA
®
(emtricitabine) and VIREAD
®
(tenofovir disoproxil fumarate also called tenofovir DF) combined in one pill. EMTRIVA and VIREAD
are HIV-1 (human immunodeficiency virus) nucleoside analog reverse transcriptase inhibitors
(NRTIs) and SUSTIVA is an HIV-1 non-nucleoside analog reverse transcriptase inhibitor (NNRTI).
VIREAD and EMTRIVA are the components of TRUVADA
®
. ATRIPLA can be used alone as a complete
regimen, or in combination with other anti-HIV-1 medicines to treat people with HIV-1 infection.
ATRIPLA is for adults age 18 and over. ATRIPLA has not been studied in children under age 18 or
adults over age 65.
HIV infection destroys CD4
+
T cells, which are important to the immune system. The immune system
helps fight infection. After a large number of T cells are destroyed, acquired immune deficiency
syndrome (AIDS) develops.
ATRIPLA helps block HIV-1 reverse transcriptase, a viral chemical in your body (enzyme) that is
needed for HIV-1 to multiply. ATRIPLA lowers the amount of HIV-1 in the blood (viral load). ATRIPLA
may also help to increase the number of T cells (CD4
+
cells), allowing your immune system to
improve. Lowering the amount of HIV-1 in the blood lowers the chance of death or infections that
happen when your immune system is weak (opportunistic infections).
Does ATRIPLA cure HIV-1 or AIDS?
ATRIPLA does not cure HIV-1 infection or AIDS. The long-term effects of ATRIPLA are not known
at this time. People taking ATRIPLA may still get opportunistic infections or other conditions that
happen with HIV-1 infection. Opportunistic infections are infections that develop because the
immune system is weak. Some of these conditions are pneumonia, herpes virus infections, and
Mycobacterium avium complex (MAC) infection. It is very important that you see your healthcare
provider regularly while taking ATRIPLA.
Does ATRIPLA reduce the risk of passing HIV-1 to others?
ATRIPLA has not been shown to lower your chance of passing HIV-1 to other people through
sexual contact, sharing needles, or being exposed to your blood.
• Do not share needles or other injection equipment.
• Do not share personal items that can have blood or body fluids on them, like
toothbrushes or razor blades.
• Do not have any kind of sex without protection. Always practice safer sex by using a latex
or polyurethane condom or other barrier to reduce the chance of sexual contact with semen,
vaginal secretions, or blood.
Who should not take ATRIPLA?
Together with your healthcare provider, you need to decide whether ATRIPLA is right for you.
Do not take ATRIPLA if you are allergic to ATRIPLA or any of its ingredients. The active ingredients
of ATRIPLA are efavirenz, emtricitabine, and tenofovir DF. See the end of this leaflet for a complete
list of ingredients.
What should I tell my healthcare provider before taking ATRIPLA? Tell your healthcare
provider if you:
• Are pregnant or planning to become pregnant (see “What should I avoid while taking
ATRIPLA?”).
• Are breast-feeding (see “What should I avoid while taking ATRIPLA?”).
• Have kidney problems or are undergoing kidney dialysis treatment.
• Have bone problems.
• Have liver problems, including hepatitis B virus infection. Your healthcare provider may
want to do tests to check your liver while you take ATRIPLA.
• Have ever had mental illness or are using drugs or alcohol.
• Have ever had seizures or are taking medicine for seizures.
What important information should I know about taking other medicines with ATRIPLA?
ATRIPLA may change the effect of other medicines, including the ones for HIV-1, and may
cause serious side effects. Your healthcare provider may change your other medicines or change
their doses. Other medicines, including herbal products, may affect ATRIPLA. For this reason, it is
very important to let all your healthcare providers and pharmacists know what medications, herbal
supplements, or vitamins you are taking.
MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA
• The following medicines may cause serious and life-threatening side effects when taken
with ATRIPLA. You should not take any of these medicines while taking ATRIPLA: Vascor
(bepridil), Propulsid (cisapride), Versed (midazolam), Orap (pimozide), Halcion (triazolam),
ergot medications (for example, Wigraine and Cafergot).
• ATRIPLA also should not be used with Combivir (lamivudine/zidovudine), EMTRIVA, Epivir,
Epivir-HBV (lamivudine), Epzicom (abacavir sulfate/lamivudine), Trizivir (abacavir
sulfate/lamivudine/zidovudine), SUSTIVA, TRUVADA, or VIREAD.
• Vfend (voriconazole) should not be taken with ATRIPLA since it may lose its effect or may
increase the chance of having side effects from ATRIPLA.
• Do not take St. John’s wort (Hypericum perforatum), or products containing St. John’s
wort with ATRIPLA. St. John’s wort is an herbal product sold as a dietary supplement. Talk
with your healthcare provider if you are taking or are planning to take St. John’s wort. Taking
St. John’s wort may decrease ATRIPLA levels and lead to increased viral load and possible
resistance to ATRIPLA or cross-resistance to other anti-HIV-1 drugs.
• ATRIPLA should not be used with HEPSERA
®
(adefovir dipivoxil).
It is also important to tell your healthcare provider if you are taking any of the following:
• Fortovase, Invirase (saquinavir), Biaxin (clarithromycin), Noxafil (posaconazole), or
Sporanox (itraconazole); these medicines may need to be replaced with another
medicine when taken with ATRIPLA.
• Calcium channel blockers such as Cardizem or Tiazac (diltiazem), Covera HS or Isoptin
(verapamil) and others; Crixivan (indinavir), Selzentry (maraviroc); the immunosuppressant
medicines cyclosporine (Gengraf, Neoral, Sandimmune, and others), Prograf (tacrolimus), or
Rapamune (sirolimus); Methadone; Mycobutin (rifabutin); Rifampin; cholesterol-lowering
medicines such as Lipitor (atorvastatin), Pravachol (pravastatin sodium), and Zocor
(simvastatin); or Zoloft (sertraline); these medicines may need to have their dose
changed when taken with ATRIPLA.
• Videx, Videx EC (didanosine); tenofovir DF (a component of ATRIPLA) may increase the
amount of didanosine in your blood, which could result in more side effects. You may need
to be monitored more carefully if you are taking ATRIPLA and didanosine together. Also, the
dose of didanosine may need to be changed.
• Reyataz (atazanavir sulfate) or Kaletra (lopinavir/ritonavir); these medicines may increase the
amount of tenofovir DF (a component of ATRIPLA) in your blood, which could result in more
side effects. Reyataz is not recommended with ATRIPLA. You may need to be monitored
more carefully if you are taking ATRIPLA and Kaletra together. Also, the dose of Kaletra may
need to be changed.
• Medicine for seizures [for example, Dilantin (phenytoin), Tegretol (carbamazepine), or
phenobarbital]; your healthcare provider may want to switch you to another medicine or
check drug levels in your blood from time to time.
These are not all the medicines that may cause problems if you take ATRIPLA. Be sure to tell
your healthcare provider about all medicines that you take.
Keep a complete list of all the prescription and nonprescription medicines as well as any herbal
remedies that you are taking, how much you take, and how often you take them. Make a new list
when medicines or herbal remedies are added or stopped, or if the dose changes. Give copies of
this list to all of your healthcare providers and pharmacists every time you visit your healthcare
provider or fill a prescription. This will give your healthcare provider a complete picture of the
medicines you use. Then he or she can decide the best approach for your situation.
ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate)
How should I take ATRIPLA?
• Take the exact amount of ATRIPLA your healthcare provider prescribes. Never change the
dose on your own. Do not stop this medicine unless your healthcare provider tells you to stop.
• You should take ATRIPLA on an empty stomach.
• Swallow ATRIPLA with water.
• Taking ATRIPLA at bedtime may make some side effects less bothersome.
• Do not miss a dose of ATRIPLA. If you forget to take ATRIPLA, take the missed dose right
away, unless it is almost time for your next dose. Do not double the next dose. Carry on with
your regular dosing schedule. If you need help in planning the best times to take your
medicine, ask your healthcare provider or pharmacist.
• If you believe you took more than the prescribed amount of ATRIPLA, contact your local
poison control center or emergency room right away.
• Tell your healthcare provider if you start any new medicine or change how you take old ones.
Your doses may need adjustment.
• When your ATRIPLA supply starts to run low, get more from your healthcare provider or
pharmacy. This is very important because the amount of virus in your blood may increase if
the medicine is stopped for even a short time. The virus may develop resistance to ATRIPLA
and become harder to treat.
• Your healthcare provider may want to do blood tests to check for certain side effects while
you take ATRIPLA.
What should I avoid while taking ATRIPLA?
• Women should not become pregnant while taking ATRIPLA and for 12 weeks after
stopping it. Serious birth defects have been seen in the babies of animals and women
treated with efavirenz (a component of ATRIPLA) during pregnancy. It is not known whether
efavirenz caused these defects. Tell your healthcare provider right away if you are
pregnant. Also talk with your healthcare provider if you want to become pregnant.
• Women should not rely only on hormone-based birth control, such as pills, injections, or
implants, because ATRIPLA may make these contraceptives ineffective. Women must use a
reliable form of barrier contraception, such as a condom or diaphragm, even if they also use
other methods of birth control. Efavirenz, a component of ATRIPLA, may remain in your blood
for a time after therapy is stopped. Therefore, you should continue to use contraceptive
measures for 12 weeks after you stop taking ATRIPLA.
• Do not breast-feed if you are taking ATRIPLA. The Centers for Disease Control and
Prevention recommend that mothers with HIV not breast-feed because they can pass the HIV
through their milk to the baby. Also, ATRIPLA may pass through breast milk and cause serious
harm to the baby. Talk with your healthcare provider if you are breast-feeding. You should
stop breast-feeding or may need to use a different medicine.
• Taking ATRIPLA with alcohol or other medicines causing similar side effects as ATRIPLA, such
as drowsiness, may increase those side effects.
• Do not take any other medicines, including prescription and nonprescription medicines and
herbal products, without checking with your healthcare provider.
• Avoid doing things that can spread HIV-1 infection since ATRIPLA does not stop you from
passing the HIV-1 infection to others.
What are the possible side effects of ATRIPLA?
ATRIPLA may cause the following serious side effects:
• Lactic acidosis (buildup of an acid in the blood). Lactic acidosis can be a medical emergency
and may need to be treated in the hospital. Call your healthcare provider right away if you
get signs of lactic acidosis. (See “What is the most important information I should know
about ATRIPLA?”)
• Serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly) and fat in
the liver (steatosis). Call your healthcare provider right away if you get any signs of liver
problems. (See “What is the most important information I should know about ATRIPLA?”)
• “Flare-ups” of hepatitis B virus (HBV) infection, in which the disease suddenly returns in
a worse way than before, can occur if you have HBV and you stop taking ATRIPLA. Your
healthcare provider will monitor your condition for several months after stopping ATRIPLA if
you have both HIV-1 and HBV infection and may recommend treatment for your HBV. ATRIPLA
is not approved for the treatment of hepatitis B virus infection. If you have advanced liver
disease and stop treatment with ATRIPLA, the “flare-up” of hepatitis B may cause your liver
function to decline.
• Serious psychiatric problems. A small number of patients may experience severe
depression, strange thoughts, or angry behavior while taking ATRIPLA. Some patients have
thoughts of suicide and a few have actually committed suicide. These problems may occur
more often in patients who have had mental illness. Contact your healthcare provider right
away if you think you are having these psychiatric symptoms, so your healthcare provider
can decide if you should continue to take ATRIPLA.
• Kidney problems (including decline or failure of kidney function). If you have had kidney
problems in the past or take other medicines that can cause kidney problems, your
healthcare provider should do regular blood tests to check your kidneys. Symptoms that may
be related to kidney problems include a high volume of urine, thirst, muscle pain, and muscle
weakness.
• Other serious liver problems. Some patients have experienced serious liver problems
including liver failure resulting in transplantation or death. Most of these serious side effects
occurred in patients with a chronic liver disease such as hepatitis infection, but there have
also been a few reports in patients without any existing liver disease.
• Changes in bone mineral density (thinning bones). Laboratory tests show changes in the
bones of patients treated with tenofovir DF, a component of ATRIPLA. Some HIV patients
treated with tenofovir DF developed thinning of the bones (osteopenia) which could lead to
fractures. If you have had bone problems in the past, your healthcare provider may need to
do tests to check your bone mineral density or may prescribe medicines to help your bone
mineral density. Additionally, bone pain and softening of the bone (which may contribute to
fractures) may occur as a consequence of kidney problems.
Common side effects:
Patients may have dizziness, headache, trouble sleeping, drowsiness, trouble concentrating, and/or
unusual dreams during treatment with ATRIPLA. These side effects may be reduced if you take
ATRIPLA at bedtime on an empty stomach. They also tend to go away after you have taken the
medicine for a few weeks. If you have these common side effects, such as dizziness, it does not
mean that you will also have serious psychiatric problems, such as severe depression, strange
thoughts, or angry behavior. Tell your healthcare provider right away if any of these side effects
continue or if they bother you. It is possible that these symptoms may be more severe if ATRIPLA is
used with alcohol or mood altering (street) drugs.
If you are dizzy, have trouble concentrating, or are drowsy, avoid activities that may be dangerous,
such as driving or operating machinery.
Rash may be common. Rashes usually go away without any change in treatment. In a small number
of patients, rash may be serious. If you develop a rash, call your healthcare provider right away.
Other common side effects include tiredness, upset stomach, vomiting, gas, and diarrhea.
Other possible side effects with ATRIPLA:
• Changes in body fat. Changes in body fat develop in some patients taking anti-HIV-1
medicine. These changes may include an increased amount of fat in the upper back and neck
(“buffalo hump”), in the breasts, and around the trunk. Loss of fat from the legs, arms, and
face may also happen. The cause and long-term health effects of these fat changes are not
known.
• Skin discoloration (small spots or freckles) may also happen with ATRIPLA.
• In some patients with advanced HIV infection (AIDS), signs and symptoms of inflammation
from previous infections may occur soon after anti-HIV treatment is started. It is believed that
these symptoms are due to an improvement in the body’s immune response, enabling the
body to fight infections that may have been present with no obvious symptoms. If you notice
any symptoms of infection, please inform your doctor immediately.
• Additional side effects are inflammation of the pancreas, allergic reaction (including swelling
of the face, lips, tongue, or throat), shortness of breath, pain, stomach pain, weakness and
indigestion.
Tell your healthcare provider or pharmacist if you notice any side effects while taking ATRIPLA.
Contact your healthcare provider before stopping ATRIPLA because of side effects or for any other
reason.
This is not a complete list of side effects possible with ATRIPLA. Ask your healthcare provider or
pharmacist for a more complete list of side effects of ATRIPLA and all the medicines you will take.
How do I store ATRIPLA?
• Keep ATRIPLA and all other medicines out of reach of children.
• Store ATRIPLA at room temperature 77 °F (25 °C).
• Keep ATRIPLA in its original container and keep the container tightly closed.
• Do not keep medicine that is out of date or that you no longer need. If you throw any
medicines away make sure that children will not find them.
General information about ATRIPLA:
Medicines are sometimes prescribed for conditions that are not mentioned in patient information
leaflets. Do not use ATRIPLA for a condition for which it was not prescribed. Do not give ATRIPLA to
other people, even if they have the same symptoms you have. It may harm them.
This leaflet summarizes the most important information about ATRIPLA. If you would like more
information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist
for information about ATRIPLA that is written for health professionals.
Do not use ATRIPLA if the seal over bottle opening is broken or missing.
What are the ingredients of ATRIPLA?
Active Ingredients: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
Inactive Ingredients: croscarmellose sodium, hydroxypropyl cellulose, microcrystalline cellulose,
magnesium stearate, sodium lauryl sulfate. The film coating contains black iron oxide, polyethylene
glycol, polyvinyl alcohol, red iron oxide, talc, and titanium dioxide.
May 2010
ATRIPLA is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. EMTRIVA, TRUVADA,
HEPSERA and VIREAD are trademarks of Gilead Sciences, Inc. SUSTIVA is a trademark
of Bristol-Myers Squibb Pharma Company. Reyataz and Videx are trademarks of
Bristol-Myers Squibb Company. Pravachol is a trademark of ER Squibb & Sons, LLC. Other
brands listed are the trademarks of their respective owners.
SF-B0001B1-05-10 21-937-GS-007 TR5827 May 2010
ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate) ATRIPLA
®
(efavirenz/emtricitabine/tenofovir disoproxil fumarate)
Job number: 697US09AB07051 Trim size 9.75" x 10.5 No BLEED Pub:
697US09AB07051_9.75x11.5_. 10/15/10 5:13 PM Page 3
NATIONALNEWS
10 washingtonblade.com • november 26, 2010
Transgender Houston attorney becomes judge 
HOUSTON — Thirty years ago, Phyllis Frye, a longtime LGBT activist, could
have been arrested for wearing women’s clothing in the Houston City Council
chamber. The Associated Press reported that Frye, a transgender Houston attor-
ney born as Phillip Frye, fought back tears last week as the mayor appointed her
to a municipal bench in the same room where she helped repeal Houston’s “cross-
dressing ordinance” in 1980.
The 63-year-old will hear traffc ticket cases and other low-level misdemeanor
trials, according to the AP report. Municipal judges are not elected. Frye said she
would be the frst transgender judge in Texas.
She knows of at least two transgender judges in other parts of the country.
Frye applied for the position several months ago and was vetted before being ap-
pointed by Mayor Annise Parker, a lesbian, on Wednesday with seven other new
associate judges.
“I don’t want to underplay this, because I understand it is very signifcant,” the
AP quoted Frye as saying. “But I don’t want to overplay it either. I don’t want people
to think I am anything other than an associate municipal court judge.” There was
some quibbling over the appointment from the Houston Area Pastor Council, the
AP reported. One local minister said she represented an “anti-family lifestyle.”
Fort Worth drops charges in gay bar fracas 
FORT WORTH, Texas — More than a year after a controversial bar inspection at
the Rainbow Lounge in Forth Worth, Texas, sent protesters to the streets and vault-
ed the city into the national spotlight, city offcials have dropped charges against
four bar patrons, the Fort Worth Star-Telegram reported.
The dismissals came two-and-a-half weeks before Chad Gibson, who suffered
a head injury in the June 28, 2009, incident, and George Armstrong had been set
to go on trial on public intoxication charges. They had both pleaded not guilty, and
Gibson had also pleaded not guilty to assaulting an agent with the Texas Alcoholic
Beverage Commission, the paper said.
In a statement released last week, city spokesman Jason Lamers confrmed
that the misdemeanor charges against Gibson and Armstrong had been dropped.
Public intoxication cases against Dylan Brown, 24, and Jose Macias, 32, were also
dropped. Within hours of the fracas at the Rainbow Lounge, local and national
protests erupted as patrons accused the offcers of using excessive force and
questioned whether the bar was targeted because of its mostly gay clientele. In-
vestigations by Fort Worth police and the alcohol commission concluded that no
excessive force was used. The commission, however, fred two agents who par-
ticipated and their supervisor, citing policy violations, the Star-Telegram reported.
Daily pill lowers HIV risk in gay men: study
In a major breakthrough in HIV research reported this week in the New England
Journal of Medicine, researchers have discovered that taking a daily retroviral pill
dramatically reduced chances of infection.
The study of 2,500 gay men in six countries found that of those who took the pill
every day, the medicine was 90 percent effective in preventing infection.
The study, known as iPrEx, was conducted by Gladstone Institutes and the Uni-
versity of California, San Francisco.
The antiretroviral pill, Truvada, is already widely available by prescription. The
fnding was praised because it puts the responsibility for prevention in the hands
of individuals, and not their sex partners who may not want to use condoms. It’s
also good news for those who lose their inhibitions while drunk or using drugs and
may fail to use a condom.
It’s a form of protection “that does not involve getting permission from the other
partner, and that’s important,” Phill Wilson, president of the Black AIDS Institute,
Trans activist Phyllis Frye has practiced criminal defense law in Houston since 1986. She now heads
a six-lawyer frm and has parlayed her expertise in LGBT legal issues into a storied legal career.
Photo courtesy of Outsmart Magazine
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: BRIAN PITTS (bpitts@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-05-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
ATTORNEY AT LAW
PERSONAL INJURY • PROBATE
WILLS/ POA’s • CIVIL LITIGATION
CONSERVATORSHIPS • GUARDIANSHIPS
2141 P STREET NW SUITE 103
WASHINGTON DC 20037
E-MAIL steveweinbergdc@aol.com
LICENSED IN DC, MD AND VA
SERVING OUR COMMUNITY FOR 30 YEARS
Steve Weinberg
202-861-0077
NATIONALNEWS
november 26, 2010 • washingtonblade.com 11
N.J. approves sweeping anti-bullying bill
TRENTON, N.J. — The state legislature voted by overwhelming majorities this
week to approve a sweeping anti-bullying bill that could become a model for simi-
lar measures across the country, according to media reports and statements from
Garden State Equality.
“As someone brutally bullied in my own youth, I can’t even begin to describe
how the passage of this bill is a moment of deeply poignant, personal healing
for me and thousands of others who have been bullied,” said Steven Goldstein,
chair of Garden State Equality. “The best revenge is to make the world a kinder
place. This legislation will make our state a kinder, safer place for students for
generations to come.”
The Anti-Bullying Bill of Rights applies to schools from kindergarten through
12th grade, strengthens an existing cyber bullying law, applies to bullying off
school grounds that carries into schools, and has a section that applies to the
state’s public universities, according to Garden State Equality.
It is the frst such bill to set deadlines for incidents of bullying to be reported,
investigated and resolved. Teachers and other school personnel will have to report
incidents of bullying to principals on the same day as a bullying incident. An in-
vestigation of the bullying must begin within one school day. A school will have to
complete its investigation of bullying within 10 school days, after which there must
be a resolution of the situation, the statewide LGBT rights group announced.
The bill passed the Senate 30-0 and the Assembly 72-1.
Philly’s settlement with Scouts
draws ire of gay leaders 
PHILADELPHIA — Prominent gay leaders in Philadelphia are voicing criticism
of a proposed legal settlement between the city and the regional Boy Scouts or-
ganization, and a key City Councilman is balking at the deal, the Philadelphia Gay
News reported.
The proposal calls for the Boy Scouts group to pay the city $500,000 to buy its
13,000-square-foot headquarters in Logan Square, the focus of a civil-rights dis-
pute that began over the Scouts’ national ban on gay members. The price tag is
less than half the appraised value of the building. But the settlement would end an
expensive legal fght and the risk that city taxpayers would eventually have to pay
the Scouts’ legal bills, now approaching $1 million.
Gay rights advocates say the city’s lawyers are putting fnancial concerns
ahead of principle, appearing to subsidize the Scouts’ discrimination, Philadelphia
Gay News reported. City Solicitor Shelley Smith and the Scouts’ attorney, Sandra
Girifalco, had issued a joint statement last week describing their agreement as
a “win-win situation” for both their clients, predicting that a necessary ordinance
would be introduced the next day in City Council. But Councilman Darrell Clarke,
whose district includes the property, said he wasn’t ready to introduce anything.
The settlement statement had been “premature,” he said, because there hadn’t
been enough communication with neighborhood residents or the gay community.
The dispute began with a 5-4 U.S. Supreme Court decision in 2000 that upheld
the legality of the national organization’s ban on gay Scouts and troop leaders. That
put the Scouts organization in confict with the city charter’s ban on discrimination
rooted in sexual orientation.
Former GLAAD official to
head S.F. AIDS Foundation 
SAN FRANCISCO — The San Francisco AIDS Foundation has appointed Neil
Giuliano as its new chief executive. He’ll start Dec. 13.
Giuliano was previously head of the Gay & Lesbian Alliance Against Defama-
tion (GLAAD) and produced its annual awards programs. He was also the mayor
of Tempe, Ariz., for 10 years beginning in 1994. He plans to publish a memoir next
year. The Foundation works to end HIV.
Though LGBT activists were already at work on anti-bullying legislation in New Jersey, the Septem-
ber suicide of Tyler Clementi, which drew national media attention, helped expedite its passage.
Washington Blade fle photo
NATIONALNEWS
12 washingtonblade.com • november 26, 2010
‘Enough, enough!’ after
bishops denounce
same-sex marriage
By LOU CHIBBARO JR.
lchibbaro@washblade.com
An organization of American Catholic
nuns has denounced the U.S. Confer-
ence of Catholic Bishops for reiterating
its opposition to legalizing same-sex
marriage at its annual meeting in Balti-
more last week while remaining silent on
anti-gay bullying and gay teen suicide.
In a statement released Tuesday, the
National Coalition of American Nuns ac-
cused the bishops of acting like “blinded
Pharisees” for waging a fight against
marriage equality while failing to speak
out on gay teen suicides brought about
by school bullying and harassment.
“More than a month has gone by since
the media broke the news about a series
of gay suicides,” the nuns’ statement says.
“During that time, the U.S. Catholic Bish-
ops failed to make a single statement re-
garding these tragic, preventable deaths.”
The statement adds, “Not one bishop’s
voice was raised to condemn a culture
where youths are bullied for being who
God created them to be and are some-
times pushed by society’s judgments to
attempt suicide.”
The Conference of Catholic Bishops,
which represents Roman Catholic bish-
ops in the U.S., held its annual fall General
Assembly meeting last week in Baltimore.
Don Clemmer, a spokesperson for the
U.S. Conference of Catholic Bishops,
said Archbishop Joseph Kurtz of Louis-
ville, Ky., the newly elected vice presi-
dent of the bishops’ conference, gave a
presentation on the marriage issue be-
fore the conference’s Ad Hoc Committee
on Defense of Marriage.
He said Cardinal Frances George of
Chicago, the outgoing president of the
conference, announced to the gathering
that the ad hoc committee was being el-
evated to an official subcommittee of the
Conference of Bishops.
Clemmer said he was not aware of
any discussion or agenda items at the
Baltimore meeting addressing gay teen
suicide or anti-gay harassment or bul-
lying. He said the final two days of the
meeting were closed to the public and
it was possible that items not posted on
the public agenda could be discussed.
“The National Coalition of Catholic
Nuns calls on all U.S. Catholics to rise
up and say, ‘Enough, enough!” says the
nuns’ statement. “No more discrimina-
tory rhetoric and repressive measures
from men who lay heavy burdens on the
shoulders of others and do not lift one
finger of human kindness and compas-
sion,” it says “We all need to work for a
holy and just society and church.”
Sister Jeannine Gramick, a longtime
supporter of LGBT rights from the D.C.-
Baltimore area, is a board member and
executive coordinator of the National Co-
alition of American Nuns.
In a separate statement, the LGBT-
supportive group Catholics for Equality
expressed concern that the U.S. Confer-
ence of Catholic Bishops broke a long-
standing tradition this week by not elect-
ing its current vice president, Bishop
Gerald Kicanas of Tucson, Ariz., as the
new president.
Kicanas, who Catholics for Equality
describes as a “social justice champion,”
was bypassed for the president’s position
when the Conference of Bishops elected
instead Archbishop Timothy Dolan of New
York, an outspoken opponent of same-
sex marriage equality and LGBT rights,
according to Catholics for Equality.
The group noted that the bishops’ con-
ference elected Archbishop Kurtz, the head
of the Ad Hoc Committee for the Defense of
Marriage, as its new vice president.
“Archbishop Kurtz … has led the Catho-
lic hierarchy’s national campaign to deny
marriage and family rights to gay and les-
bian citizens,” Catholics for Equality said in
a statement released Wednesday.
“That campaign has been financially as-
sisted by the national office of the Knights
of Columbus, most recently through the
production of videos that demean and
discredit gay and lesbian relationships, as
well as single parent and extended family
households,” the statement says.
“In his report from the Ad Hoc Commit-
tee for the Defense of Marriage, Archbishop
Kurtz makes it clear that our bishops are
waging a new political campaign to change
the laws in our country,” said Ariello Alioto, a
Catholics for Equality board member.
Sister Jeannine Gramick, a longtime sup-
porter of LGBT rights from the D.C.-Balti-
more area, is a board member of the Na-
tional Coalition of American Nuns, which
condemned anti-gay bullying last week.
Photo courtesy of Gramick
Nuns call on Catholics to
rise up against bullying
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: CR4 ISSUE DATE: 100910 SALES REP: JP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 101008 SALES REPRESENTATIVE: Jeryl Parade (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
KidsPeace takes extra care in placing the right kids into the right homes. We will provide
you with special training and professional, round-the-clock support. You don’t need to be
wealthy or married. You don’t need to have kids of your own or a Ph.D. in child psychology.
What you do need is a desire to provide a safe, nurturing environment to a child.
Call us today between 8:30 a.m. and 4:30 p.m. M–F at 866-4-KIDSPEACE (866-454-3773)
or visit kidspeace.org.
KidsPeace is seeking foster parents for children who have
self identifed as gay, lesbian, transgender, or questioning.
NATIONALNEWS
november 26, 2010 • washingtonblade.com 13
Repeal hearings likely to
begin early next month
By CHRIS JOHNSON
cjohnson@washblade.com
The Pentagon has announced its
study on “Don’t Ask, Don’t Tell” will be
complete a day earlier than previously
scheduled following requests from U.S.
senators and LGBT advocates to make
the report available as soon as possible.
In a statement, Geoff Morrell, a Pen-
tagon spokesperson, said Defense
Secretary Robert Gates is “pushing all
involved” with the Pentagon “Don’t Ask,
Don’t Tell” working group to have the
study ready for the public by Nov. 30.
“Frankly, December 1st was already
an aggressive deadline by which to com-
plete the report, incorporate the views of
service secretaries and chiefs and for the
Secretary to make a recommendation on
the way ahead, but he has further com-
pressed the timeline in order to support
Congress’ wish to consider repeal before
they adjourn,” Morrell added.
Morrell said Gates has instructed his
staff to make the report available a day
sooner “without cutting any corners” be-
cause the secretary wants members of the
Senate Armed Services Committee to be
able to “read and consider the complex,
lengthy report before holding hearings with
its authors and the Joint Chiefs of Staff.”
A measure to repeal “Don’t Ask, Don’t
Tell” is currently pending before the U.S.
Senate as part of the fscal year 2011 de-
fense authorization bill. LGBT advocates
are urging Congress to pass the legisla-
tion during the lame duck session before
adjourning for the year.
Last week, Sens. Joseph Lieberman
(I-Conn.) and Susan Collins (R-Maine)
sent the Pentagon a letter asking off-
cials to make the report available prior to
the Dec. 1 deadline. The Human Rights
Campaign had also issued a statement
calling on the Defense Department to
make the report available “as soon as
possible,” arguing that its release could
prompt more senators to support “Don’t
Ask, Don’t Tell” repeal.
In a joint statement, Lieberman and
Collins thanked Gates for expediting the
release of the report “so that Congress
will have as much time as possible to
review the fndings and proceed with re-
peal this year.”
“Secretary Gates’ decision to release
the report early as we requested and Sec-
retary Gates’ leadership calling for repeal
are two more reasons why we think Con-
gress can and should repeal this discrimi-
natory policy now,” the senators said.
Collins was among the senators who
voted with the GOP to block consider-
ation of the defense authorization bill
when a previous attempt was made
to bring the legislation to the Senate foor
in September. She said she wanted a
more open amendment process as part
of consideration of the legislation.
During a congressional hearing last
week, Senate Armed Services Commit-
tee Chair Carl Levin (D-Mich.) also asked
Army Gen. Carter Ham, a co-chair of the
Pentagon working group, to make the
study available as soon as possible.
In a statement, Levin also said he’s
“pleased” Gates has made the decision
to release the report on an expedited ba-
sis and said he plans to make fnal plans
soon for hearings on the study.
“I believe our hearings on the report
will be a boost to the goal of passing a
National Defense Authorization Act, in-
cluding provisions related to repeal of
“Don’t Ask, Don’t Tell,” Levin said.
Alex Nicholson, executive director of
Servicemembers United, said the ear-
lier release of the report is benefcial be-
cause “time is going to be in very short
supply” after lawmakers return from
Thanksgiving recess.
Nicholson said he had been “beg-
ging” Senate Majority Leader Harry Reid
(D-Nev.) to start the process for consid-
eration of the defense authorization bill
prior to Thanksgiving break to allow more
time for consideration of the legislation.
Lawmakers have now gone on break and
aren’t set to return until Nov. 29.
“The report coming out on November
30th might make the difference between
being able to hold hearings the frst
week of December versus the second
week, which may be too late,” Nicholson
added. “Hopefully Sen. Levin will now
schedule a hearing for December 1st or
December 2nd so that the process con-
sidering the full bill can get under way.”
The Pentagon announced this week that De-
fense Secretary Robert Gates is pushing for
an early release of the working group study
on ‘Don’t Ask, Don’t Tell’ repeal.
Washington Blade fle photo by Michael Key
Pentagon to release ‘Don’t
Ask’ report a day early
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 1 ISSUE DATE: 100514 SALES REP: BP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source
a clean house
a clean mind
satisfaction guaranteed
services provided in DC, VA and MD
commercial and residential
licensed, bonded, insured
free estimates
703.892.8648
www.acleaningserviceinc.com
a

c
l
e
a
n
i
n
g


s
e
r
v
i
c
e
,


i
n
c
.
a

c
l
e
a
n
i
n
g


s
e
r
v
i
c
e
,


i
n
c
.
Proof
Proof # CR Issue Date 071019 Sales Repbp
Please check your ad copy for accuracy. The ad will be
presumed correct if proof corrections are not submitted by
24 hrs. of receipt of this copy of your ad.
Signature:
washington
Blade
Logo correct?
Are phone number & address correct?
Are prices accurate?
Corrections?
OK as is
NATIONALNEWS
14 washingtonblade.com • november 26, 2010
Gibbs says unanimous
agreement not needed to
advance repeal
By CHRIS JOHNSON
cjohnson@washblade.com
White House Press Secretary Rob-
ert Gibbs on Monday said he’s unsure
whether the results of the Pentagon
study on “Don’t Ask, Don’t Tell” will move
the four service chiefs to support an end
to the law and he suggested that unani-
mous support among the military leaders
isn’t necessary to move forward.
Asked by the Washington Blade wheth-
er President Obama anticipates that the
service chiefs will favor repeal following
completion of the Pentagon report, Gibbs
said he doesn’t “want to presume” where
they would stand after the study is fnished,
noting the president hasn’t yet seen it.
“I think the service chiefs as I under-
stand it are meeting with the chairman of
the Joint Chiefs and the secretary as we
get closer to this report coming out in order
to discuss where they are based on that
survey,” Gibbs said. “The president has
not yet seen that survey, so I don’t want to
presume whether based on those results
that would change their opinions on it.”
Pressed to clarify whether the intent of
the year-long study was to bring the mili-
tary leaders such as the service chiefs
on board with repeal, Gibbs hinted that
“whether you have unanimous agree-
ment or not” among the military leaders
isn’t necessary to move forward.
“The president has known where peo-
ple have stood on this policy for as long
as he’s supported changing that policy,”
Gibbs said. “So, I think it will be impor-
tant to again view the attitudes and to use
those attitudes to craft a pathway to im-
plementing a changed legislative policy.”
Gibbs also implied that the president
hasn’t recently spoken to the service
chiefs about getting them to support
repeal during the lame duck session of
Congress as he noted Obama had previ-
ously spoken to them on the issue.
“I know the president has spoken
previously with the service chiefs on this
subject and expect that as this report is f-
nalized and released that he’ll have an op-
portunity to speak directly with the chair,
the vice-chair and the service chiefs as
the process moves forward,” Gibbs said.
Obama has said — notably in January
during the State of the Union address —
that part of his effort at repealing “Don’t
Ask, Don’t Tell” is working with the mili-
tary to make it happen. The Pentagon
working group, established by Defense
Secretary Robert Gates in February, was
seen as part of this process.
The service chiefs have heretofore
opposed the legislative effort to repeal
“Don’t Ask, Don’t Tell.” In May, the ser-
vice chiefs of the Navy, Army, Air Force
and Marine Corps sent a joint letter to
Congress urging lawmakers to wait for
the Pentagon report — now set for re-
lease on Nov. 30 — before taking action.
But in an interview last week with the
National Journal, Navy Chief of Staff. Adm.
Gary Roughead reportedly praised the
Pentagon report — and the surveys sent
to 400,000 service members that were a
component of that study — and said he’s
“just trying to put it all in context.”
“I think the survey, without question,
was the most expansive survey of the
American military that’s ever been under-
taken,” Roughead was quoted as saying.
“I think the work that has been done is
extraordinary.”
The Navy chief reportedly added that
he’s “eager to see” where repeal “goes
on the Hill.”
The last public statements of the Army
and Air Force chiefs have them on the
record as wanting Congress to hold off
before pursuing legislative action. New
Marine Corps Commandant Gen. James
Amos has spoken out against repeal.
A number of U.S. senators have said
they’re awaiting testimony from military
service chiefs before making a decision
on “Don’t Ask, Don’t Tell.” In his defense
of the law, Sen. John McCain (R-Ariz.)
has emphasized that the service chiefs
— in particular Amos — have asked
Congress to hold off on legislative action.
A spokesperson for Sen. John Ensign (R-
Nev.) recently said the senator is await-
ing testimony from the service chiefs be-
fore making a decision on the issue.
Will Pentagon study shift
military views of gay ban?
Continues on page 20
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 1 ISSUE DATE: 100514 SALES REP: JP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source



P060347 1/08
D
got your back with the right coverage
a car insurance. Call me today.




SAVE MONEY ON CAR INSURANCE,
NOT ON A HAIRCUT.
Your State Farm® agent’s got your back
with the right coverage, and discounts up to 40%
on car insurance. Call today.
P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0

P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0

P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0
P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0

P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0

P
R
O
U
D
L
Y

S
E
R
V
I
N
G

O
U
R

C
O
M
M
U
N
I
T
Y

S
I
N
C
E

1
9
9
0
Jonna S. Wooten, Agent
8148 Electric Avenue
Vienna, VA 22182
703-560-7804
jonna.wooten.loy3@statefarm.com
Like a Good Neighbor, state farm is there.
®
statefarm.com
®
Affordable
Health Insurance
Plans for individuals, families,
small businesses and the self-employed
• Replace Expensive COBRA Insurance
• Choose your own doctors/hospitals
• Doctor Office Co-Pay Available
• Prescriptions, Disability, Life
• Preventive care benefits
• Fast, fair claims & great service
William J. McNamara
202.333.8325
Since 1993
We offer 25+ plans. We will help you
choose the plan that works best for you.
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 2 ISSUE DATE: 100212 SALES REP: AH
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
dcagenda
the lgbtq community’s news source
Call for
a FREE
Quote!
Aiken and Louis Van Amstel, host of the
show “Dancing with the Stars,” joined parents
Sirdeaner Walker of Massachusetts and Tam-
my Aaberg of Minnesota in making an impas-
sioned plea for lawmakers to pass the two bills.
Sirdeaner and Aaberg’s sons took their own
lives earlier this year due to anti-gay bullying.
“Over the past few months I have
heard so many stories about other youth
who were suffering,” said Walker, who
lost her 11-year-old son Carl Joseph
Walker, who hanged himself in his bed-
room with an electrical cord.
“Too many of our children are being
tormented in schools – and not enough
of our adults are doing the right thing
and teaching respect for all. Enough is
enough,” she said.
Sen. Bob Casey (D-Pa.) and Rep. Lin-
da Sanchez (D-Calif.), who introduced
the Safe Schools Improvement Act, and
Sen. Al Franken (D-Minn.) and Rep.
Jared Polis (D-Colo.), who introduced
the Student Non-Discrimination Act, also
spoke at the briefng, calling on their col-
leagues to support the legislation.
“No student should have to dread go-
ing to school because they fear being bul-
lied,” Franken told those gathered for the
event, held in a committee hearing room
at the Rayburn House Offce Building.
“We must address bullying and harass-
ment in schools in the next Congress.”
Polis, who is gay, said school bullying
affects students living in both Republi-
can and Democratic leaning states, say-
ing he would work with his colleagues on
both sides of the political isle to push for
passage of the legislation.
“Every student has the right to an edu-
cation free from bullying, harassment and
violence, and we are here today to show
that Congress is ready to take a stand
against bullying in our schools,” he said.
Franken and Casey cited recent cas-
es of suicides due to anti-gay bullying in
their home states. They pointed to what
they called a courageous decision by
Walker and Aaberg to speak at Thurs-
day’s briefng to tell the stories of the loss
of their own teenage sons as a means of
drawing support for the legislation.
“Recent stories of the tragic effects
of bullying in Pennsylvania and through-
out the country are evidence of the ur-
gent need to address this issue in our
schools,” Casey said. “We owe it to our
children to do whatever we can to ensure
their pleas for help do not go unheard.”
Casey introduced to the briefng Joey
Kemmerling, a high school student in
Bucks County, Pa., near Philadelphia,
who helped form an anti-bullying group
as well as a Gay-Straight Alliance organi-
zation at his school.
“I came out in eighth grade and ever
since then I have been bullied every day,”
Kemmerling told the briefng. “There’s
not been a day that has gone by where I
have not heard the word faggot, queer or
fairy or told that I was not human.”
He described an incident when an-
other male student threatened him with a
knife on the school grounds after school
offcials declined Kemmerling’s plea that
they search the student for a weapon.
“He came up to me and he looked
me in the eyes and he had the look of
hatred,” Kammerling recounted. “I didn’t
know who he was but I knew that he hat-
ed me. And he said, ‘Your life is in my
hands.’ And he walked away.”
The incident caused him to become
deeply depressed and to contemplate
suicide, Kammerling said.
“I thought I didn’t deserve to live. I was
gay so did my life really matter? I didn’t
think so,” he said.
“I almost committed suicide, and
somehow I overcame that and started
working to change the schools,” he said.
“I was so thankful to meet GLSEN and
work with them to fght all injustices all
around the United States.
“I really just hope you’ll join me in that fght
because the real change is going to come
from society and the change is going to come
from the people stepping up and saying, ‘I
don’t want to see another kid ever go through
what I went through and what the students
went through that committed suicide.’”
His remarks drew a loud and pro-
longed applause from the audience,
which included staff members of sena-
tors and members of the House.
GLSEN Executive Director Eliza Byard
said she was hopeful that Congress
would act on the two bills next year
despite reports by Capitol Hill observ-
ers that the new Republican controlled
House of Representatives would block
all LGBT-supportive legislation.
“They currently have bipartisan sup-
port in this Congress,” Byard said. “And
I think just as children’s safety, it’s not a
gay or straight issue, it is not a Republi-
can or Democratic issue.”
The Safe Schools Improvement Act re-
quires schools receiving federal funds to
develop policies to prohibit bullying based
on race, sex, national origin, religion, sexual
orientation and gender identity and expres-
sion. It has 130 co-sponsors in the House
and 15 co-sponsors in the Senate.
The Student Non-Discrimination Act
calls for providing protections to stu-
dents who are targeted for bullying, ha-
rassment and discrimination based on
their “actual or perceived” sexual orien-
tation or gender identity. It currently has
127 co-sponsors in the House and 30 co-
sponsors in the Senate.
Franken said he has proposed that
the Student Non-Discrimination Act be
incorporated as an amendment to legis-
lation reauthorizing the longstanding and
highly popular Elementary and Second-
ary Education Act, which Congress is
scheduled to vote on next year.
NATIONALNEWS
Continued from page 1
Students, parents ask
Congress to act
november 26, 2010 • washingtonblade.com 15
16 washingtonblade.com • november 26, 2010
Fight HI V your way.
687US10AB06411_AdSpread Trim Size: 9.75" x 11.5" 280 D-Max Pub:
W
e
d
n
e
s
d
a
y
M
a
r
y
’s

b
i
r
t
h
d
a
y


p
a
r
t
y
T
h
u
r
sd
a
y
5
:3
0

C
h
o
ir

p
r
a
c
t
ic
e
B
uy
ne
w
sh
oe
s
for
L
atish
a
Please see Important Patient Information
about REYATAZ on the adjacent pages.
On REYATAZ, how you spen d your time is up to you.
INDICATION: REYATAZ is a prescription medicine used in combination with other medicines
to treat people who are infected with the human immunodeficiency virus (HIV). REYATAZ has
been studied in a 48-week trial in patients who have taken anti-HIV medicines and a 96-week
trial in patients who have never taken anti-HIV medicines.
REYATAZ does not cure HIV or lower your chance of passing HIV to others.
IMPORTANT SAFETY INFORMATION:
Do not take REYATAZ if you are taking the following medicines due to potential for
serious, life-threatening side effects or death: Versed
®
(midazolam) when taken by mouth,
Halcion
®
(triazolam), ergot medicines (dihydroergotamine, ergonovine, ergotamine, and
methylergonovine such as Cafergot
®
, Migranal
®
, D.H.E. 45
®
, ergotrate maleate, Methergine
®
,
and others), Propulsid
®
(cisapride), or Orap
®
(pimozide).
Do not take REYATAZ with the following medicines due to potential for serious
side effects: Camptosar
®
(irinotecan), Crixivan
®
(indinavir), Mevacor
®
(lovastatin),
Zocor
®
(simvastatin), Uroxatral
®
(alfuzosin), or Revatio
®
(sildenafil).
Do not take REYATAZ with the following medicines as they may lower the amount of
REYATAZ in your blood, which may lead to increased HIV viral load and resistance to
REYATAZ or other anti-HIV medicines: rifampin (also known as Rimactane
®
, Rifadin
®
,
Rifater
®
, or Rifamate
®
), St. John’s wort (Hypericum perforatum)-containing products, or
Viramune
®
(nevirapine).
Serevent Diskus
®
(salmeterol) and Advair
®
(salmeterol with fluticasone) are not recommended
with REYATAZ.
Do not take Vfend
®
(voriconazole) if you are taking REYATAZ and Norvir
®
(ritonavir).
The above lists of medicines are not complete. Taking REYATAZ with some other medicines
may require your therapy to be monitored more closely or may require a change in dose
or dose schedule of REYATAZ or the other medicine. Discuss with your healthcare provider all
prescription and non-prescription medicines, vitamin and herbal supplements, or other health
preparations you are taking or plan to take.
Tell your healthcare provider if you are pregnant, breast-feeding, planning to become
pregnant or breast-feed, or if you have end-stage kidney disease managed with hemodialysis
or severe liver dysfunction.
Tell your healthcare provider right away if you have any side effects, symptoms, or conditions,
including the following:
• Mild rash (redness and itching) without other symptoms sometimes occurs in patients taking
REYATAZ, most often in the first few weeks after the medicine is started, and usually goes away
within 2 weeks with no change in treatment.
• Severe rash has occurred in a small number of patients taking REYATAZ. This type of rash is
associated with other symptoms that could be serious and potentially cause death. If you
develop a rash with any of the following symptoms, stop using REYATAZ and call
your healthcare provider right away:
• Yellowing of the skin and/or eyes may occur due to increases in bilirubin levels
in the blood (bilirubin is made by the liver).
• A change in the way your heart beats may occur. You may feel
dizzy or lightheaded. These could be symptoms of a heart problem.
• Diabetes and high blood sugar may occur in patients taking
protease inhibitor medicines like REYATAZ. Some patients
may need changes in their diabetes medicine.
• If you have liver disease, including hepatitis B or C, it may
get worse when you take anti-HIV medicines like REYATAZ.
• Kidney stones have been reported in patients taking REYATAZ.
Signs or symptoms of kidney stones include pain in your side,
blood in your urine, and pain when you urinate.
• Some patients with hemophilia have increased bleeding problems
with protease inhibitor medicines like REYATAZ.
• Changes in body fat have been seen in some patients taking anti-HIV medicines.
The cause and long-term effects are not known at this time.
• Gallbladder disorders (including gallstones and gallbladder inflammation) have been
reported in patients taking REYATAZ.
Other common side effects of REYATAZ taken with other anti-HIV medicines include: nausea;
headache; stomach pain; vomiting; diarrhea; depression; fever; dizziness; trouble sleeping;
numbness, tingling, or burning of hands or feet; and muscle pain.
You should take REYATAZ once daily with food (a meal or snack). Swallow the capsules whole; do
not open the capsules. You should take REYATAZ and your other anti-HIV medicines exactly as
instructed by your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
– Shortness of breath
– General ill-feeling or “flu-like”
symptoms
– Fever
– Muscle or joint aches
– Conjunctivitis (red or inflamed eyes,
like “pink-eye”)
– Blisters
– Mouth sores
– Swelling of your face
REYATAZ is one of several treatment options your doctor may consider.
Individual results may vary.
Find out if you can save on REYATAZ.
Call 1-888-281-8981 or visit
ReyatazSavings.com for details.
Subject to terms and conditions. Restrictions apply.
Once-daily REYATAZ can help fight your HIV.
REYATAZ, a protease inhibitor (PI), in HIV combination therapy:
N Can help lower your viral load and raise your T-cell (CD4+ cell) count
N Has a low chance of diarrhea (shown in clinical trials)
- REYATAZ in combination therapy had a 1%-3% rate of moderate-to-severe diarrhea in adults
N Is taken once a day with a snack or meal
Do not take REYATAZ if you are allergic to REYATAZ or to any of its ingredients.
Ask your healthcare team about REYATAZ www.REYATAZ.com
REYATAZ does not cure HIV and has not been shown to reduce the risk of passing HIV to others.
REYATAZ is a registered trademark of Bristol-Myers Squibb.
All other trademarks are the property of their respective owners
and not of Bristol-Myers Squibb.
©2010 Bristol-Myers Squibb, Princeton, NJ 08543 U.S.A.
687US10AB06411 06/10
687US10AB06411_AdSpd_9.75x11.5 11/19/10 6:49 PM Page 1
november 26, 2010 • washingtonblade.com 17
Fight HI V your way.
687US10AB06411_AdSpread Trim Size: 9.75" x 11.5" 280 D-Max Pub:
W
e
d
n
e
s
d
a
y
M
a
r
y
’s

b
i
r
t
h
d
a
y


p
a
r
t
y
T
h
u
r
sd
a
y
5
:3
0

C
h
o
ir

p
r
a
c
t
ic
e
B
uy
ne
w
sh
oe
s
for
L
atish
a
Please see Important Patient Information
about REYATAZ on the adjacent pages.
On REYATAZ, how you spen d your time is up to you.
INDICATION: REYATAZ is a prescription medicine used in combination with other medicines
to treat people who are infected with the human immunodeficiency virus (HIV). REYATAZ has
been studied in a 48-week trial in patients who have taken anti-HIV medicines and a 96-week
trial in patients who have never taken anti-HIV medicines.
REYATAZ does not cure HIV or lower your chance of passing HIV to others.
IMPORTANT SAFETY INFORMATION:
Do not take REYATAZ if you are taking the following medicines due to potential for
serious, life-threatening side effects or death: Versed
®
(midazolam) when taken by mouth,
Halcion
®
(triazolam), ergot medicines (dihydroergotamine, ergonovine, ergotamine, and
methylergonovine such as Cafergot
®
, Migranal
®
, D.H.E. 45
®
, ergotrate maleate, Methergine
®
,
and others), Propulsid
®
(cisapride), or Orap
®
(pimozide).
Do not take REYATAZ with the following medicines due to potential for serious
side effects: Camptosar
®
(irinotecan), Crixivan
®
(indinavir), Mevacor
®
(lovastatin),
Zocor
®
(simvastatin), Uroxatral
®
(alfuzosin), or Revatio
®
(sildenafil).
Do not take REYATAZ with the following medicines as they may lower the amount of
REYATAZ in your blood, which may lead to increased HIV viral load and resistance to
REYATAZ or other anti-HIV medicines: rifampin (also known as Rimactane
®
, Rifadin
®
,
Rifater
®
, or Rifamate
®
), St. John’s wort (Hypericum perforatum)-containing products, or
Viramune
®
(nevirapine).
Serevent Diskus
®
(salmeterol) and Advair
®
(salmeterol with fluticasone) are not recommended
with REYATAZ.
Do not take Vfend
®
(voriconazole) if you are taking REYATAZ and Norvir
®
(ritonavir).
The above lists of medicines are not complete. Taking REYATAZ with some other medicines
may require your therapy to be monitored more closely or may require a change in dose
or dose schedule of REYATAZ or the other medicine. Discuss with your healthcare provider all
prescription and non-prescription medicines, vitamin and herbal supplements, or other health
preparations you are taking or plan to take.
Tell your healthcare provider if you are pregnant, breast-feeding, planning to become
pregnant or breast-feed, or if you have end-stage kidney disease managed with hemodialysis
or severe liver dysfunction.
Tell your healthcare provider right away if you have any side effects, symptoms, or conditions,
including the following:
• Mild rash (redness and itching) without other symptoms sometimes occurs in patients taking
REYATAZ, most often in the first few weeks after the medicine is started, and usually goes away
within 2 weeks with no change in treatment.
• Severe rash has occurred in a small number of patients taking REYATAZ. This type of rash is
associated with other symptoms that could be serious and potentially cause death. If you
develop a rash with any of the following symptoms, stop using REYATAZ and call
your healthcare provider right away:
• Yellowing of the skin and/or eyes may occur due to increases in bilirubin levels
in the blood (bilirubin is made by the liver).
• A change in the way your heart beats may occur. You may feel
dizzy or lightheaded. These could be symptoms of a heart problem.
• Diabetes and high blood sugar may occur in patients taking
protease inhibitor medicines like REYATAZ. Some patients
may need changes in their diabetes medicine.
• If you have liver disease, including hepatitis B or C, it may
get worse when you take anti-HIV medicines like REYATAZ.
• Kidney stones have been reported in patients taking REYATAZ.
Signs or symptoms of kidney stones include pain in your side,
blood in your urine, and pain when you urinate.
• Some patients with hemophilia have increased bleeding problems
with protease inhibitor medicines like REYATAZ.
• Changes in body fat have been seen in some patients taking anti-HIV medicines.
The cause and long-term effects are not known at this time.
• Gallbladder disorders (including gallstones and gallbladder inflammation) have been
reported in patients taking REYATAZ.
Other common side effects of REYATAZ taken with other anti-HIV medicines include: nausea;
headache; stomach pain; vomiting; diarrhea; depression; fever; dizziness; trouble sleeping;
numbness, tingling, or burning of hands or feet; and muscle pain.
You should take REYATAZ once daily with food (a meal or snack). Swallow the capsules whole; do
not open the capsules. You should take REYATAZ and your other anti-HIV medicines exactly as
instructed by your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
– Shortness of breath
– General ill-feeling or “flu-like”
symptoms
– Fever
– Muscle or joint aches
– Conjunctivitis (red or inflamed eyes,
like “pink-eye”)
– Blisters
– Mouth sores
– Swelling of your face
REYATAZ is one of several treatment options your doctor may consider.
Individual results may vary.
Find out if you can save on REYATAZ.
Call 1-888-281-8981 or visit
ReyatazSavings.com for details.
Subject to terms and conditions. Restrictions apply.
Once-daily REYATAZ can help fight your HIV.
REYATAZ, a protease inhibitor (PI), in HIV combination therapy:
N Can help lower your viral load and raise your T-cell (CD4+ cell) count
N Has a low chance of diarrhea (shown in clinical trials)
- REYATAZ in combination therapy had a 1%-3% rate of moderate-to-severe diarrhea in adults
N Is taken once a day with a snack or meal
Do not take REYATAZ if you are allergic to REYATAZ or to any of its ingredients.
Ask your healthcare team about REYATAZ www.REYATAZ.com
REYATAZ does not cure HIV and has not been shown to reduce the risk of passing HIV to others.
REYATAZ is a registered trademark of Bristol-Myers Squibb.
All other trademarks are the property of their respective owners
and not of Bristol-Myers Squibb.
©2010 Bristol-Myers Squibb, Princeton, NJ 08543 U.S.A.
687US10AB06411 06/10
687US10AB06411_AdSpd_9.75x11.5 11/19/10 6:49 PM Page 1
18 washingtonblade.com • november 26, 2010
FDA-Approved Patient Labeling
Patient Information
REYATAZ
®
(RAY-ah-taz)
(generic name = atazanavir sulfate)
Capsules
ALERT: Find out about medicines that should NOT be taken with REYATAZ.
Read the section “What important information should I know about taking REYATAZ
with other medicines?”
Read the Patient Information that comes with REYATAZ before you start using it
and each time you get a refill. There may be new information. This leaflet provides
a summary about REYATAZ and does not include everything there is to know
about your medicine. This information does not take the place of talking with your
healthcare provider about your medical condition or treatment.
What is REYATAZ?
REYATAZ is a prescription medicine used with other anti-HIV medicines to treat
people who are infected with the human immunodeficiency virus (HIV). HIV is the
virus that causes acquired immune deficiency syndrome (AIDS). REYATAZ is a
type of anti-HIV medicine called a protease inhibitor. HIV infection destroys CD4+
(T) cells, which are important to the immune system. The immune system helps
fight infection. After a large number of (T) cells are destroyed, AIDS develops.
REYATAZ helps to block HIV protease, an enzyme that is needed for the HIV
virus to multiply. REYATAZ may lower the amount of HIV in your blood, help your
body keep its supply of CD4+ (T) cells, and reduce the risk of death and illness
associated with HIV.
Does REYATAZ cure HIV or AIDS?
REYATAZ does not cure HIV infection or AIDS. At present there is no cure for
HIV infection. People taking REYATAZ may still get opportunistic infections or other
conditions that happen with HIV infection. Opportunistic infections are infections
that develop because the immune system is weak. Some of these conditions are
pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC)
infections. It is very important that you see your healthcare provider regularly
while taking REYATAZ.
REYATAZ does not lower your chance of passing HIV to other people through
sexual contact, sharing needles, or being exposed to your blood. For your
health and the health of others, it is important to always practice safer sex by
using a latex or polyurethane condom or other barrier to lower the chance of sexual
contact with semen, vaginal secretions, or blood. Never use or share dirty needles.
Who should not take REYATAZ?
Do not take REYATAZ if you:
º are taking certain medicines. (See “What important information should I
know about taking REYATAZ with other medicines?”) Serious life-threatening
side effects or death may happen. Before you take REYATAZ, tell your
healthcare provider about all medicines you are taking or planning to take.
These include other prescription and nonprescription medicines, vitamins,
and herbal supplements.
º are allergic to REYATAZ or to any of its ingredients. The active ingredient
is atazanavir sulfate. See the end of this leaflet for a complete list of
ingredients in REYATAZ. Tell your healthcare provider if you think you have
had an allergic reaction to any of these ingredients.
What should I tell my healthcare provider before I take REYATAZ?
Tell your healthcare provider:
º If you are pregnant or planning to become pregnant. It is not known if
REYATAZ can harm your unborn baby. Pregnant women have experienced
serious side effects when taking REYATAZ with other HIV medicines called
nucleoside analogues. You and your healthcare provider will need to decide
if REYATAZ is right for you. If you use REYATAZ while you are pregnant, talk
to your healthcare provider about the Antiretroviral Pregnancy Registry.
º If you are breast-feeding. You should not breast-feed if you are HIV-positive
because of the chance of passing HIV to your baby. Also, it is not known if
REYATAZ can pass into your breast milk and if it can harm your baby. If you
are a woman who has or will have a baby, talk with your healthcare provider
about the best way to feed your baby.
º If you have liver problems or are infected with the hepatitis B or C virus.
See “What are the possible side effects of REYATAZ?”
º If you have end stage kidney disease managed with hemodialysis.
º If you have diabetes. See “What are the possible side effects of REYATAZ?”
º If you have hemophilia. See “What are the possible side effects of
REYATAZ?”
º About all the medicines you take including prescription and nonprescription
medicines, vitamins, and herbal supplements. Keep a list of your medicines
with you to show your healthcare provider. For more information, see “What
important information should I know about taking REYATAZ with other
medicines?” and “Who should not take REYATAZ?” Some medicines can
cause serious side effects if taken with REYATAZ.
How should I take REYATAZ?
º Take REYATAZ once every day exactly as instructed by your healthcare
provider. Your healthcare provider will prescribe the amount of REYATAZ
that is right for you.
º For adults who have never taken anti-HlV medicines oefore, the dose
is 300 mg once daily with 100 mg of NORVIR
®
(ritonavir) once daily
taken with food. For adults who are unable to tolerate ritonavir, 400 mg
(two 200-mg capsules) once daily (without NORVIR
®
) taken with food
is recommended.
º For adults who have taken anti-HlV medicines in the past, the usual
dose is 300 mg plus 100 mg of NORVIR
®
(ritonavir) once daily taken
with food.
º Your dose will depend on ]our liver function and on the other anti-HlV
medicines that you are taking. REYATAZ is always used with other anti-HIV
medicines. If you are taking REYATAZ with SUSTIVA
®
(efavirenz) or with
VIREAD
®
(tenofovir disoproxil fumarate), you should also be taking NORVIR
®

(ritonavir).
º Always take REYATAZ with food (a meal or snack) to help it work better.
Swallow the capsules whole. Do not open the capsules. Take REYATAZ at
the same time each day.
º If you are taking antacids or didanosine (VIDEX
®
or VIDEX
®
EC), take
REYATAZ 2 hours before or 1 hour after these medicines.
º If you are taking medicines for indigestion, heartburn, or ulcers
such as AXID
®
(nizatidine), PEPCID AC
®
(famotidine), TAGAMET
®

(cimetidine), ZANTAC
®
(ranitidine), AcipHex
®
(rabeprazole), NEXIUM
®

(esomeprazole), PREVACID
®
(lansoprazole), PRILOSEC
®
(omeprazole),
or PROTONIX
®
(pantoprazole), talk to your healthcare provider.
º Do not change your dose or stop taking REYATAZ without first talking
with your healthcare provider. It is important to stay under a healthcare
provider’s care while taking REYATAZ.
º When your supply of REYATAZ starts to run low, get more from your
healthcare provider or pharmacy. It is important not to run out of REYATAZ.
The amount of HIV in your blood may increase if the medicine is stopped for
even a short time.
º If you miss a dose of REYATAZ, take it as soon as possible and then take
your next scheduled dose at its regular time. If, however, it is within 6 hours
of your next dose, do not take the missed dose. Wait and take the next dose
at the regular time. Do not double the next dose. It is important that you
do not miss any doses of REYATAZ or your other anti-HIV medicines.
º If you take more than the prescribed dose of REYATAZ, call your
healthcare provider or poison control center right away.
Can children take REYATAZ?
Dosing recommendations are available for children 6 years of age and older for
REYATAZ Capsules. Dosing recommendations are not available for children from
3 months to less than 6 years of age. REYATAZ should not be used in babies under
the age of 3 months.
What are the possible side effects of REYATAZ?
The following list of side effects is not complete. Report any new or continuing
symptoms to your healthcare provider. If you have questions about side effects,
ask your healthcare provider. Your healthcare provider may be able to help you
manage these side effects.
The following side effects have been reported with REYATAZ:
º mild rash (redness and itching) without other symptoms sometimes occurs
in patients taking REYATAZ, most often in the first few weeks after the
medicine is started. Rashes usually go away within 2 weeks with no change
in treatment. Tell your healthcare provider if rash occurs.
º severe rash: In a small number of patients, a rash can develop that is
associated with other symptoms which could be serious and potentially
cause death.
If you develop a rash with any of the following symptoms stop using
REYATAZ and call your healthcare provider right away:
º shortness of oreath
º deneral ill feelind or "flu-like" s]mptoms
º fever
º muscle or joint aches
º conjunctivitis (red or inflamed e]es, like "pink e]e"ì
º olisters
º mouth sores
º swellind of ]our face
º yellowing of the skin or eyes. These effects may be due to increases
in bilirubin levels in the blood (bilirubin is made by the liver). Call your
healthcare provider if your skin or the white part of your eyes turn yellow.
Although these effects may not be damaging to your liver, skin, or eyes, it is
important to tell your healthcare provider promptly if they occur.
REYATAZ
®
(atazanavir sulfate)
º a change in the way your heart beats (heart rhythm change). Call your
healthcare provider right away if you get dizzy or lightheaded. These could
be symptoms of a heart problem.
º diabetes and high blood sugar (hyperglycemia) sometimes happen in
patients taking protease inhibitor medicines like REYATAZ. Some patients
had diabetes before taking protease inhibitors while others did not. Some
patients may need changes in their diabetes medicine.
º if you have liver disease including hepatitis B or C, your liver disease may
get worse when you take anti-HIV medicines like REYATAZ.
º kidney stones have been reported in patients taking REYATAZ. If you
develop signs or symptoms of kidney stones (pain in your side, blood in your
urine, pain when you urinate) tell your healthcare provider promptly.
º some patients with hemophilia have increased bleeding problems with
protease inhibitors like REYATAZ.
º changes in body fat. These changes may include an increased amount of
fat in the upper back and neck (“buffalo hump”), breast, and around the
trunk. Loss of fat from the legs, arms, and face may also happen. The cause
and long-term health effects of these conditions are not known at this time.
Other common side effects of REYATAZ taken with other anti-HIV medicines
include nausea; headache; stomach pain; vomiting; diarrhea; depression; fever;
dizziness; trouble sleeping; numbness, tingling, or burning of hands or feet; and
muscle pain.
Gallbladder disorders (which may include gallstones and gallbladder
inflammation) have been reported in patients taking REYATAZ.
What important information should I know about taking REYATAZ with other
medicines?
Do not take REYATAZ if you take the following medicines (not all brands may
be listed; tell your healthcare provider about all the medicines you take).
REYATAZ may cause serious, life-threatening side effects or death when
used with these medicines.
º Erdot medicines. dih]droerdotamine, erdonovine, erdotamine, and
methylergonovine such as CAFERGOT
®
, MIGRANAL
®
, D.H.E. 45
®
, ergotrate
maleate, METHERGINE
®
, and others (used for migraine headaches).
º 0RAP
®
(pimozide, used for Tourette’s disorder).
º PR0PUl8lD
®
(cisapride, used for certain stomach problems).
º Triazolam, also known as HAlCl0h
®
(used for insomnia).
º Nidazolam, also known as VER8ED
®
(used for sedation), when taken by
mouth.
Do not take the following medicines with REYATAZ because of possible
serious side effects:
º CANPT08AR
®
(irinotecan, used for cancer).
º CRlXlVAh
®
(indinavir, used for HlV infectionì. Both REYATAZ and CRlXlVAh
sometimes cause increased levels of bilirubin in the blood.
º Cholesterol-lowering medicines MEVACOR
®
(lovastatin) or ZOCOR
®
(simvastatin).
º UR0XATRAl
®
(alfuzosin, used to treat benign enlargement of the prostate).
º REVATl0
®
(sildenafil, used to treat pulmonary arterial hypertension).
Do not take the following medicines with REYATAZ because they may lower
the amount of REYATAZ in your blood. This may lead to an increased HIV viral
load. Resistance to REYATAZ or cross-resistance to other HIV medicines may
develop.
º Rifampin (also known as RlNACTAhE
®
, RIFADIN
®
, RIFATER
®
, or RIFAMATE
®
,
used for tuberculosis).
º 8t. John's wort (Hypericum perforatum), an herbal product sold as a dietary
supplement, or products containind 8t. John's wort.
º VlRANUhE
®
(nevirapine, used for HIV infection).
The following medicines are not recommended with REYATAZ:
º 8EREVEhT Dl8KU8
®
(salmeterol) and ADVAIR
®
(salmeterol with fluticasone),
used to treat asthma, emphysema/chronic obstructive pulmonary disease
also known as COPD.
Do not take the following medicine if you are taking REYATAZ and NORVIR
®

together:
º VFEhD
®
(voriconazole).
The following medicines may require your healthcare provider to monitor
your therapy more closely (for some medicines a change in the dose or dose
schedule may be needed):
º ClAll8
®
(tadalafil), LEVITRA
®
(vardenafil), or VIAGRA
®
(sildenafil), used to
treat erectile dysfunction. REYATAZ may increase the chances of serious
side effects that can happen with CIALIS, LEVITRA, or VIAGRA. Do not use
CIALIS, LEVITRA, or VIAGRA while you are taking REYATAZ unless your
healthcare provider tells you it is okay.
º ADClRCA
®
(tadalafil) or TRACLEER
®
(bosentan), used to treat pulmonary
arterial hypertension.
º llPlT0R
®
(atorvastatin) or CRESTOR
®
(rosuvastatin). There is an increased
chance of serious side effects if you take REYATAZ with this cholesterol-
lowering medicine.
º Nedicines for aonormal heart rh]thm. C0RDAR0hE
®
(amiodarone), lidocaine,
quinidine (also known as CARDIOQUIN
®
, 0UlhlDEX
®
, and others).
º NYC0BUTlh
®
(rifabutin, an antibiotic used to treat tuberculosis).
º BUPREhEX
®
, 8UBUTEX
®
, 8UB0X0hE
®
, (buprenorphine or buprenorphine/
naloxone, used to treat pain and addiction to narcotic painkillers).
º VA8C0R
®
(bepridil, used for chest pain).
º C0UNADlh
®
(warfarin).
º Tric]clic antidepressants such as ElAVll
®
(amitriptyline), NORPRAMIN
®

(desipramine), SINEQUAN
®
(doxepin), SURMONTIL
®
(trimipramine),
TOFRANIL
®
(imipramine), or VIVACTIL
®
(protriptyline).
º Nedicines to prevent ordan transplant rejection. 8AhDlNNUhE
®
or NEORAL
®

(cyclosporin), RAPAMUNE
®
(sirolimus), or PROGRAF
®
(tacrolimus).
º The antidepressant trazodone (DE8YREl
®
and others).
º Fluticasone propionate (Fl0hA8E
®
, FLOVENT
®
), given by nose or inhaled to
treat allergic symptoms or asthma. Your doctor may choose not to keep you
on fluticasone, especially if you are also taking NORVIR
®
.
º Colchicine (C0lCRY8
®
), used to prevent or treat gout or treat familial
Mediterranean fever.
The following medicines may require a change in the dose or dose schedule
of either REYATAZ or the other medicine:
º lhVlRA8E
®
(saquinavir).
º h0RVlR
®
(ritonavir).
º 8U8TlVA
®
(efavirenz).
º Antacids or ouffered medicines.
º VlDEX
®
(didanosine).
º VlREAD
®
(tenofovir disoproxil fumarate).
º NYC0BUTlh
®
(rifabutin).
º Calcium channel olockers such as CARDlZEN
®
or TIAZAC
®
(diltiazem),
COVERA-HS
®
or ISOPTIN SR
®
(verapamil) and others.
º BlAXlh
®
(clarithromycin).
º Nedicines for indidestion, heartourn, or ulcers such as AXlD
®
(nizatidine),
PEPCID AC
®
(famotidine), TAGAMET
®
(cimetidine), or ZANTAC
®
(ranitidine).
Talk to your healthcare provider about choosing an effective method of
contraception. REYATAZ may affect the safety and effectiveness of hormonal
contraceptives such as birth control pills or the contraceptive patch. Hormonal
contraceptives do not prevent the spread of HIV to others.
Remember:
1. Know all the medicines you take.
2. Tell your healthcare provider about all the medicines you take.
3. Do not start a new medicine without talking to your healthcare provider.
How should I store REYATAZ?
º 8tore REYATAZ Capsules at room temperature, 59° to 8O° F (15° to 8O° Cì.
Do not store this medicine in a damp place such as a bathroom medicine
cabinet or near the kitchen sink.
º Keep ]our medicine in a tidhtl] closed container.
º Keep all medicines out of the reach of children and pets at all times. Do not
keep medicine that is out of date or that you no longer need. Dispose of
unused medicines through community take-back disposal programs when
available or place REYATAZ in an unrecognizable, closed container in the
household trash.
General information about REYATAZ
This medicine was prescribed for your particular condition. Do not use REYATAZ
for another condition. Do not give REYATAZ to other people, even if they have the
same symptoms you have. It may harm them. Keep REYATAZ and all medicines
out of the reach of children and pets.
This summary does not include everything there is to know about REYATAZ.
Medicines are sometimes prescribed for conditions that are not mentioned in
patient information leaflets. Remember no written summary can replace careful
discussion with your healthcare provider. If you would like more information, talk
with ]our healthcare provider or ]ou can call 1-8OO-821-1885.
What are the ingredients in REYATAZ?
Active Ingredient: atazanavir sulfate
Inactive Ingredients: Crospovidone, lactose monohydrate (milk sugar),
magnesium stearate, gelatin, FD&C Blue #2, and titanium dioxide.
VlDEX
®
and REYATAZ
®
are registered trademarks of Bristol-Myers Squibb
Company. COUMADIN
®
and SUSTIVA
®
are registered trademarks of Bristol-Myers
Squibb Pharma Company. DESYREL
®
is a redistered trademark of Nead Johnson
and Company. Other brands listed are the trademarks of their respective owners
and are not trademarks of Bristol-Myers Squibb Company.
Princeton, hJ O8548 U8A
1246226A7 F1-B0001B-04-10 Rev April 2010
REYATAZ
®
(atazanavir sulfate) REYATAZ
®
(atazanavir sulfate)
687US10AB06411_AdSpread Trim Size: 9.75" x 11.5" 280 D-Max Pub:
687US10AB06411_AdSpd_9.75x11.5 11/19/10 6:49 PM Page 3
november 26, 2010 • washingtonblade.com 19
FDA-Approved Patient Labeling
Patient Information
REYATAZ
®
(RAY-ah-taz)
(generic name = atazanavir sulfate)
Capsules
ALERT: Find out about medicines that should NOT be taken with REYATAZ.
Read the section “What important information should I know about taking REYATAZ
with other medicines?”
Read the Patient Information that comes with REYATAZ before you start using it
and each time you get a refill. There may be new information. This leaflet provides
a summary about REYATAZ and does not include everything there is to know
about your medicine. This information does not take the place of talking with your
healthcare provider about your medical condition or treatment.
What is REYATAZ?
REYATAZ is a prescription medicine used with other anti-HIV medicines to treat
people who are infected with the human immunodeficiency virus (HIV). HIV is the
virus that causes acquired immune deficiency syndrome (AIDS). REYATAZ is a
type of anti-HIV medicine called a protease inhibitor. HIV infection destroys CD4+
(T) cells, which are important to the immune system. The immune system helps
fight infection. After a large number of (T) cells are destroyed, AIDS develops.
REYATAZ helps to block HIV protease, an enzyme that is needed for the HIV
virus to multiply. REYATAZ may lower the amount of HIV in your blood, help your
body keep its supply of CD4+ (T) cells, and reduce the risk of death and illness
associated with HIV.
Does REYATAZ cure HIV or AIDS?
REYATAZ does not cure HIV infection or AIDS. At present there is no cure for
HIV infection. People taking REYATAZ may still get opportunistic infections or other
conditions that happen with HIV infection. Opportunistic infections are infections
that develop because the immune system is weak. Some of these conditions are
pneumonia, herpes virus infections, and Mycobacterium avium complex (MAC)
infections. It is very important that you see your healthcare provider regularly
while taking REYATAZ.
REYATAZ does not lower your chance of passing HIV to other people through
sexual contact, sharing needles, or being exposed to your blood. For your
health and the health of others, it is important to always practice safer sex by
using a latex or polyurethane condom or other barrier to lower the chance of sexual
contact with semen, vaginal secretions, or blood. Never use or share dirty needles.
Who should not take REYATAZ?
Do not take REYATAZ if you:
º are taking certain medicines. (See “What important information should I
know about taking REYATAZ with other medicines?”) Serious life-threatening
side effects or death may happen. Before you take REYATAZ, tell your
healthcare provider about all medicines you are taking or planning to take.
These include other prescription and nonprescription medicines, vitamins,
and herbal supplements.
º are allergic to REYATAZ or to any of its ingredients. The active ingredient
is atazanavir sulfate. See the end of this leaflet for a complete list of
ingredients in REYATAZ. Tell your healthcare provider if you think you have
had an allergic reaction to any of these ingredients.
What should I tell my healthcare provider before I take REYATAZ?
Tell your healthcare provider:
º If you are pregnant or planning to become pregnant. It is not known if
REYATAZ can harm your unborn baby. Pregnant women have experienced
serious side effects when taking REYATAZ with other HIV medicines called
nucleoside analogues. You and your healthcare provider will need to decide
if REYATAZ is right for you. If you use REYATAZ while you are pregnant, talk
to your healthcare provider about the Antiretroviral Pregnancy Registry.
º If you are breast-feeding. You should not breast-feed if you are HIV-positive
because of the chance of passing HIV to your baby. Also, it is not known if
REYATAZ can pass into your breast milk and if it can harm your baby. If you
are a woman who has or will have a baby, talk with your healthcare provider
about the best way to feed your baby.
º If you have liver problems or are infected with the hepatitis B or C virus.
See “What are the possible side effects of REYATAZ?”
º If you have end stage kidney disease managed with hemodialysis.
º If you have diabetes. See “What are the possible side effects of REYATAZ?”
º If you have hemophilia. See “What are the possible side effects of
REYATAZ?”
º About all the medicines you take including prescription and nonprescription
medicines, vitamins, and herbal supplements. Keep a list of your medicines
with you to show your healthcare provider. For more information, see “What
important information should I know about taking REYATAZ with other
medicines?” and “Who should not take REYATAZ?” Some medicines can
cause serious side effects if taken with REYATAZ.
How should I take REYATAZ?
º Take REYATAZ once every day exactly as instructed by your healthcare
provider. Your healthcare provider will prescribe the amount of REYATAZ
that is right for you.
º For adults who have never taken anti-HlV medicines oefore, the dose
is 300 mg once daily with 100 mg of NORVIR
®
(ritonavir) once daily
taken with food. For adults who are unable to tolerate ritonavir, 400 mg
(two 200-mg capsules) once daily (without NORVIR
®
) taken with food
is recommended.
º For adults who have taken anti-HlV medicines in the past, the usual
dose is 300 mg plus 100 mg of NORVIR
®
(ritonavir) once daily taken
with food.
º Your dose will depend on ]our liver function and on the other anti-HlV
medicines that you are taking. REYATAZ is always used with other anti-HIV
medicines. If you are taking REYATAZ with SUSTIVA
®
(efavirenz) or with
VIREAD
®
(tenofovir disoproxil fumarate), you should also be taking NORVIR
®

(ritonavir).
º Always take REYATAZ with food (a meal or snack) to help it work better.
Swallow the capsules whole. Do not open the capsules. Take REYATAZ at
the same time each day.
º If you are taking antacids or didanosine (VIDEX
®
or VIDEX
®
EC), take
REYATAZ 2 hours before or 1 hour after these medicines.
º If you are taking medicines for indigestion, heartburn, or ulcers
such as AXID
®
(nizatidine), PEPCID AC
®
(famotidine), TAGAMET
®

(cimetidine), ZANTAC
®
(ranitidine), AcipHex
®
(rabeprazole), NEXIUM
®

(esomeprazole), PREVACID
®
(lansoprazole), PRILOSEC
®
(omeprazole),
or PROTONIX
®
(pantoprazole), talk to your healthcare provider.
º Do not change your dose or stop taking REYATAZ without first talking
with your healthcare provider. It is important to stay under a healthcare
provider’s care while taking REYATAZ.
º When your supply of REYATAZ starts to run low, get more from your
healthcare provider or pharmacy. It is important not to run out of REYATAZ.
The amount of HIV in your blood may increase if the medicine is stopped for
even a short time.
º If you miss a dose of REYATAZ, take it as soon as possible and then take
your next scheduled dose at its regular time. If, however, it is within 6 hours
of your next dose, do not take the missed dose. Wait and take the next dose
at the regular time. Do not double the next dose. It is important that you
do not miss any doses of REYATAZ or your other anti-HIV medicines.
º If you take more than the prescribed dose of REYATAZ, call your
healthcare provider or poison control center right away.
Can children take REYATAZ?
Dosing recommendations are available for children 6 years of age and older for
REYATAZ Capsules. Dosing recommendations are not available for children from
3 months to less than 6 years of age. REYATAZ should not be used in babies under
the age of 3 months.
What are the possible side effects of REYATAZ?
The following list of side effects is not complete. Report any new or continuing
symptoms to your healthcare provider. If you have questions about side effects,
ask your healthcare provider. Your healthcare provider may be able to help you
manage these side effects.
The following side effects have been reported with REYATAZ:
º mild rash (redness and itching) without other symptoms sometimes occurs
in patients taking REYATAZ, most often in the first few weeks after the
medicine is started. Rashes usually go away within 2 weeks with no change
in treatment. Tell your healthcare provider if rash occurs.
º severe rash: In a small number of patients, a rash can develop that is
associated with other symptoms which could be serious and potentially
cause death.
If you develop a rash with any of the following symptoms stop using
REYATAZ and call your healthcare provider right away:
º shortness of oreath
º deneral ill feelind or "flu-like" s]mptoms
º fever
º muscle or joint aches
º conjunctivitis (red or inflamed e]es, like "pink e]e"ì
º olisters
º mouth sores
º swellind of ]our face
º yellowing of the skin or eyes. These effects may be due to increases
in bilirubin levels in the blood (bilirubin is made by the liver). Call your
healthcare provider if your skin or the white part of your eyes turn yellow.
Although these effects may not be damaging to your liver, skin, or eyes, it is
important to tell your healthcare provider promptly if they occur.
REYATAZ
®
(atazanavir sulfate)
º a change in the way your heart beats (heart rhythm change). Call your
healthcare provider right away if you get dizzy or lightheaded. These could
be symptoms of a heart problem.
º diabetes and high blood sugar (hyperglycemia) sometimes happen in
patients taking protease inhibitor medicines like REYATAZ. Some patients
had diabetes before taking protease inhibitors while others did not. Some
patients may need changes in their diabetes medicine.
º if you have liver disease including hepatitis B or C, your liver disease may
get worse when you take anti-HIV medicines like REYATAZ.
º kidney stones have been reported in patients taking REYATAZ. If you
develop signs or symptoms of kidney stones (pain in your side, blood in your
urine, pain when you urinate) tell your healthcare provider promptly.
º some patients with hemophilia have increased bleeding problems with
protease inhibitors like REYATAZ.
º changes in body fat. These changes may include an increased amount of
fat in the upper back and neck (“buffalo hump”), breast, and around the
trunk. Loss of fat from the legs, arms, and face may also happen. The cause
and long-term health effects of these conditions are not known at this time.
Other common side effects of REYATAZ taken with other anti-HIV medicines
include nausea; headache; stomach pain; vomiting; diarrhea; depression; fever;
dizziness; trouble sleeping; numbness, tingling, or burning of hands or feet; and
muscle pain.
Gallbladder disorders (which may include gallstones and gallbladder
inflammation) have been reported in patients taking REYATAZ.
What important information should I know about taking REYATAZ with other
medicines?
Do not take REYATAZ if you take the following medicines (not all brands may
be listed; tell your healthcare provider about all the medicines you take).
REYATAZ may cause serious, life-threatening side effects or death when
used with these medicines.
º Erdot medicines. dih]droerdotamine, erdonovine, erdotamine, and
methylergonovine such as CAFERGOT
®
, MIGRANAL
®
, D.H.E. 45
®
, ergotrate
maleate, METHERGINE
®
, and others (used for migraine headaches).
º 0RAP
®
(pimozide, used for Tourette’s disorder).
º PR0PUl8lD
®
(cisapride, used for certain stomach problems).
º Triazolam, also known as HAlCl0h
®
(used for insomnia).
º Nidazolam, also known as VER8ED
®
(used for sedation), when taken by
mouth.
Do not take the following medicines with REYATAZ because of possible
serious side effects:
º CANPT08AR
®
(irinotecan, used for cancer).
º CRlXlVAh
®
(indinavir, used for HlV infectionì. Both REYATAZ and CRlXlVAh
sometimes cause increased levels of bilirubin in the blood.
º Cholesterol-lowering medicines MEVACOR
®
(lovastatin) or ZOCOR
®
(simvastatin).
º UR0XATRAl
®
(alfuzosin, used to treat benign enlargement of the prostate).
º REVATl0
®
(sildenafil, used to treat pulmonary arterial hypertension).
Do not take the following medicines with REYATAZ because they may lower
the amount of REYATAZ in your blood. This may lead to an increased HIV viral
load. Resistance to REYATAZ or cross-resistance to other HIV medicines may
develop.
º Rifampin (also known as RlNACTAhE
®
, RIFADIN
®
, RIFATER
®
, or RIFAMATE
®
,
used for tuberculosis).
º 8t. John's wort (Hypericum perforatum), an herbal product sold as a dietary
supplement, or products containind 8t. John's wort.
º VlRANUhE
®
(nevirapine, used for HIV infection).
The following medicines are not recommended with REYATAZ:
º 8EREVEhT Dl8KU8
®
(salmeterol) and ADVAIR
®
(salmeterol with fluticasone),
used to treat asthma, emphysema/chronic obstructive pulmonary disease
also known as COPD.
Do not take the following medicine if you are taking REYATAZ and NORVIR
®

together:
º VFEhD
®
(voriconazole).
The following medicines may require your healthcare provider to monitor
your therapy more closely (for some medicines a change in the dose or dose
schedule may be needed):
º ClAll8
®
(tadalafil), LEVITRA
®
(vardenafil), or VIAGRA
®
(sildenafil), used to
treat erectile dysfunction. REYATAZ may increase the chances of serious
side effects that can happen with CIALIS, LEVITRA, or VIAGRA. Do not use
CIALIS, LEVITRA, or VIAGRA while you are taking REYATAZ unless your
healthcare provider tells you it is okay.
º ADClRCA
®
(tadalafil) or TRACLEER
®
(bosentan), used to treat pulmonary
arterial hypertension.
º llPlT0R
®
(atorvastatin) or CRESTOR
®
(rosuvastatin). There is an increased
chance of serious side effects if you take REYATAZ with this cholesterol-
lowering medicine.
º Nedicines for aonormal heart rh]thm. C0RDAR0hE
®
(amiodarone), lidocaine,
quinidine (also known as CARDIOQUIN
®
, 0UlhlDEX
®
, and others).
º NYC0BUTlh
®
(rifabutin, an antibiotic used to treat tuberculosis).
º BUPREhEX
®
, 8UBUTEX
®
, 8UB0X0hE
®
, (buprenorphine or buprenorphine/
naloxone, used to treat pain and addiction to narcotic painkillers).
º VA8C0R
®
(bepridil, used for chest pain).
º C0UNADlh
®
(warfarin).
º Tric]clic antidepressants such as ElAVll
®
(amitriptyline), NORPRAMIN
®

(desipramine), SINEQUAN
®
(doxepin), SURMONTIL
®
(trimipramine),
TOFRANIL
®
(imipramine), or VIVACTIL
®
(protriptyline).
º Nedicines to prevent ordan transplant rejection. 8AhDlNNUhE
®
or NEORAL
®

(cyclosporin), RAPAMUNE
®
(sirolimus), or PROGRAF
®
(tacrolimus).
º The antidepressant trazodone (DE8YREl
®
and others).
º Fluticasone propionate (Fl0hA8E
®
, FLOVENT
®
), given by nose or inhaled to
treat allergic symptoms or asthma. Your doctor may choose not to keep you
on fluticasone, especially if you are also taking NORVIR
®
.
º Colchicine (C0lCRY8
®
), used to prevent or treat gout or treat familial
Mediterranean fever.
The following medicines may require a change in the dose or dose schedule
of either REYATAZ or the other medicine:
º lhVlRA8E
®
(saquinavir).
º h0RVlR
®
(ritonavir).
º 8U8TlVA
®
(efavirenz).
º Antacids or ouffered medicines.
º VlDEX
®
(didanosine).
º VlREAD
®
(tenofovir disoproxil fumarate).
º NYC0BUTlh
®
(rifabutin).
º Calcium channel olockers such as CARDlZEN
®
or TIAZAC
®
(diltiazem),
COVERA-HS
®
or ISOPTIN SR
®
(verapamil) and others.
º BlAXlh
®
(clarithromycin).
º Nedicines for indidestion, heartourn, or ulcers such as AXlD
®
(nizatidine),
PEPCID AC
®
(famotidine), TAGAMET
®
(cimetidine), or ZANTAC
®
(ranitidine).
Talk to your healthcare provider about choosing an effective method of
contraception. REYATAZ may affect the safety and effectiveness of hormonal
contraceptives such as birth control pills or the contraceptive patch. Hormonal
contraceptives do not prevent the spread of HIV to others.
Remember:
1. Know all the medicines you take.
2. Tell your healthcare provider about all the medicines you take.
3. Do not start a new medicine without talking to your healthcare provider.
How should I store REYATAZ?
º 8tore REYATAZ Capsules at room temperature, 59° to 8O° F (15° to 8O° Cì.
Do not store this medicine in a damp place such as a bathroom medicine
cabinet or near the kitchen sink.
º Keep ]our medicine in a tidhtl] closed container.
º Keep all medicines out of the reach of children and pets at all times. Do not
keep medicine that is out of date or that you no longer need. Dispose of
unused medicines through community take-back disposal programs when
available or place REYATAZ in an unrecognizable, closed container in the
household trash.
General information about REYATAZ
This medicine was prescribed for your particular condition. Do not use REYATAZ
for another condition. Do not give REYATAZ to other people, even if they have the
same symptoms you have. It may harm them. Keep REYATAZ and all medicines
out of the reach of children and pets.
This summary does not include everything there is to know about REYATAZ.
Medicines are sometimes prescribed for conditions that are not mentioned in
patient information leaflets. Remember no written summary can replace careful
discussion with your healthcare provider. If you would like more information, talk
with ]our healthcare provider or ]ou can call 1-8OO-821-1885.
What are the ingredients in REYATAZ?
Active Ingredient: atazanavir sulfate
Inactive Ingredients: Crospovidone, lactose monohydrate (milk sugar),
magnesium stearate, gelatin, FD&C Blue #2, and titanium dioxide.
VlDEX
®
and REYATAZ
®
are registered trademarks of Bristol-Myers Squibb
Company. COUMADIN
®
and SUSTIVA
®
are registered trademarks of Bristol-Myers
Squibb Pharma Company. DESYREL
®
is a redistered trademark of Nead Johnson
and Company. Other brands listed are the trademarks of their respective owners
and are not trademarks of Bristol-Myers Squibb Company.
Princeton, hJ O8548 U8A
1246226A7 F1-B0001B-04-10 Rev April 2010
REYATAZ
®
(atazanavir sulfate) REYATAZ
®
(atazanavir sulfate)
687US10AB06411_AdSpread Trim Size: 9.75" x 11.5" 280 D-Max Pub:
687US10AB06411_AdSpd_9.75x11.5 11/19/10 6:49 PM Page 3
NATIONALNEWS
Also during the news con-
ference, Gibbs counted “Don’t
Ask, Don’t Tell” repeal among
the legislative items that Obama
wants to see happen during the
lame duck session of Congress
and argued that legislative ac-
tion is better than having the
courts overturn the law. Senate
Majority Leader Harry Reid (D-
Nev.) has committed to a vote
on “Don’t Ask, Don’t Tell” before
the year’s end.
“There are issues around
‘Don’t Ask, Don’t Tell’ that the
president and, I think, many
people believe are best dealt
with through the legislative pro-
cess and not through a legal
system,” Gibbs said.
Gibbs maintained that over-
turning the gay ban through court
order is “not likely to provide the
Pentagon and others with a path-
way” for implementing repeal
and said “doing this legislatively”
is the best way to end the law.
A partial transcript of Gibbs’
remarks on “Don’t Ask, Don’t
Tell” follows:
Robert Gibbs [on the legisla-
tive agenda for lame duck]: …
There are issues around “Don’t
Ask, Don’t Tell” that the president
and, I think, many people be-
lieve are best dealt with through
the legislative process and not
through a legal system. …
National Public Radio: Has
the president asked the Pentagon
to hurry up to Nov. 30 the report
— its internal report –
Gibbs: I think the original
date was Dec. 1. Obviously,
the report is being released a
day or so early in order to have
some informed hearings on the
survey and its results. I think
those, hearings, if I’m not mis-
taken, start on the frst.
But I think it’s important if you
look at what others have said par-
ticularly — take for instance Sec-
retary Gates — we know we can
do this legislatively. The House
has done this; the Senate can do
this — do this legislatively, which
provides an avenue to implement
the policy. The court doing this is
not likely to provide the Pentagon
and others with a pathway for do-
ing this, and I think in order to do
this in a way that the president
want to see that doing this legisla-
tively is the best way to do this. …
Washington Blade: Robert,
back on “Don’t Ask, Don’t Tell,”
the service chief of the Navy re-
cently praised the Pentagon re-
port and said he’s eager to see
what happens with the Hill with
regard to repeal. But the remain-
ing three service chiefs — they’re
all on the record as saying they
want to wait for the report to
come out before Congress takes
action. Does the president be-
lieve that once the report comes
out, the service chiefs will be on
board in favor of repeal?
Gibbs: I don’t — I think the
service chiefs as I understand it
are meeting with the chairman
of the Joint Chiefs and the sec-
retary as we get closer to this
report coming out in order to
discuss where they are based
on that survey. The president
has not yet seen that survey, so
I don’t want to presume wheth-
er based on those results that
would change their opinions on
it. I think it’s best not to get too
far down the road on comment-
ing on that until we chance to
personally see the substance.
Blade: But wasn’t that the
purpose of the study, though?
You’ve said the president has
supported repeal since you’ve
known him, and the president
has said he wants to work with
military leaders — in the State
of the Union address — he said
he wants to work with military
leaders to get them on board
with repeal. So, what’s the point
of this report if not to get those
service chiefs on [board]?
Gibbs: I’m not saying they
won’t. I’m just saying — I think
the original question you asked
me is would that report change
their mind. I haven’t seen the
report, and the president hasn’t
seen that report and neither of
us have had an opportunity to
talk with the chiefs. That’s not
to say that it won’t; that’s not to
say that — and quite frankly,
that’s not to say whether or not
— whether you have unani-
mous agreement or not that the
policy — look, the president is
going where people have stood
on this policy for as long as he
supported changing that policy.
So, I think it will be important
to again view the attitudes and
to use those attitudes to craft
a pathway to implementing a
changed legislative policy.
That’s what the president
has advocated through this
process. Again, I can’t — we
may have a better sense of that
when we get an opportunity to
talk to those who have seen the
report and get a chance to look
at that report ourselves.
Blade: Has the president had
conversations directly with the
service chiefs to get them in favor
of legislative repeal during the
lame duck session of Congress?
Gibbs: I know the president
has spoken previously with the
service chiefs on this subject
and expect that as this report is
fnalized and released that he’ll
have an opportunity to speak
directly with the chair, the vice-
chair and the service chiefs as
the process moves forward.
Continued from page 14
Senators await Pentagon study on ‘Don’t Ask’
20 washingtonblade.com • november 26, 2010
Make Black Friday Green
at aMeri can Plant
Bethesda-Chevy Chase
5258 River Road
Bethesda, MD 20816
301-656-3311
Beltway
7405 River Road
Bethesda, MD 20817
301-469-7690
www.americanplant.net
Great Falls
10106 Georgetown Pike
Great Falls, VA 22066
703-438-8880
Landscape Division
301-762-6301
Includes Cut Trees, Wreaths, Garlands,
Poinsettias, Holiday Décor & Gifts
SAVE 20% on Entire Purchase Storewide
Friday, November 26, 8 AM – 7 PM
Take advantage of storewide savings on holiday décor, inside and out,
great gifts, and more. From fresh cut trees and greens, to seasonal
fowering plants, make your Black Friday green and save!
Sale excludes landscape services.
Continued from page 1
NATIONALNEWS
Amendment process key to GOP support for repeal
november 26, 2010 • washingtonblade.com 21
about two weeks in the Senate. Given
that slightly more than one month re-
mains in the legislative session this
year, time for a debate and vote in the
Senate — as well as time for conferenc-
ing the legislation — would have to be
compressed to move forward.
“Normally, that would involve several
weeks or months,” Sarvis said. “For us
to succeed here, all those elements,
debate on the foor, conference, votes
in the two chambers on the conference
report would have to be compressed to
about eight or 10 days on the foor, in
conference and back to the two cham-
bers. That’s part of the challenge.”
Sarvis said he expects the defense
authorization bill would likely come to
the foor after the Senate Armed Ser-
vices Committee holds hearings on the
Pentagon “Don’t Ask, Don’t Tell” report.
Levin has said he wants to hear testi-
mony early in December.
“If the hearing is [Dec.] 2, I could
see a scenario where the leader might
make the motion on Friday the third, or,
if the hearing is the sixth, then maybe
the next day,” Sarvis said.
One major question is whether
enough senators will vote in the affr-
mative to reach the 60-vote threshold
to move forward with debate on the
legislation. In September, a previous
attempt to move forward with the mea-
sure failed by a vote of 56-43.
A senior Democratic aide, who spoke
to the Washington Blade on condition
of anonymity, expressed confdence
about being able to move forward with
the fscal year 2011 defense authoriza-
tion bill.
“I think that we may be close to hav-
ing 60 votes to begin debate on the
bill,” the aide said. “I’ve seen some
positive signs from unexpected Repub-
licans in recent days.”
Sarvis said the ability to move for-
ward will depend on whether at least
a handful of Republicans are willing to
break ranks with their caucus.
“If you just look at Democrats, the
numbers don’t add up to 60,” Sarvis
said. “I don’t care how you slice it. So, if
we can persuade a handful of Republi-
cans, and I think we can, we will hit 60.”
A number of senators who are seen
as key to moving forward with “Don’t
Ask, Don’t Tell” repeal have said they
want to see an open amendment pro-
cess in place.
In September, when Senate leader-
ship made an earlier attempt to bring
the legislation to the foor, a number
of senators said they were voting “no”
because they didn’t feel the Republi-
cans could offer a suffcient number of
amendments to the legislation.
Last week, Sen. Joseph Lieber-
man (I-Conn.), the sponsor of repeal
language in the Senate, expressed
confdence during a news conference
about having at least 60 votes to move
forward — provided certain conditions
are met with the amendment process
on the Senate foor.
“I am confdent that we have more
than 60 votes prepared to take up the
defense authorization bill with the re-
peal of ‘Don’t Ask, Don’t Tell’ if only
there will be a guarantee of a fair and
open amendment process,” Lieberman
said.
Lieberman said he’s received as-
surances from Sens. Susan Collins
(R-Maine) and Richard Lugar (R-Ind.)
— as well as “others privately” — that
they would vote for moving forward with
the defense authorization bill if a more
open amendment process is in place.
The amendment process these sen-
ators are seeking remains somewhat
nebulous. What standard for the pro-
cess are these fence-sitting seeking to
win their support for moving forward?
Asked about this during the news
conference, Lieberman said the exact
terms are up for negotiation.
“It’s hard to put a number on it now,”
Lieberman said. “That’s what I hope is
going to be negotiated. Of course, we’ll
do our best to encourage Sen. Reid to
reach out to allow a somewhat larger
number.”
Some Democrats speculate the call
Continues on page 22
for a change in the amendment pro-
cess could be an excuse for some
fence-sitting senators to vote “no” on
moving forward with the defense au-
thorization bill.
Jim Manley, a Reid spokesperson,
said the senator has “always been
committed to having a fair debate and
votes” on the defense authorization
bill and specifcally on the “Don’t Ask,
Don’t Tell” provision.
“We are prepared to proceed in a
way that would allow Senators on both
sides to voice their concerns and to of-
fer relevant amendments to the bill,”
Manley said.
Manley said critics of “Don’t Ask,
Don’t Tell” are spinning “a myth” that
Reid “is somehow trying to bypass de-
bate on this critical issue.”
The Democratic aide said this call for
a more open amendment process could
enable some senators to vote against
moving toward fnal passage of the bill
after the legislation comes to the foor.
“You could have ... some Republi-
cans using process arguments to say,
“No, we haven’t had enough debate
time and I cannot support moving to-
ward fnal passage of the bill yet,’” the
aide said. “The Republicans might just
try to run out the clock.”
The aide said a fair amendment pro-
cess in the Senate has “never, ever
meant” that debate can continue “as
long as anybody wants to continue the
debate, as long as there are amend-
ments to be talked about and voted on.”
Sarvis noted that unlike in Septem-
ber, Reid has said the DREAM Act, an
immigration-related bill, wouldn’t be of-
fered as an amendment to the defense
authorization the next time around and
would instead come to the foor as
standalone legislation.
“By doing so, he has shown his good
faith in proceeding toward a fair and
open manner in which senators on both
sides of the aisle have an opportunity
to offer amendments,” Sarvis said.
Sarvis also said Reid’s commitment
to allow amendments on the “Don’t Ask,
Don’t Tell” and abortion-related provi-
sions in the defense authorization bill
was evidence of the majority leader’s
commitment to fairness during debate
on the legislation.
It’s possible that in exchange for re-
pealing “Don’t Ask, Don’t Tell,” Senate
leadership will have to agree to a vote
on amendments that would rile the
White House, such as a measure related
to the terrorist detention facility at Guan-
tanamo Bay or an amendment to try ter-
rorist suspects by military commission.
Sarvis said he doesn’t “think it’s any
secret” that Republicans may be look-
ing at amendments like that.
“Are there some Republicans who
would like to put the administration
on the hot seat with respect to some
amendments?” Sarvis said. “Perhaps.
But my hope would be that when the
‘Don’t Ask, Don’t Tell’ provisions are de-
bated on the foor that amendments [in
that nature] would not be in the mix or
part of that debate.”
The Democratic aide said deals are
often cut at late stages in the game, but
he doesn’t think opponents of “Don’t
Ask, Don’t Tell” repeal in the Senate
would allow moving forward with end-
ing the law even with an agreement to
have a vote on those issues.
“My sense is that [Sen. John] Mc-
Cain and [Sen. Lindsey] Graham and
their crew are dead set on stopping the
repeal of ‘Don’t Ask, Don’t Tell,’” the
aide said. ‘I don’t think that they’re will-
ing to deal that away.”
As these questions linger, eyes will
be on several key senators to deter-
mine whether the chamber can reach
the 60-vote threshold needed to move
forward when the legislation comes be-
fore the Senate again.
The offces of both senators Lieber-
man mentioned as “yes” votes under a
different amendment process — Collins
and Lugar — said they would be open to
moving forward with the defense autho-
rization bill if certain conditions are met.
Mark Helmke, a Lugar spokesper-
son, said the senator hasn’t taken a po-
sition on “Don’t Ask, Don’t Tell” and is
waiting for the Pentagon report on the
issue, which is now set for release on
Nov. 30.
“He is in favor of having a full debate
on the matter as part of the defense
authorization bill if there is a consent
agreement for timed debate and votes
on a number of issues,” Helmke added.
Kevin Kelley, a Collins spokesperson,
confrmed the Maine senator was con-
cerned about what she perceived as the
lack of an open process the last time the
legislation was brought up for a vote.
“In September, she was disap-
pointed that the Democratic majority
leader chose to shut down debate and
exclude Republicans from offering any
amendments to the defense authoriza-
tion bill, which contains the repeal lan-
guage,” Kelley said. “She believes that
was unfair and contrary to the rules and
tradition of the Senate.”
Still, Kelley maintained that Collins
agrees with Defense Secretary Robert
Gates and Chairman of the Joint Chiefs
of Staff Adm. Mike Mullen that the mili-
tary’s gay ban “should be repealed”
and recalled that the senator voted in
favor of a repeal amendment in com-
mittee during the spring.
Another senator who could be in
play is Sen. Lisa Murkowski (R-Alaska).
Fresh off her re-election win as an inde-
pendent write-in candidate in her state,
Murkowski isn’t beholden to the far right
for her victory on Election Day. She also
didn’t vote one way or the other on the
motion to proceed on the defense au-
thorization bill when it came before the
Senate in September.
A local TV station in Alaska reported
last week that Murkowski was in a po-
sition to vote to advance the defense
authorization bill. But Michael Brumas,
a Murkowski spokesperson, later clari-
fed that this support is dependent on
the result of the Pentagon report.
“Sen. Murkowski would not oppose a
defense authorization bill that includes
a repeal of [‘Don’t Ask, Don’t Tell’] if the
Pentagon study shows that repeal is
supported by the troops, doesn’t hurt
performance, morale or recruitment
and the military allows for an orderly
transition,” Brumas said.
Additionally, Brumas said the man-
ner in which Senate leadership handles
the amendment process would be im-
portant for Murkowski’s support.
“If the majority attempts to push it
through allowing little or no debate or
votes on amendments, Sen. Murkowski
would be inclined to oppose those ef-
forts,” Brumas said.
One surprise senator who could
vote to move forward with the defense
authorization bill is Sen. John Ensign
(R-Nev.). Last week, LGBT advocates
asserted one of his staffers informed
them that he wants to repeal “Don’t
Ask, Don’t Tell” and would vote for clo-
ture on the defense authorization bill.
Laura Martin, communications di-
rector for the Stonewall Democratic
Club of Southern Nevada, said she
and other activists met with Margot Al-
len, Ensign’s regional representative on
military issues, who informed the group
of the senator’s position.
“The frst question was about ‘Don’t
Ask, Don’t Tell’ and his staffer said he
supports repeal,” Martin said. “We
asked her to clarify three times and she
said he will vote in the affrmative on the
defense authorization with ‘Don’t Ask,
Don’t Tell’ repeal in it.”
Jennifer Cooper, an Ensign spokes-
person, later said the senator was
awaiting the Pentagon report “to see
if any changes to this policy can or
should be done” with regard to “Don’t
Ask, Don’t Tell.” She also said he wants
to hear testimony from the military ser-
vice chiefs.
“Also, he plans to review all of the
merits of the Defense Authorization
bill before voting one way or another;
hopefully it will be a fully open amend-
ment process,” she added.
Other senators that are seen as be-
ing in play are moderate Republicans
Scott Brown (R-Mass.), George Voinov-
ich (R-Ohio) and Olympia Snowe (R-
Maine). The two Democratic senators
who joined Republicans in voting “no”
in September on moving forward with
the defense authorization — Arkansas
Sens. Mark Pryor and Blanche Lincoln
— could also change their votes.
None of these senators’ offces re-
sponded to the Blade’s request to com-
ment on how they would vote on the de-
fense authorization when it comes up
during the lame duck session.
The slightly different composition of
the Senate also raises questions about
the votes from Sen. Joe Manchin (D-W.
Va.), who assumed his seat after win-
ning election on Nov. 2, and Republi-
can Senator-elect Mark Kirk of Illinois,
who is set to take his seat during the
lame duck session of Congress.
During his campaign, Manchin said he
wants to wait to hear from military leaders
before moving forward with “Don’t Ask,
Don’t Tell” repeal. As a U.S. House mem-
ber, Kirk voted against an amendment
that would have repealed the military’s
gay ban when it came to the foor in May.
Neither the offce of Manchin nor Kirk’s
transition team responded to the Blade’s
request for comment on the issue.
NATIONALNEWS
Several GOP senators could back ‘Don’t Ask’ repeal
Continued from page 21
22 washingtonblade.com • november 26, 2010
Allred calls for hate crime probe in Betts case
Gloria Allred, an attorney known for taking on high-profle celebrity cases, said
Tuesday she will call on the U.S. Justice Department to investigate the murder of
gay D.C. middle school principal Brian Betts to determine if the killing was moti-
vated by anti-gay bias.
Allred made the statements at a news conference following the sentencing of
defendant Alante Saunders to 40 years in jail for the murder of Betts. Saunders, 19,
pleaded guilty last month to frst-degree felony murder.
Betts’ family has hired Allred to represent their interests. They may pursue a
hate crime charge with the U.S. Justice Department and Allred said she will seek
an explanation from the D.C. government about how a defendant in the case was
allowed to escape a halfway house to commit the crime.
LOU CHIBBARO JR.
A defendant in the murder of Brian Betts was sentenced to 40 years in prison this week.
Washington Blade fle photo
november 26, 2010 • washingtonblade.com 23
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
A Special Holiday Tradition
H
O
LIDAY
O
P
E
N
H
OU
S
E
Join us for our
Check out our new website: MerrifeldGardenCenter.com
Merrifield

703-560-6222
8132 Lee Hwy., Merrifield,VA
Fair Oaks

703-968-9600
12101 Lee Hwy., Fairfax,VA
Gainesville

703-368-1919
6895 Wellington Rd., Gainesville,VA Holiday hours begin Nov. 26th: Mon. - Sat. 8 am - 9 pm • Sun. 9 am - 7 pm
This Friday, saTurday & sunday, november 26
Th
– 28
Th
Enjoy refreshments and discover our array of
Collectible Ornaments and Decorations • Holiday Ribbon & Handmade Bows
Live, Fresh Cut and Everlasting Trees & Greens • Poinsettias and Holiday Plants
Custom Designed Wreaths and Centerpieces • Wonderful Gift Ideas
Don’t miss our
Free decoraTing demonsTraTions
December 4
th
at 10 a.m. at our
Fair Oaks and Gainesville Locations
The “Real” SanTa ClauS
aRRiveS aT noon on nov 27Th
aT ouR MeRRifield loCaTion!
Also visit our Fair Oaks and Gainesville Santas
See our website for the full schedule
mgc blade11-25-10 clr.indd 1 11/19/2010 12:58:48 PM
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 101008 SALES REPRESENTATIVE: Jeryl Parade (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Size does matter. Reduce your carbon
footprint by taking advantage of the
$1,500 Federal Tax Credit for High-
Effciency HVAC Systems. Act now!
Program expires 12/31/10.
Gay Owned & Operated
Call 703-281-6300 or contact us through our Website at argenthvac.com.
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 1 ISSUE DATE: 100205 SALES REP: BP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
dcagenda
the lgbtq community’s news source
Just Say: I Need A Plumber!
©
Dial A Plumber, LLC
®
202-251-1479
Kim
Kenny
Full Service
• Bathroom Sinks, Tubs, Vanities
• Kitchen Sinks, Disposals
• Boilers & Furnaces
• Hot Water Heaters
• Drain Service
Licensed
Bonded
Insured
DC Plumbers License # 707
Visa, Mastercard & American Express accepted
The following was submitted
as a letter to the editor. Visit
washingtonblade.com to join
the discussion.
Re: “Md. attorney gen’l:
No marriage bill in 2011”
(news, Nov. 11)
I am writing in response to
Maryland Attorney General
Doug Gansler’s recent com-
ments regarding the fight for
marriage equality in the Free
State. While I appreciate
his leadership on preserv-
ing fair treatment for LGBT
citizens under Maryland law
through his groundbreak-
ing legal opinion that has
provided enhanced rights
to couples with valid out-
of-state marriage licenses,
I must respectfully disagree
with his claim that marriage
for same-sex couples is not
likely to win in the upcoming
legislative session.
Gansler claimed that the
courts are more likely to ad-
vance equal marriage rights.
While we welcome the op-
portunity for the legal im-
plications of discrimination
against loving and commit-
ted couples to be consid-
ered in the courts, the time
for equality is now.
According to a compre-
hensive poll released by
the Washington Post in the
spring, a clear majority of
Marylanders support mar-
riage equality. The State of
Maryland recently updated
the Employee and Retiree
Health and Welfare Bene-
fits Program to be inclusive
of same-sex couples and
we have seen several ad-
vances through relationship
recognition laws in recent
years. Furthermore, this Jan-
uary will see the return of a
large number of pro-equality
incumbents and the addition
of new legislative leaders
ready to stand up for fair-
ness. The governor has also
committed to signing the
marriage bill when it reaches
his desk.
But we are not j ust rel y-
i ng on l awmakers to do the
ri ght thi ng. We are work-
i ng hard for every si ngl e
vote. Over the past si x
months, we have i denti fi ed
thousands of new vol un-
teers and supporti ve voters
through our statewi de post-
card dri ve. We have bui l t on
the ground power through
vol unteer trai ni ngs, phone
banks and our commu-
ni ty Acti on Teams. We re-
l aunched our Pri de i n Fai th
program to engage cl ergy
and fai th communi ti es who
bel i eve i n soci al j usti ce.
We have also built incred-
ibly strong partnerships with
local, state and national or-
ganizations that are ready
to stand with us. It is only
through these types of or-
ganized, focused initiatives
that we will pass the Re-
ligious Freedom and Civil
Marriage Protection Act.
We have a plan in place
through the end of the year
to shore up our co-sponsors
so that we kick off the ses-
sion stronger than ever. We
also have a detailed, com-
prehensive plan for every
week of the session to se-
cure the votes we will need
to make marriage equality a
reality.
We have what it takes to
make it happen. We simply
need every Marylander who
believes in fairness from
the attorney general to the
neighbor next door to be
there with us in words and in
actions.
—Morgan Meneses-Sheets,
executive director,
Equality Maryland
INSIDELGBTWASHINGTON
24 washingtonblade.com • november 26, 2010
Time is running out
for ‘Don’t Ask’ repeal
By PETER ROSENSTEIN
The frustration among those
wanting to see repeal of “Don’t
Ask, Don’t Tell” this year is pal-
pable. It is diffcult to listen to the
nonsense spouted from those
like Sen. John McCain (R-Ariz.),
about whom Rachel Maddow re-
cently said: “John McCain’s posi-
tions on every major policy issue
that he has faced in the Senate
are now utterly incoherent ... if
you wait fve minutes, John Mc-
Cain is likely to have a totally dif-
ferent stance on the same issue.”
Stances on LGBT issues often
depend on the age of the per-
son talking. We know that young
people today generally have no
problem working and interact-
ing with lesbian and gay people.
One reads about girl-on-girl kiss-
ing and even boy-on-boy kissing
among college youth and young
adults and it doesn’t mean they
are gay. They just have no hang-
ups about interacting with a per-
son of the same sex. There isn’t
the fear that my generation had
that if you looked at another man
for too long, or shook his hand
for too long, someone would
think you are gay.
Listening to McCain, it be-
comes immediately apparent that
he is from that older generation
whose views are slowly dying out.
Then there is General Amos,
the newly appointed Marine
Corps commandant, who re-
cently spoke of his support for
“Don’t Ask, Don’t Tell.” My frus-
tration isn’t with him but with
President Obama and Secre-
tary Gates. How could they ap-
point someone who disagrees
with them and then allow him to
speak out on those differences?
Isn’t there a chain of command?
Wasn’t this discussed before his
appointment?
Congress must repeal the gay
ban in the lame duck session. I
thank Majority Leader Harry Reid
(D-Nev.) for his recent supportive
statements and want to see him
work out a deal with Republi-
cans like Sens. Olympia Snowe
(Maine), John Ensign (Nev.), Lisa
Murkowski (Ala.) and Susan Col-
lins (Maine) and wavering Demo-
crats like Sen. Jim Webb (Va.).
We should thank the president for
fnally making the calls needed to
rally support.
The Department of Defense
report leaked to the Washing-
ton Post shows that 70 percent
of service members don’t have
a problem serving with gays
and lesbians. It shouldn’t mat-
ter that McCain doesn’t like this
result. It is time for someone in
power to remind McCain he is
no longer serving so this is not
about him and his generation.
It is about the young men and
women volunteering today. It
is about what they think even if
we should never have needed
to ask them. It is about civil and
human rights and dignity. It is
about letting those who want
to serve our nation do so hon-
estly. It is about those who are
already serving and giving their
lives for our country.
President Obama says he is
on our side and has asked us to
hold his feet to the fre. We have
and it now appears he is begin-
ning to act. Maybe the GetEqual
demonstrations helped. Who
can tell? But he needs to contin-
ue to say: “I want this done now
and let’s cut the deal needed
to make it happen!” Harry Reid
now needs to get this done. We
need to call our senators and
demand they act.
Letters arrive regularly from
the DNC, DCCC and the DSCC
asking for money. They say what
they will do if only we keep giv-
ing them more. Well this is their
chance to prove what they can
do with their congressional ma-
jorities in the lame duck session.
The kind of majorities they may
not see again for years to come.
Maybe the president will tell
Sen. Blanche Lincoln that if
she doesn’t vote yes on repeal
he won’t consider offering her,
or anyone she recommends, a
job. Maybe he will tell the oth-
ers who just eked out their re-
elections that if you don’t come
along on this, don’t expect any-
thing in the next two years. And
just maybe the DNC, DCCC and
DSCC will tell these men and
women the same thing. Demo-
crats must stand up for equality
now; otherwise, don’t come to
us for support next time.
The time is now for Demo-
crats to “put up or shut up.”
Time is running out to convince
supporters you really mean
what you say.
Democrats must put up or shut up
washingtonblade
Volume 41 • Issue 48
Address
PO Box 73647
Washington dC 20056
PhOne
202-747-2077
e-mAil
news@washblade.com
internet
www.washingtonblade.com
PuBlished By
Brown naff Pitts Omnimedia, inc.
PuBlisher
lynne J. BrOWn
lbrown@washblade.com ext. 8075
editOriAl
editOr
Kevin nAff
knaff@washblade.com ext. 8088
feAtures & multimediA editOr
JOey diGuGlielmO
joeyd@washblade.com ext. 8081
sr. neWs rePOrter
lOu ChiBBArO Jr.
lchibbaro@washblade.com ext. 8079
neWs rePOrter
Chris JOhnsOn
cjohnson@washblade.com ext. 8083
editOriAl intern
Juliette eBner
stAff PhOtOGrAPher
miChAel Key
mkey@washblade.com
CreAtive
CreAtive direCtOr
JAmes m neAl
jneal@washblade.com ext. 8074
seniOr GrAPhiC desiGner
riChArd W.C. sKiPPOn
rskippon@washblade.com
sAles & AdministrAtiOn
sr. ACCt. exeCutive
BriAn Pitts
bpitts@washblade.com ext. 8089
ACCt. exeCutive
Jeryl PArAde
jparade@washblade.com ext. 8072
ClAssified AdvertisinG
PhilliP G. rOCKstrOh
prockstroh@washblade.com ext. 8092
for distribution, contact lynne Brown
at 202-747-2077, ext. 8075
Accounting services provided
by martin & Wall, P.C. C.P.A.
distributed by mediaPoint, llC
All material in the Washington Blade is pro-
tected by federal copyright law and may not
be reproduced without the written consent of
the Washington Blade. the sexual orientation
of advertisers, photographers, writers and car-
toonists published herein is neither inferred nor
implied. the appearance of names or pictorial
representation does not necessarily indicate
the sexual orientation of that person or persons.
Although the Washington Blade is supported
by many fne advertisers, we cannot accept re-
sponsibility for claims made by advertisers.
unsolicited editorial material is accepted
by the Washington Blade, but the paper can-
not take responsibility for its return. the edi-
tors reserve the right to accept, reject or edit
any submission.
A single copy of the Washington Blade is
available from authorized distribution points, to
any individual within a 50-mile radius of Wash-
ington, d.C. multiple copies are available from
the Washington Blade offce only. Call for rates.
if you are unable to get to a convenient free
distribution point, you may receive a 52-week
mailed subscription for $175 per year. Checks
or credit card orders can be sent to Phil rock-
stroh at prockstroh@washblade.com.
Postmaster: send address changes to the
Washington Blade, PO BOx 73647 Wash-
ington, dC 20056. the Washington Blade is
published weekly, on friday, by Brown naff
Pitts Omnimedia, inc. individual subscrip-
tions are $175 per year for 52 issues (only
$3.37 per issue mailed to you usPs). rates
for businesses/institutions are $350 per year.
Periodical postage paid at Washington, d.C.,
and additional mailing offces.
editorial positions of the Washington Blade
are expressed in editorials and in editors’
notes as determined by the paper’s editors.
Other opinions are those of the writers and do
not necessarily represent the opinion of the
Washington Blade or its staff.
to submit a letter or commentary: letters
should be fewer than 400 words; commentar-
ies should be fewer than 750 words. submis-
sions may be edited for content and length,
and must include a name, address and phone
number for verifcation. send submissions by
e-mail to knaff@washblade.com.
©2010 Brown naff Pitts Omnimedia, inc.
FEEDBACK
Peter Rosenstein is a d.C.-based lGBt
rights and democratic Party activist. he
writes regularly for the Blade.
The party must stand up for
equality now; otherwise, don’t come to
us for support next time.
VIEWPOINT
november 26, 2010 • washingtonblade.com 25
‘Hide/Seek’ exhibit
ofers 100 same-sex
portraits
By KATHI WOLFE

A picture is worth a thousand
words.
Queers know not only the
truth of this cliché, but that we’re
usually out of the picture. His-
torically (even often now) open-
ly queer subjects have seldom
been found in class pictures,
family photo albums — let alone
in portraits on museum walls.
Thankfully, we’re becoming
part of the picture. A new ex-
hibition “Hide/Seek: Difference
and Desire in American Portrai-
ture,” at the Smithsonian Institu-
tion’s National Portrait Gallery,
containing 100 works from the
late 19th century until today, is
the frst major museum exhibit
of same-sex portraits. At a cul-
tural moment when same-sex
marriage and gender identity
are the cutting edge issues of
the day, the exhibit couldn’t be
more timely.
Growing up, like many of us,
I rarely saw pictures of people
like myself — in the domain of
the personal or in the realm of
art. As a teen who liked girls but
didn’t dare tell anyone, I didn’t
view photos of girlfriends hold-
ing hands in my high school
yearbook. I loved looking at
paintings and reading about
the lesbian scene in Paris in the
early 20th century, yet I discov-
ered no photographs of lesbian
salons on my visits to the Phila-
delphia Museum of Art.
If we don’t see images of
people like ourselves in art, it’s
hard for us to look within our-
selves — to know who we truly
are — to discover our historical
context. If we’re not in the pic-
ture, we wonder, “Why aren’t we
there? Shouldn’t we be straight
like that boy and girl holding
hands in that painting?”
“Portraiture ... permits us
to enter into the lives of others
and explore how identities were
forged in the past in ways that
connect with our own search
for meaning,” says a brochure
for the “Hide/Seek” exhibit. “By
looking at others across the
course of history, we ultimately
end up looking at ourselves
through portraiture.”
It’s thrilling to view the many,
varied, stirring portraits of
“Hide/Seek,” as I did one recent
afternoon. Perusing the work of
well-known gay artists such as
Andy Warhol, closeted queer
artists such as photographer
Carl Van Vechten, Romaine
Brooks and other lesbian paint-
ers, and straight artists, includ-
ing, Andrew Wyeth (whose
1979 portrait “The Clearing” of
a young blonde-haired hunk
will make any gay male’s mouth
water), I realized we present-
day queers are part of an his-
torical context, our history has
helped shape our art, and art
has helped shape us.
Until recently, LGBTQ people
have had to be largely closeted.
Even now, though things have
greatly improved in parts of the
United States and other coun-
tries, many of us still encounter
many forms of homophobia from
hate crimes to same-sex mar-
riage bans to employment dis-
crimination to anti-gay “jokes.”
As a result of this prejudice,
queer artists, like other queers,
historically have been outsiders.
They’ve had to be closeted in
their work — to allude to same-
sex subjects in code.
“Much of the work in this ex-
hibition necessarily trades in
subtext, indirection and code,
artifacts of a time when sexual
difference was actively policed
& prosecuted,” wrote Jonathan
D. Katz, co-curator of “Hide/
Seek, “ in an e-mail to the Blade.
“Learning to survive under this
regime meant learning codes,
ways of signaling sexuality that,
very often, entailed talking out
of both sides of one’s mouth,
addressing different languages
to queer and non-queer popula-
tions at the same time.”
One of the more striking ex-
amples of this in “Hide/Seek”
is a Carl Van Vechten photo of
choreographer Antony Taylor
and his partner (and dance
protégée) Hugh Laing. I had to
look twice before realizing they
were lovers.
Another example of coded
same-sex imagery in the exhibit
is a 1914 ad. In it are two men,
advertising Arrow shirts. Only at
second glance, do you get that
they’re queer.
“Those who see themselves
as outsiders often have the
most informed perspective on
the language of power — for
it is a matter of survival,” Katz,
director of the visual studies
doctoral program at the State
University of New York at Buf-
falo, added in his e-mail.
In 1989, the Corcoran Gallery
of Art, bowing to political pres-
sure, canceled a Robert Map-
plethorpe retrospective. Today,
our “outsider,” queer perspec-
tive is so welcomed that our art
is on view in our nation’s capital.
The “Hide/Seek” exhibit runs
through Feb. 13 at the National
Portrait Gallery. Visit npg.si.edu
for more information.
Smithsonian puts LGBT people in the picture
Kathi Wolfe is a writer, poet and regu-
lar contributor to the Blade. She can be
reached through this publication.
CFC number 35004
Build Power
Take ACtion
CreaTe ChAnge
CHECK LOCAL LISTINGS FOR THEATERS AND SHOWTIMES

THE MOST FUN YOU’LL
HAVE THIS HOLIDAY!

LAUREN SANCHEZ, EXTRA
ERIC DANE CHER SCREEN GEMS PRESENTS A DE LINE PICTURES PRODUCTION A FILM BY STEVEN ANTIN CHRISTINA AGUILERA “BURLESQUE”
ALAN CUMMING PETER GALLAGHER WITH KRISTEN BELL AND STANLEY TUCCI JULIANNE HOUGH CAM GIGANDET
MUSIC
SUPERVISOR BUCK DAMON
MUSIC
BY CHRISTOPHE BECK
EXECUTIVE
PRODUCERS STACY KOLKER CRAMER RISA SHAPIRO
PRODUCED
BY DONALD DE LINE
WRITTEN AND
DIRECTED BY STEVEN ANTIN
By SUE GOODHART
As the Washington Metro
area heads into the holiday
season, it is a great time for
homeowners to be thankful for
a more stable real estate mar-
ket. Although by no means are
we back to 2006 heights (and
frankly, probably won’t be for
a long time), we have seen a
steadying of home prices re-
sulting in more buying activity
in the lower and higher
price ranges. My
prediction for 2011?
Slow and steady
progress in sales
and prices.
What might
derail this steady
upward trend? In
1994, when Con-
gress did not pass
the budget resolution,
the federal government
shut down. As a result, the
Washington Metro area real es-
tate market suffered through a
tough time. Federal workers,
contractors and suppliers were
crippled and it took some sev-
eral years to recover from the
loss of income. There has been
some talk of shutting down the
government again which could
have a far-reaching effect on
our local real estate market.
Nevertheless, the spring
market is still shaping up to be
an active one. All indications
show that interest rates will re-
main low through the first half of
2011 coupled with lower inven-
tory of homes than in years
past are good signs for
our market. If you are
planning to put your
home on the
mar-
ket after t h e
holidays, the time to start
is now. Regardless of being a
hot market or slow market, the
condition of the property is criti-
cal to whether it will sell quickly
and at a good price. Below are
some of my favorite tips to get
your home in the best possible
showing condition.
Your first step is getting rid of
the clutter! Less is more when
selling a home. When potential
pur chas- e r s
look at a property,
they have to be able to envision
themselves and their posses-
sions in the home. Take a good
hard look at all of the items in
each room. If you don’t use
it, give it away or sell it. If you
can’t bear to part with your stuff
now then pack it up and put it
in storage to sort through when
you have time. Just remem-
ber that you will be paying to
store it and move it, so consider
whether the items, pa-
pers, furniture
or books are
worth that
cost.
Step two
is paint,
r e -
f i n -
ish hard-
wood floors and clean,
stretch or replace carpeting.
Painting freshens the property
and gives it a cleaner look.
While dark paint colors are great
for personalizing your home
and accenting your furniture,
neutrals are best when it comes
time to sell. As hard as it may be,
when selling a home your goal
should be to strip out your per-
sonality to allow anyone to imag-
ine living in the home. There are
some great of shades of cream,
taupe and off white that will form
a soft palette for the new buyer.
Two more essential tasks
are cleaning the windows and
scrubbing the interior of the
home until it sparkles. I have
sold many homes that were not
the most updated, but were
spotless and clutter free and
therefore, very inviting. Being
able to “eat off the floor” is
a sure fire way to sell!
All of these tips
are great ways to
prepare your home
for the market—or
to give it a new
look! For more sug-
gestions, feel free to
e-mail me or give me a
call for a consultation. Also,
remember that the camera
does not lie! Most buyers shop
on the internet and are all looking
for “house beautiful”. Be sure they
don’t move on to the next property
before they have even walked in
the door!
Giving thanks for a stable market
Sue Goodhart is the top producing
agent at McEnearney Associates,
Inc, 109 S Pitt Street. Alexandria, VA
22314 and is licensed in DC, VA &
MD. Sue can be reached at (703)
549-9292 ext 257 or at sue@sue-
goodhart.com. Equal Housing Op-
portunity.
washingtonblade.com • vol. 41, issue 48 • november 26, 2010 • Page 26
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 1 ISSUE DATE: 100709 SALES REP: BP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source
Licensed in DC, MD & VA
The Realtors you refer
to your Friends & Family
The Gale Storm Team
571.236.9329 • info@gayrealtors.us.com
www.gayrealtors.us.com
PUBLIC REAL ESTATE AUCTION
E S T AT E S A L E
www. Aucti onBrokers. net
#1 IN REAL ESTATE MARKETING
410-426-2622
TERMS: Deposit: $3,000dueattimeofsale.
Cash, certified funds, personal or business
check with ID. 30-day settlement. 10%
buyer’spremium. Brokerco-opinvited. See
websiteforfull termsandconditions.
*SaleonPremises
A Charles Parrish Company
410- 426- 2622
THURSDAY, DEC. 9
TH
@ 11AM
CHARLES VILLAGE!
5BR/2.5BA, 2 full
kitchens, separate gas &
electric meters. Must sell
to settle estate.
23 W 27
th
St, Baltimore, MD 21218
John Irvin
443-807-6847
Homeowner or Investor Opportunity
november 26, 2010 • washingtonblade.com 27
MIS-N-10099A.indd
11-1-2010 4:29 PM
Carl / Carl
3
Job
Client
Client #
Media Type
Bleed
Trim
Live
Pubs
Ad Name
Size
Color
MIS-N-10099A
Merck/Isentress
8100030833
Newspaper
None
9.75 in x 10.375 in
None
Watermark November 2010
Job info
None
Notes
Art Director
Copywriter
Account Mgr
Studio Mgr
Proofreader
Yury Vargas
Michelle Mulligan
Anjoli Bido
Wayne Robinson
Lorna Smedman
Approvals
Fonts
Helvetica Neue LT Std (43 Light Extended, 63
Medium Extended, 47 Light Condensed, 77 Bold
Condensed), Optima (Bold)
Images
D85_8036-PA_ISN_brendan_v4-NP.silo.tif
(CMYK; 514 ppi; 136.06%), CoverWing_Rev.
ai (143.75%), MRK24285_ISENTRESS_RGB_
Rbw.ai (34.87%), MRK03741_MERCK_smL-
ogoKO.ai (59.54%)
Inks
Cyan, Magenta, Yellow, Black
Fonts & Images
Date Created None from
Administrator’s Computer
by Printed At
Round
Spell Checked
-- DATE_____________
11-1-2010 5:27 PM Saved at
None
Special Instructions
share:Volumes:share:• CLIENT...-N-10099A Folder:MIS- Save Path
Hey have you heard...
None
4 color
No
T:9.75 in
T
:
1
0
.
3
7
5

i
n
Introducing the Savings Coupon
a
for
ISENTRESS. Eligibility restrictions, terms,
and conditions apply.
a
To find out more, call
1-866-350-9232 or visit isentress.com.
You are encouraged to report negative side
effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.
For eligible privately insured patients. Not valid for
residents of Massachusetts. Restrictions apply.
Please see full Terms and Conditions on isentress.com.
a
Hey, have you heard the news?
For eligible patients, Merck covers
up to $400 on out-of-pocket costs,
for each of up to 12 prescriptions.
Copyright © 2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 21052655(15)-11/10-ISN-CON
28 washingtonblade.com • november 26, 2010
MIS-N-10077B.indd
9-24-2010 10:06 AM
Carl / Carl
2
Job
Client
Client #
Media Type
Bleed
Non-Bleed
Live
Pubs
Ad Name
Size
Color
MIS-N-10077B
Merck Isentress
10077
Newspaper
None
9.75 in x 11.4 in
None
Washington Blade 10/14/10 Florida
Agenda 10/14/10 Gay City News
10/12/10
Job info
Washington Blade 10/14/10
Florida Agenda 10/14/10
Gay City News 10/12/10
Notes
Art Director
Copywriter
Account Mgr
Studio Mgr
Proofreader
John Church
Michelle Mulligan
Anjoli Bido
Wayne Robinson
Lorna Smedman
Approvals
Fonts
Optima LT Std (Bold), Helvetica Neue LT
Std (43 Light Extended, 55 Roman, 56 Italic, 63
Medium Extended, 47 Light Condensed, 77 Bold
Condensed, 47 Light Condensed Oblique)
Images
DiamondBullet.eps, MRK24286_ISENTRESS_
CMYK_R.eps, Supportv2.eps
Inks
Cyan, Magenta, Yellow, Black
Fonts & Images
Date Created None from
Administrator’s Computer
by Printed At
Round
Spell Checked
-- DATE_____________
10-4-2010 10:29 AM Saved at
None Special Instructions
QStudio3:Users:admin:Desktop:M...ers:MIS-N- Save Path
I Am Outgoing...
9.75 x11.4
4 color
No
LEFT PAGE
INDICATIONS
ISENTRESS is an anti-HIV medicine used for the treatment of HIV. ISENTRESS must be used with other
anti-HIV medicines, which may increase the likelihood of response to treatment.
The safety and effectiveness of ISENTRESS in children has not been studied.
It is important that you remain under your doctor’s care.
ISENTRESS will NOT cure HIV infection or reduce your chance of passing HIV to others through sexual
contact, sharing needles, or being exposed to your blood.
IMPORTANT RISK INFORMATION
A condition called Immune Reconstitution Syndrome can happen in some patients with advanced HIV
infection (AIDS) when anti-HIV treatment is started. Signs and symptoms of infammation from opportunistic
infections may occur as the medicines work to treat the HIV infection and strengthen the immune system.
Call your doctor right away if you notice any signs or symptoms of an infection after starting ISENTRESS.
Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness while
taking ISENTRESS. This is because on rare occasions muscle problems can be serious and can lead to
kidney damage.
When ISENTRESS has been given with other anti-HIV drugs, side effects included nausea, headache,
tiredness, weakness, trouble sleeping, stomach pain, dizziness, depression, and suicidal thoughts and actions.
Rash occurred more often in patients taking ISENTRESS and darunavir together than with either drug separately,
but was generally mild.
T:9.75 in
T
:
1
1
.
4

i
n
november 26, 2010 • washingtonblade.com 29
MIS-N-10077B.indd
9-24-2010 10:06 AM
Carl / Carl
2
Job
Client
Client #
Media Type
Bleed
Non-Bleed
Live
Pubs
Ad Name
Size
Color
MIS-N-10077B
Merck Isentress
10077
Newspaper
None
9.75 in x 11.4 in
None
Washington Blade 10/14/10 Florida
Agenda 10/14/10 Gay City News
10/12/10
Job info
Washington Blade 10/14/10
Florida Agenda 10/14/10
Gay City News 10/12/10
Notes
Art Director
Copywriter
Account Mgr
Studio Mgr
Proofreader
John Church
Michelle Mulligan
Anjoli Bido
Wayne Robinson
Lorna Smedman
Approvals
Fonts
Optima LT Std (Bold), Helvetica Neue LT
Std (43 Light Extended, 55 Roman, 56 Italic, 63
Medium Extended, 47 Light Condensed, 77 Bold
Condensed, 47 Light Condensed Oblique)
Images
DiamondBullet.eps, MRK24286_ISENTRESS_
CMYK_R.eps, Supportv2.eps
Inks
Cyan, Magenta, Yellow, Black
Fonts & Images
Date Created None from
Administrator’s Computer
by Printed At
Round
Spell Checked
-- DATE_____________
10-5-2010 10:57 AM Saved at
None Special Instructions
QStudio3:Users:admin:Desktop:M...ers:MIS-N- Save Path
I Am Outgoing...
9.75 x11.4
4 color
No
I am outgoing.
I am on the go.
I am a newlywed.
I am HIV positive.
You are special, unique, and different from anyone else.
And so is your path to managing HIV. When you’re ready
to start HIV therapy, talk to your doctor about a medication
that may ft your needs and lifestyle.
In clinical studies lasting 96 weeks, patients being treated with HIV medication for the
frst time who took ISENTRESS plus Truvada:
Had a low rate of side effects
— The most common side effect of moderate to severe intensity (that interfered
with or kept patients from performing daily activities) was trouble sleeping
— This side effect occurred more often in patients taking ISENTRESS plus Truvada
(4%) versus Sustiva plus Truvada (3%)
Experienced less effect on LDL cholesterol (“bad” cholesterol)
— Cholesterol increased an average of 7 mg/dL with ISENTRESS plus Truvada
versus 21 mg/dL with Sustiva plus Truvada
Ask your doctor about ISeNTReSS.
Not sure where to start? Visit isentress.com/questions
ISENTRESS is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Copyright © 2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
21052250(20)(110)-10/10-ISN-CON
Sustiva is a registered trademark of Bristol-Myers Squibb
Truvada is a registered trademark of Gilead Sciences, Inc.
People taking ISENTRESS may still develop infections, including opportunistic infections or other conditions that
occur with HIV infection.
Tell your doctor about all of your medical conditions, including if you have any allergies, are pregnant or plan to
become pregnant, or are breast-feeding or plan to breast-feed. ISENTRESS is not recommended for use during
pregnancy. Women with HIV should not breast-feed because their babies could be infected with HIV through their
breast milk.
Tell your doctor about all the medicines you take, including prescription medicines like rifampin (a medicine used
to treat infections such as tuberculosis), non-prescription medicines, vitamins, and herbal supplements.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For more information about ISENTRESS, please read the Patient Information on the following page.
Call 1-866-350-9232 Need help paying for ISENTRESS?
RIGHT PAGE
T:9.75 in
T
:
1
1
.
4

i
n
30 washingtonblade.com • november 26, 2010
MIS-N-10081B.indd
9-24-2010 11:12 AM
Carl / Carl
1
Job
Client
Client #
Media Type
Bleed
Trim
Live
Pubs
Ad Name
Size
Color
MIS-N-10081B
Merck Isentress
10077
Newspaper
None
9.75 in x 11.4 in
None
Wash.Blade 10/14-10/28 Florida
Agenda 10/14
Gay City News 10/12
Job info
Wash.Blade 10/14-10/28 Florida Agenda 10/14
Gay City News 10/12
Notes
Art Director
Copywriter
Account Mgr
Studio Mgr
Proofreader
John Church
Michelle Mulligan
Anjoli Bido
Wayne Robinson
Lorna Smedman
Approvals
Fonts
None
Images
MIS-N-10081B.ART.x1a .pdf (102.7%)
Inks
Cyan, Magenta, Yellow, Black
Fonts & Images
Date Created None from
Administrator’s Computer
by Printed At
Round
Spell Checked
-- DATE_____________
9-27-2010 11:17 AM Saved at
None
Special Instructions
QStudio3:Users:admin:Desktop:M...ers:MIS-N- Save Path
PPI
9.75 x16
B&W
No
MIS-M-10073C.indd
9-8-2010 11:43 AM
Carl / Carl
1
Job
Client
Client #
Media Type
Bleed
Non-Bleed
Live
Pubs
Ad Name
Size
Color
MIS-M-10073C
Merck
8100030833/1001
Magazine
None
7 in x 9.75 in
None
HIV PLUS
Job info
SEPTEMBER 2010
Notes
Art Director
Copywriter
Account Mgr
Studio Mgr
Proofreader
John Church
Michelle Mulligan
Anjoli Bido
Wayne Robinson
Lorna Smedman
Approvals
Fonts
Helvetica Neue (57 Condensed, 77 Bold
Condensed)
Images
MRK24287_ISENTRESS_BLK_R.eps
Inks
Black
Fonts & Images
Date Created None from
Administrator’s Computer
by Printed At
Round
Spell Checked
-- DATE_____________
9-17-2010 10:05 AM Saved at
None
Special Instructions
QStudio3:Users:admin:Desktop:M...ORK:MIS-M- Save Path
PPI
7X10
B&W
No
Read the patient information that comes with ISENTRESS
1
before you start taking
it and each time you get a refll. There may be new information. This leafet is a
summary of the information for patients. Your doctor or pharmacist can give you
additional information. This leafet does not take the place of talking with your
doctor about your medical condition or your treatment.
What is ISENTRESS?
• ISENTRESS is an anti-HIV (antiretroviral) medicine used for the treatment
of HIV. The term HIV stands for Human Immunodefciency Virus. It is the
virus that causes AIDS (Acquired Immune Defciency Syndrome). ISENTRESS
is used along with other anti-HIV medicines. ISENTRESS will NOT cure HIV
infection.
• PeopletakingISENTRESSmaystilldevelopinfections,including
opportunistic infections or other conditions that happen with HIV infection.
• StayunderthecareofyourdoctorduringtreatmentwithISENTRESS.
• The safety and effectiveness of ISENTRESS in children has not been studied.
ISENTRESS must be used with other anti-HIV medicines.
How does ISENTRESS work?
• ISENTRESSblocksanenzymewhichthevirus(HIV)needsinordertomake
morevirus.TheenzymethatISENTRESSblocksiscalledHIVintegrase.
• Whenusedwithotheranti-HIVmedicines,ISENTRESSmaydotwothings:
1. Reduce the amount of HIV in your blood. This is called your “viral load”.
2. Increase the number of white blood cells called CD4 (T) cells.
• ISENTRESSmaynothavetheseeffectsinallpatients.
Does ISENTRESS lower the chance of passing HIV to other people?
No. ISENTRESS does not reduce the chance of passing HIV to others through sexual
contact,sharingneedles,orbeingexposedtoyourblood.
• Continuetopracticesafersex.
• Uselatexorpolyurethanecondomsorotherbarriermethodstolowerthe
chance of sexual contact with any body fuids. This includes semen from a
man,vaginalsecretionsfromawoman,orblood.
• Neverre-useorshareneedles.
Ask your doctor if you have any questions about safer sex or how to prevent
passing HIV to other people.
What should I tell my doctor before and during treatment with ISENTRESS?
Tell your doctor about all of your medical conditions. Include any of the following
thatappliestoyou:
• Youhaveanyallergies.
• Youarepregnantorplantobecomepregnant.
- ISENTRESS is not recommended for use during pregnancy.
ISENTRESS has not been studied in pregnant women. If you take
ISENTRESSwhileyouarepregnant,talktoyourdoctorabouthow
youcanbeincludedintheAntiretroviralPregnancyRegistry.
• Youarebreast-feedingorplantobreast-feed.
- It is recommended that HIV-infected women should not breast-feed
their infants. This is because their babies could be infected with HIV
through their breast milk.
- Talk with your doctor about the best way to feed your baby.
Tell your doctor about all the medicines you take. Include the following:
• prescriptionmedicines,includingrifampin(amedicineusedtotreatsome
infections such as tuberculosis)
• non-prescriptionmedicines
• vitamins
• herbalsupplements
Know the medicines you take.
• Keepalistofyourmedicines.Showthelisttoyourdoctorandpharmacist
when you get a new medicine.
How should I take ISENTRESS?
Take ISENTRESS exactly as your doctor has prescribed. The recommended
dose is as follows:
• Takeonlyone400-mgtabletatatime.
• Takeittwiceaday.
• Takeitbymouth.
• Takeitwithorwithoutfood.
Do not change your dose or stop taking ISENTRESS or your other anti-HIV
medicines without frst talking with your doctor.

IMPORTANT: Take ISENTRESS exactly as your doctor prescribed and at the
right times of day because if you don’t:
• Theamountofvirus(HIV)inyourbloodmayincreaseifthemedicineis
stopped for even a short period of time.
• The virus may develop resistance to ISENTRESS and become harder to treat.
• YourmedicinesmaystopworkingtofghtHIV.
• TheactivityofISENTRESSmaybereduced(duetoresistance).
1
RegisteredtrademarkofMerckSharp&DohmeCorp.,asubsidiaryofMerck & Co., Inc.
Copyright©2010MerckSharp&DohmeCorp.,asubsidiaryofMerck & Co., Inc.
All rights reserved.
Patient Information
ISENTRESS
®
(eye sen tris)
(raltegravir) Tablets
If you fail to take ISENTRESS the way you should, here’s what to do:
• Ifyoumissadose,takeitassoonasyouremember.Ifyoudonot
rememberuntilitistimeforyournextdose,skipthemisseddoseandgo
back to your regular schedule. Do NOT take two tablets of ISENTRESS at the
sametime.Inotherwords,doNOTtakeadoubledose.
• IfyoutaketoomuchISENTRESS,callyourdoctororlocalPoisonControl
Center.
Be sure to keep a supply of your anti-HIV medicines.
• WhenyourISENTRESSsupplystartstorunlow,getmorefromyourdoctor
or pharmacy.
• Donotwaituntilyourmedicinerunsouttogetmore.
What are the possible side effects of ISENTRESS?
When ISENTRESS has been given with other anti-HIV drugs, side effects
included:
• nausea
• headache
• tiredness
• weakness
• troublesleeping
• stomachpain
• dizziness
• depression
• suicidalthoughtsandactions
Other side effects includerash,severeskinreactions,feelinganxious,paranoia,
low blood platelet count.
A condition called Immune Reconstitution Syndrome can happen in some
patients with advanced HIV infection (AIDS) when combination antiretroviral
treatment is started. Signs and symptoms of infammation from opportunistic
infections that a person has or had may occur as the medicines work to treat
the HIV infection and help to strengthen the immune system. Call your doctor
right away if you notice any signs or symptoms of an infection after starting
ISENTRESS with other anti-HIV medicines.
Contactyourdoctorpromptlyifyouexperienceunexplainedmusclepain,
tenderness,orweaknesswhiletakingISENTRESS.Thisisbecauseonrare
occasions,muscleproblemscanbeseriousandcanleadtokidneydamage.
Rash occurred more often in patients taking ISENTRESS and darunavir together
thanwitheitherdrugseparately,butwasgenerallymild.
Tell your doctor if you have any side effects that bother you.
ThesearenotallthesideeffectsofISENTRESS.Formoreinformation,ask
your doctor or pharmacist.
How should I store ISENTRESS?
• StoreISENTRESSatroomtemperature(68to77°F).
• Keep ISENTRESS and all medicines out of the reach of children.
General information about the use of ISENTRESS
Medicines are sometimes prescribed for conditions that are not mentioned in
patient information leafets.
• DonotuseISENTRESSforaconditionforwhichitwasnotprescribed.
• DonotgiveISENTRESStootherpeople,eveniftheyhavethesame
symptoms you have. It may harm them.
This leafet gives you the most important information about ISENTRESS.
• Ifyouwouldliketoknowmore,talkwithyourdoctor.
• Youcanaskyourdoctororpharmacistforadditionalinformationabout
ISENTRESS that is written for health professionals.
• Formoreinformationgotowww.ISENTRESS.comorcall1-800-622-4477.
What are the ingredients in ISENTRESS?
Active ingredient:Eachflm-coatedtabletcontains400mgofraltegravir.
Inactive ingredients:Microcrystallinecellulose,lactosemonohydrate,calcium
phosphatedibasicanhydrous,hypromellose2208,poloxamer407(contains0.01%
butylatedhydroxytolueneasantioxidant),sodiumstearylfumarate,magnesium
stearate.Inaddition,theflmcoatingcontainsthefollowinginactiveingredients:
polyvinylalcohol,titaniumdioxide,polyethyleneglycol3350,talc,redironoxide
and black iron oxide.
Distributedby:
MerckSharp&DohmeCorp.,asubsidiaryofMerck & Co., Inc.
WhitehouseStation,NJ08889,USA
RevisedJune2010
9795110
U.S.PatentNos.US7,169,780 21052250(20)(110)-10/10-ISN-CON
T:9.75 in
T
:
1
1
.
4

i
n
november 26, 2010 • washingtonblade.com 31
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: BRIAN PITTS (bpitts@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Uptown DC Offce 202.362.3400
Valerie M. Blake
Associate Broker, GRI
202.246.8602
Valerie@DCHomeQuest.com
www.DCHomeQuest.com
Valerrealestate.blogspot.com
I used to hate my commute.
The Beltway was insane
but now my new condo’s just
a ffteen-minute ride on the train.
Sung to the tune of: I Whistle a Happy Tune
W
h
is
t
lin
g
o
n
t
h
e
M
e
t
r
o
32 washingtonblade.com • november 26, 2010
TI S THE SEASON. . . TO SAVE
Two great packages startingat
$99.The perfect holiday gift.
VISIT studiotheatre.org/3Play
OR CALL 202.332.3300 14TH AND P STREETS, NW
Marcus; Or the Secret of Sweet
by Tarell Alvin McCraney
The New Electric Ballroom by Enda Walsh
Venus in Fur by David Ives
1
2
P A C K A G E
Tynan by Richard Nelson and Colin Chambers
The Walworth Farce by Enda Walsh
The History of Kisses
written and performed by David Cale
P A C K A G E
STUDIO
THEATRE
By Juliette M. eBner
Editor’s note: This is the second of a fve-part series on holiday gift-giving ideas. We’ll ex-
plore gift ideas in several categories. This week: electronics, gadgets and more.
As Black Friday and Cyber Monday come up again, a lot of retailers will be offering big
sales. Here are some electronics to look for that will likely be offered at some great prices.
Techie wonders
Here are several red hot stocking stuffers that’ll have you
surfng, texting and gaming in new, fun ways
WASHI NGTONBLADE. COM NOVEMBER 26, 2010 • 33
eReadeRs
Amazon’s Kindle with WiFi now comes in a different color, graphite. The new reader is
smaller, but has the same 6-inch screen. It’s 17 percent lighter and has double the stor-
age. Out-of-copyright books are free as well as samples and all other books are $9.99 or
less. The Kindle is $139 and can be bought at amazon.com or Staples.
Barnes & Noble’s NOOK now comes with a 7-inch color touchscreen. The NOOKcolor
includes a new feature, NOOKkids, which brings picture books to life for children and will
even read the books out loud. Books are $9.99 or less. NOOKcolor with wif is $249 and
can be purchased from b&n.com or other stores including Best Buy.
Sony’s Reader Touch Edition features a 6-inch clear touch screen that “reads like a real book.”
Coming in two colors, red or black, the Reader can hold up to 50,000 books, allows for freehand
highlight and note taking, and can play MP3 audio fles. The Reader costs $229.99 and can be
purchased as sony.com or many other stores including Wal-Mart.
apple
Apple has redesigned its iPod Nano. Now just big enough to
ft a small touchscreen, the Nano no longer has the click wheel
like the Classic and you can shuffe through songs with a quick
shake. You can even listen to FM radio. Also has a built-in clip
to listen hands free. An 8GB nano is $149 and a 16GB is $179.
iPod Touch has received an update as well. It now fea-
tures FaceTime, HD video recording and a dual camera
for taking pictures on either side of the iPod. An 8GB
Touch is $229, a 32GB is $299 and a 64GB is $399.
Apple iPad, starting from $499, has a 9.7-inch Multi-
Touch display and features many of the same apps as
an iPhone, with some apps only compatible on the iPad.
Makes for a great photo album or screen to watch mov-
ies. The iPad comes in 16GB, 32GB and 64GB models.
Apple TV ($99) hooks up to your television at home giving
you instant access to HD movies on iTunes as well as Netfix,
YouTube and more. Have an iPod, iPhone or iPad? Download
the remote app and control Apple TV with one touch.
Continues on page 34
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered final and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF # 4 ISSUE DATE 11.19.10 SALES REPRESENTATIVE JERYL PARADE jparade@washblade.com
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
202.833.8724 • DUPONT CIRCLE • 1325 18TH ST NW SUITE 203 • FOGGY BOTTOM • 730 24TH ST NW SUITE 9 • dcdentalspa.com
THE COMPLETE BEAUTY PACKAGE
COMPLETE INVISALIGN TREATMENT
CLEANING FOR 1 YR
TEETH WHITENING
AT END OF TREATMENT
• early morning & late evening appointments
• both locations are metro accessible
• 0% financing, up to 12 months
• conscious sedation available
• 3D imaging scanning
• biolase laser - no shot, no drill, no pain
CALL NOW TO SCHEDULE YOUR FREE SMILE CONSULTATION
RESTRICTIONS & LIMITATIONS APPLY.
MUST PRESENT THIS AD TO RECEIVE
THIS SPECIAL.
REX H. HOANG, DMD
FI ND THE 10 MOST INTERESTING APPS FOR i PHONE ON WASHINGTONBLADE.COM
34 • NOVEMBER 26, 2010 WASHI NGTONBLADE. COM
CONTINUED FROM PAGE 33
Techie wonders
VIDEO GAMES
Playstation 3 has come out with new hard-
ware giving games a more interactive feel with
MOVE. Amazon.com is offering a bundle with
a 320 GB console and a Move starter pack
which includes the EyeCam, Move controller
and Sports Champions game for $399.
PS3 game, HEAVY RAIN ($59.99), is an ac-
tion-packed adventure with four playable char-
acters with savable chapters. It has become
Move compatible through a Playstation Net-
work software update.
In celebration of the 25th anniversary of the “Super
Mario Bros.” game, Ninetendo is releasing a spe-
cial limited edition RED WII BUNDLE this holiday
season. The bundle includes red versions of the
console, Wii remote, nunchuck and a copy of New
Super Mario Bros. Wii and Wii Sports ($199.99).
“DONKEY KONG COUNTRY RETURNS”
($49.99) is on Wii and is the first time in the fran-
chise history that two people can play together at
the same time, one as Donkey Kong and one as
Diddy Kong.
Xbox 360 also has new hardware to make its
games more interactive with KINECT, which makes
the player the controller. Microsoft is offering a bun-
dle with a 250 GB console, the Kinect censor, “Ki-
nect Adventures” game and a choice of a second
game, including “Kinect Sports,” all for $449.98.
“DANCE CENTRAL” is a new game with a
soundtrack that spans today’s current pop, hip-
hop and R&B artists with dance routines that
incorporate authentic choreography without the
use of any controller.
GADGETS AND ACCESSORIES
HEARTBEATS (pictured on page 33) are
high performance in-ear headphones de-
signed by Lady Gaga. These give pitch-
perfect highs and club caliber bass. Avail-
able in Black Chrome, Bright Chrome and
Rose Red with or without ControlTalk, a
built-in mic that enables hands-free calls
and chat ($119.95 or $149.95).
C.H.I.M.P REARVIEW MONITOR MIRROR,
available at thinkgeek.com, is a mirror that fits
easily on either corner of a monitor with velcro
to see who is coming up from behind ($7.99).
MIMOBOT offers a variety of designer
USB Flash Drives including characters
from Hello Kitty, Star Wars, Halo and Happy
Tree Friends as well as original characters
like Fairybit. Prices range from $24.95 for
a 2GB drive to $79.95 for 16GB. Visit mi-
moco.com to purchase.
KIWI U-POWERED ($59.99) can be
charged by USP port, car charger, solar
energy and a wall charger then will hold its
power for at least six months. Compatible
with phones, iPods, iPad, GPS and more,
the charger comes with a pack of 11 differ-
ent tips to charge all your electronic gad-
gets. Find at kiwichoice.com.
THE HARMONY ONE ADVANCED UNI-
VERSAL REMOTE ($249.99) from Logitech
features a backlit, full-color touch screen,
can control up to 15 devices and recharges
with included base, getting rid of the need
for batteries. Available at logitech.com.
THINKGEEK.COM’S RETRO PHONE
HANDSET ($29.99) connects to most cell
phones via a 2.5mm jack, but not some
newer Blackberry models, RAZR or Nokia
phones and no batteries required. You can
also get the Bluetooth Retro Handset which
works with Bluetooth V1.0, 1.1 and 1.2 with
a USB charged battery ($29.99).
november 26, 2010 • washingtonblade.com 35
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 10.29.10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
a & s sales, inc.
Get Excited!
From conception to completion, our professional design
consultants will assist you with any project, large or small.
View photos of completed projects at asgranite.com.
Your Complete Source for Kitchen & Bath Remodeling • Serving the Community since 1971
Granite • marble • ceramic tile • cabinetry
www.asgranite.com • sales@asgranite.com
458 S. Pickett Street • Alexandria, VA 22304 • 703-461-8200
9834 Liberty Road • Frederick, MD 21701 • 301-898-7400
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #2 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
36 washingtonblade.com • november 26, 2010
Wednesday, december 1, 2010
candlelight Vigil
5:30 pm | Dupont CirCle
Co-presented by Bet Mishpachah & the DC Center
AIDS DAY
WORLD
Persistent Voices
a special night of poetry, reflection, art, fellowship & remembrance
thurgooD marshall Center | 1816 12th st., nW | 6:30 pm
Presented by the DC Center, Us Helping Us, Ganymede Arts,
the Vaccine Research Center & Whitman-Walker Clinic.
Wednesday, december 1, 2010
Free conFidential hiV testing
elizabeth taylor meDiCal Center | 1701 14th st., nW | 9:00 am – 5:00 pm
max robinson Center | 2301 mlk Jr. ave., se | 9:00 am – 4:30 pm
red hot night at Urbana
to benefit Whitman-Walker
hotel palomar | 2121 p st., nW | 5:30 – 8:30 pm
tUesday, noVember 30, 2010
arts & entertainment
washingtonblade.com • vol. 41, issue 48 • november 26, 2010 • Page 37
Bishop Rainey Cheeks ansWeRs 20 Gay
QUesTions, paGe 38
Continues on page 49
Singer/actor Levi Kreis fnds redemption
in open living and catchy pop songs
great balls of honesty
By DaViD J. hoFFMan
In an extraordinary double-bill of gay musical talent, sing-
er-songwriters Levi Kreis and Eric Himan perform together
here for one night only — Monday — at Jammin’ Java, a
music club in Vienna, in suburban Fairfax County, Virginia.
Tony Award-winning Kreis himself stands on the verge of
big-time success with superstardom likely just around the
corner, born of songs both tender and tough-minded, about
being gay and searching for love in today’s changing America.
Kreis and Himan each have new albums fully “out” in their
openness, their music videos are often in heavy rotation on
MTV’s Logo Channel, and their songs are big on Sirius XM
satellite radio’s OUTQ Channel. Kreis’s new album, “Where
I Belong,” is “all about acceptance and surrender,” he says,
while Himan, who is often compared with singers John May-
er, Ani DiFranco and Tracy Chapman, already has six studio
albums including his newest, “Resonate.”
He opens for Kreis, who vaulted to mainstream recogni-
tion earlier this year when he won the Tony for Best Actor
in a Musical playing rock ‘n’ roll icon Jerry Lee Lewis, the
Louisiana wild man famed for “Great Balls of Fire,” in the
hit Broadway show “Million Dollar Quartet” about what was
arguably rock’s frst supergroup.
Like Lewis, Kreis is also a Southern boy, but at 29, he is
a soulful pop-gospel crooner whose sultry-but-smooth-as-
silk voice hints much more of Harry Connick, Jr. and confes-
sional bearings of the heart than tearing up the foor like the
hyper-kinetic Lewis.
With his freshly minted Tony award and his new album,
Kreis is on a career roll. Now on his national tour during
those Mondays when Broadway shows go dark, he seeks
that connection with his audience that studio albums can’t
provide.
His messages — from “Let it rain, let it pour, this is what I
came here for” in the closing refrain of his characteristically
upbeat love song, “I’m Not Afraid,” to the urgent demand of
“give me everything or nothing at all” — have resonated with
fans. Kreis has been openly gay since his 2005 album, “One
of the Ones.”
“These were personal songs about guys,” he says, “and I
decided to come out with this CD.”
Even so, sometimes his lyrics are written as if sung to a
woman and others are quite gender-neutral like the gospel-
styled “Nothing At All.” Many of his fans today are, he says,
“35- to 40-year-old straight women.” His looks help in that
department, cer-
tainly, but also his
accessible songs and
obvious talent — he’s
also a keyboard wiz.
His origins are buckle on
the Bible Belt. Born in Oliver
Springs, Tenn., where he grew
up in a fundamentalist Baptist
home, christened Matthew, it was
only later that he decided to change
his name to Levi after studying the Torah,
the fve books of the prophet Moses. Re-
naming himself was a defnite statement
of what he calls his “amalgamated spiri-
tual views from a lifetime of seeking.”
“I may not ft neatly into any box, and I
certainly don’t ft into Christianity, but I still
seek the experience of God, and that’s the
bottom line,” he told the Blade in a phone
interview from New York City. “I believe in
a very all-inclusive God, expressing itself
through you and through me just as we are.”
These days, in fact, he is starting his third year
studying religion with classes offered through the
United Centers for Spiritual Living, connected with
the Unity Church.
His singing and his spirituality remain in their es-
sence one and the same. He learned his gospel and
country roots, he says, “when I was knee-high to a grass-
hopper,” and in church he says, “you learn very quickly that
people sing out of conviction. They are singing to let you
know that you are loved, forgiven and you can be healed.”
Aged 6, he came home from kindergarten graduation and
sat down at the piano playing the orchestral march “Pomp
and Circumstance” by ear. His legs were still so short his
older brother had to work the pedals for him.
His parents soon enrolled him in formal piano lessons and
at 8 he began to perform in churches, touring throughout the
South, and he produced his frst gospel album — “Just Trust”
— at age 15. While still in high school, he studied classical
piano and music theory and history at Vanderbilt University in
Nashville, and after fnishing high school he moved on to Bel-
mont University, the largest Christian university in Tennessee.
Levi kreis joins fellow singer/songwriter Eric
Himan on the ‘SideXSide Tour’ at Jammin’
Java Monday. (Photo courtesy of LaFamos)
By JOEY DiGUGLIELMO
joeyd@washblade.com
Bishop Kwabena Rainey Cheeks, 58, is the
pastor of Washington’s Inner Light Ministries. The
long-time HIV activist says the disease — which
will be commemorated Wednesday for World
AIDS Day — is still a major issue and young peo-
ple should take it seriously.
“The term that gets me is ‘manageable dis-
ease,’” he says. “When you see people taking 10
or 15 pills a day, when you see people who can-
not get up out of bed still happening today, you
don’t see the effects today as it was back then. In
the early days, you could tell when someone was
positive. You could see they were sick, they lost
weight. You don’t see that much today but peo-
ple are still dying today. I’m still in hospitals with
people today. I hear people say, ‘Oh, but it doesn’t
affect me.’ I’m going, ‘Ahhh.” It is a big deal. Even
today you have people who are drug resistant.”
Cheeks, who’s openly gay and HIV-positive,
preaches a doctrine of what he calls “radical in-
clusiveness,” which he says affrms “God’s uncon-
ditional acceptance and universal law of love.”
The Washington native grew up Catholic in an
abusive home but eventually found respite in martial arts. In 2002 he founded the
non-denominational “Inner Light,” a Christian church that he says welcomes anyone.
He previously managed the Club House, a formerly popular black nightlife spot that
closed in 1990. His own battle with HIV and the staggering toll it took on his friends
— he often mentions the 17 funerals he conducted in November 1988 — inspired
him to found Us Helping Us, a local HIV charity.
Cheeks has one son, Kwaku or “Q.” He enjoys African drumming and is a li-
censed massage therapist. He likes relaxing with close friends and a good glass of
wine. Cheeks is single and lives in Columbia Heights.
QUEERY: 20 Questions for Kwabena Rainey Cheeks
38 washingtonblade.com • november 26, 2010
How long have you been out and who
was the hardest person to tell?
I was never in. The hardest person to
tell my mother. After that I did not care.
Who’s your gay hero?
I can’t say I have a hero but I will say
I have a lot of respect for many people
on the frontline. I will name Billy S. Jones
as one — and every LGBT person who
dares to live in the truth of who they are.
What is Washington’s best nightspot,
past or present?
The Club House — great friends,
great music and one of the best sound
systems ever. You had to be there.
Describe your dream gay wedding.
It keeps changing but it will be a small
intimate setting with a couple hundred of
my friends.
What non-gay issue are you most
passionate about?
Freedom and rights for all regardless
of race or gender.
What historical outcome would you
change?
None because it would change where
we are today. Learn from the past and
move forward.
What’s been the most memorable pop
culture moment of your lifetime?
Disco clubs. That era was so much fun.
On what do you insist?
Honesty frst always in all ways. With
that everything else has a foundation to
work from.
What was your last Facebook post or
Tweet?
Whatever you truly believe about your-
self you will fnd a way to prove it.
If your life were a book, what would
the title be?
“Thank God I Had a Ball and I Would
Do it Again!”
If science discovered a way to change
sexual orientation, what would you do?
Turn the page and move on. There is noth-
ing for me to change. I love me just as I am.
What do you believe in beyond the
physical world?
Some may use the term God or Divine
Presence. There is something greater
than this and one day everyone will have
to face all that they have done or said.
What’s your advice for LGBT move-
ment leaders?
Remember it is not about you. Make
sure that you remember those who were
before you. Reach back and help the
next generation of young leaders behind
you without being too critical. And take
time to enjoy the journey.
What would you walk across hot
coals for?
My son and some good chocolate.
But please don’t tell my trainer about the
chocolate!
What gay stereotype annoys you most?
That all gay folks want is to do is party
and have sex. We are so much more than
that but even some of us have bought
into that image.
What’s your favorite gay movie?
I have two: “Victor/Victoria” and “Holi-
day Heart.” Both of them will make you
laugh one minute and cry the next.

What’s the most overrated social
custom?
“Texting.” I know it’s good for a short
message like “on the way” or “be there in
a min.” But after that I think I deserve a
personal call. I know, I know.
What trophy or prize do you most covet?
I was a silver medalist in the frst world
championship in Tae Kwon Do.
What do you wish you’d known at 18?
I think how to handle money like in-
vestments. I’m trying to make sure my
son learns it to make sure his life is easier.
Why Washington?
I have been around the world but I
love D.C. because it has a little of every-
thing here. Not too slow or too fast.
Washington Blade photo by Michael Key
Washington Blade photo by Michael Key
Quality sleep remains elusive for many.
Photo courtesy of iStockphoto.com
Tips for catching some
zzzzzzs when counting
sheep won’t cut it
By KEVIN M. NORRIS
Lack of sleep is insipid and can affect
everything you do throughout your day.
Chronic insomnia can be fatiguing and
can leave you exhausted, taking a toll
on your energy, your mood and ability to
function and think clearly.
Insomnia is the inability to get the sleep
your body needs to wake up feeling rest-
ed, refreshed and wide-eyed. Since ev-
eryone needs different amounts of sleep,
insomnia is defined by the quality of your
sleep. While eight hours may seem like a
healthy amount, it is only if you are sleep-
ing well and wake up feeling rejuvenated.
While insomnia is the sleep complaint,
it is not the sole issue. Insomnia is caused
by a myriad of factors and symptoms and
the roots of insomnia differ from person to
person generally with underlying concerns
causing the insomnia. The good news is
that insomnia can commonly be cured
through a series of strategies and habits.
Ironically, I started writing this column at
4 in the morning. I have been having sleep
issues for some time and over the years I
have applied countless sleep techniques
to help me fall asleep and techniques to
get me back to sleep if I wake up too early.
In researching this column, I was be-
sieged by the extensive research on the
myriad of causes and the variety of rem-
edies. While some work for me and some
have little effect, my quest for a good
night’s sleep remains constant and I will
continue on this journey.
Here is my list of what I have found suc-
cessful coupled with what I have learned
from others and an abridged version of the
more regarded research from Mayo Clinic,
Scientific American, WebMD and others.
Insomnia can be a sign of an undiag-
nosed medical or psychological condi-
tion. If insomnia persists for more than a
few weeks, it’s best to see your doctor
for a physical exam. Determining the
causes, particularly medically based,
can also help you discover healthy sleep
habits and get the treatment you need.
What causes insomnia? There are too
many possibilities to count. Some of the
most common and wide-spread are stress,
anxiety, depression, restless legs syndrome,
sleep apnea and certain medications.
The list for insomnia remedies is ex-
tensive as well. What are some of the
most successful insomnia remedies? I
have narrowed this list to the more preva-
lent and widely regarded solutions.
Avoid exercise or vigorous activity at
least two hours before going to bed.
Avoid heavy meals 90 minutes before
bed, especially fat-laden foods.
Avoid alcohol in excess, which can cause
interrupted sleep and dehydrate you. Also,
avoid caffeine and other stimulants such as
nicotine, at least six hours before bedtime.
Take a hot bath. My secret home remedy is
1 cup of kosher salt, one-fourth cup of olive oil,
10 chamomile or lavender mint tea bags and
bath wash. The salt permeates your muscles,
the olive oil moistens your skin and the cham-
omile, lavender and mint relaxes you. Light
some candles and play soft music as well.
Maintain a regular sleep schedule
including weekends to help set your
body’s clock to keep your sleep patterns
consistent. Avoid naps unless absolutely
necessary. Naps should not be longer
than 90 minutes.
Use your bed for sleeping and sex
only. Watch TV and read in another room.
Eat some sleep-inducing foods such
as a banana, turkey or peanut butter and
drink herbal tea or warm milk.
Avoid stimulating activities and stress-
ful situations before going to bed, such
as working on the computer or preparing
for a morning meeting.
Adopt a relaxing bedtime routine. Dim the
lights and listen to calming, soothing music
with some aroma sleep-inducing therapeutic
oils like lavender, orange and rosemary.
If you wake up and cannot get back
to sleep within a few minutes, get up and
do something relaxing. Tossing and turn-
ing and trying to force yourself to sleep
will be to no avail.
Helpguide.org has sleep tips and re-
laxation techniques as do a bounty of
other websites.
I hope by developing healthy habits and
sound strategies that you will be on your
way to better sleep. I would love to hear
from you with your insomnia remedies and
suggestions. Please send me an e-mail
with your most successful sleep remedies.
Sleep well.
FITNESSAGENDA
Elusive slumber
november 26, 2010 • washingtonblade.com 39
Kevin M. Norris is a
health and fitness
columnist for the Blade
and owner of Mind
our Own Body, LLC.
Personal Training. Reach
him at kevinmnorris@aol.com.
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered final and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-12-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Tsunami hits DC • NOW OPEN!
Tsunami
Sushi & Lounge
We don’t make waves.
We make sushi.
MONDAY - THURSDAY
Lunch: 12 pm - 3 pm
Dinner: 5 pm - 12 am
FRIDAY
Lunch: 12 pm - 3 pm
Dinner: 5 pm - 1 am
SATURDAY
12 pm - 1 am
SUNDAY
12 pm - 12 am
Happy Hour Specials • 5-8 pm
Lounge Area Only
Monday-Friday
$2 Tsunami Shot
$4 Sapporos Beer
$5 Rail Drinks, House Frozen Drinks
$5 Hot Sake (300ml)
$7 Special Cocktails
50% off Starters Menu
Sunday Sake Night
$5 Hot Sake (300ml)
25% off all Cold Sake bottles all night - Cool Deal!
50% off Starters Menu
Lunch Specials Only $14.95
Tsunami Sushi & Lounge
1326 14th Street, NW • 2nd Floor • Washington, DC 20005
Phone: 202.588.5889/202.588.5599 • Fax: 202.588.5788 • Email: info@tsushi.us
Owned and Operated by Thai Tanic staff.
Consuming raw or under cooked meats, poultry, seafood,shellfsh, or eggs may increase your risk of food-bourne illnesses, especially if you have certain
medical conditions. *Please advise a member of our staff regarding any queries about allergies. *Prices subject to change without notice.
THE GUIDE TO ARTS & CULTURE
40 washingtonblade.com • november 26, 2010
HOT HITS AND HIDDEN JEWELS
NSO Pops: Jennifer Holliday in Concert
Marvin Hamlisch, conductor
Nov 26 - Nov 27
National Symphony Orchestra
Kennedy Center
202-467-4600
kennedy-center.org
Tony Award winner Jennifer Holliday performs with the NSO
Pops and conductor Marvin Hamlisch in a program that in-
cludes such Dreamgirls hits as ‘And I Am Telling You I’m Not
Going’ and ‘Changing,’ along with other audience favorites.
The King’s Singers: Joy to the World
Wed, Dec 1
Strathmore
301-581-5100
strathmore.org
The King’s Singers concert is an evening among gloriously
gifted friends. The Grammy Award winning ensemble re-
turns to Strathmore with a holiday program that takes the
audience from medieval treasures to 20th century favor-
ites, including ‘The Angel Gabriel,’ ‘What Child Is This,’ ‘Stille
Nacht’ and ‘The Twelve Days of Christmas.’
Call Me Madam - A Tribute to Irving Berlin
Sat, Dec 4
The Embassy Series
Embassy of Luxembourg
202-625-2361
embassyseries.org
Perle Mesta, the ‘hostess with the mostest’ was one of the
foremost socialites in Washington in the 30’s, 40’s and 50’s
and was appointed Ambassador to Luxembourg by Presi-
dent Truman. Madam Ambassador inspired Irving Berlin to
write a great musical ‘Call Me Madam.’ The unique program
will feature songs from the musical.
The Master and Margarita
Through Dec 12
Synetic Theater
Lansburgh Theatre
202-547-1122
synetictheater.org
The Master and Margarita reunites Paata and Irina Tsi-
kurishvili in an adaptation of Mikhail Bulgakov’s master-
piece about the devil’s visit to Stalin’s Moscow ñ a power-
ful tale about the juxtaposition of good and evil, sacrifcing
for love, and artistic struggles in a repressive society.
The Guide to Arts & Culture is produced by CultureCapital.com, the one-stop shop to arts & culture for
Metro DC, a program of the Cultural Alliance of Greater Washington. MASTER AND MARGARITA: Sup-
plied by Synetic Theater; JENNIFER HOLLIDAY: Supplied by National Symphony Orchestra; THE KING’S
SINGERS: Supplied by Strathmore; CALL ME MADAM: Supplied by The Embassy Series.
OPENINGS
Wed, Dec. 1
A Wrinkle in Time, Round House The-
atre Bethesda. 240-644-1100. round-
housetheatre.org
Mojo, Studio Theatre. 202-332-3300.
studiotheatre.org
Thu, Dec. 2
Almost, Maine, American University
Rude Mechanicals, American University
Katzen Arts Center. 239-738-4450. au-
rudemechanicals.com
National Symphony Orchestra: Em-
manuel Krivine, conductor Louis Lortie,
piano, plays Beethoven, Kennedy Cen-
ter. 202-467-4600. kennedy-center.org
The Washington Ballet: The Nutcracker,
Warner Theatre. 202-397-7328. washing-
tonballet.org
LAST CHANCE
Sat, Nov. 27
13th International Festival of Hispanic
Theater, Teatro de la Luna, Gunston The-
atre Two. 703-548-3092. teatrodelaluna.org
Drops of Water/Gotas de Agua,Teatro
de la Luna, Gunston Theatre Two. 703-
548-3092. teatrodelaluna.org
One Night with Fanny Brice, American
Century Theater, Rosslyn Spectrum. 703-
998-4555. americancentury.org
Sun, Nov. 28
The Joffrey Ballet: The Nutcracker,
Kennedy Center. 202-467-4600. kenne-
dy-center.org
House of Gold, Woolly Mammoth. 202-
393-3939. woollymammoth.net
The Odd Couple, Theater J. 800-494-
8497. washingtondcjcc.org
The War of the Worlds by Orson Welles
& Howard Koch, SCENA Theatre, H
Street Playhouse. 202-683-2824. scena-
theater.org
LIMITED ENGAGEMENT
Nov. 26 - Nov. 27
Wistful Memories/Techaga’u ñ AÒoran-
za, Teatro de la Luna, Gunston Theatre
Two. 703-548-3092. teatrodelaluna.org
Nov. 26 - Nov. 28
Celebrating Movement, Del Ray Artisans.
703-501-1732. theDelRayArtisans.org
ONE NIGHT ONLY
Fri, Nov. 26
The Grandsons, Wolf Trap.
1-877-WOLFTRAP. wolftrap.org
Sat, Nov. 27
John Eaton - The Roaring ‘20s, Wolf
Trap. 1-877-WOLFTRAP. wolftrap.org
Mon, Nov. 29
National Geographic Live: Find-
ing Happiness, National Geographic.
events.nationalgeographic.com
Tue, Nov. 30
National Geographic Live: Dateline:
Sahara, National Geographic. events.
nationalgeographic.com
Wed, Dec. 1
Artist in Residence Mentor: Jamie
Broumas, jazz vocalist, Strathmore. 301-
581-5100. strathmore.org
Music on Photography: Neko Case,
National Geographic. 202-857-7700.
events.nationalgeographic.com
Thu, Dec. 2
Our Intoxicating Quest for the Perfect
Drink: It’s Just Human Nature. With Se-
lected Tastings. Smithsonian Resident
Associate Program. 202-633-3030. resi-
dentassociates.org
The 2010 Kenny G Holiday Show, Strath-
more. 301-581-5100. strathmore.org
ONGOING STAGE
Washington Shakespeare Company: Rich-
ard III and Mary Stuart, Washington Shake-
speare Company, ARTISPHERE. 703-418-
4808. washingtonshakespeare.org
Golden Boy, Keegan Theatre, Church
Street Theater. 703-892-0202. keegan-
theatre.com
A Christmas Carol, Ford’s Theatre. 202-
397-7328. fords.org
Superior Donuts, Studio Theatre. 202-
332-3300. studiotheatre.org
ONGOING EXHIBITONS
Corcoran Gallery of Art. 202-639-1700.
corcoran.org. Spencer Finch: My Busi-
ness, with the Cloud, Washington Color
and Light.
National Archives. archives.gov. Dis-
covering the Civil War - Consequences,
National Gallery of Art. nga.gov. Ar-
cimboldo, 1526-1593: Nature and Fan-
tasy, The Pre-Raphaelite Lens: British
Photography and Painting, 1848-1875,
From Impressionism to Modernism: The
Chester Dale Collection. In the Tower:
Mark Rothko.
National Geographic. 202-857-7588.
events.nationalgeographic.com. Geck-
os: From Tails to Toepads, Great Migra-
tions: A Photography Exhibition
Museum of Women in the Arts. Loös
Mailou Jones: A Life in Vibrant Color.
The Textile Museum. 202-667-0441.
textilemuseum.org. Colors of the Oasis:
Central Asian Ikats
ONGOING GALLERIES
Workhouse Works: The 4th Annual
Small Works Exhibition, Workhouse
Arts Center. workhousearts.org
Mind Sets: Andrew Carnie, Terry Gips,
and Meg Walker, Montpelier Arts Center.
301-377-7800. pgparks.com
David Brosch, Resident Artist Gallery,
Montpelier Arts Center. 301-377-7800.
pgparks.com
Robert Keating’s The C&O Canal:
Places and Stories, The Art League.
703-683-1780. theartleague.org
Tang: Freedom & Its Owner, Transformer.
transformergallery.org
TV personality Paul Wharton will co-host “Kimpton’s Red Hot Night in the Nation’s Capital,” a
cocktail party benefting Whitman-Walker Clinic next month.
Washington Blade fle photo by Michael Key
Several area restaurants
have deals for those dining
out on Thursday
By WILLIAM GEORGE
Be honest with yourself — sometimes
you don’t want to worry about spending
all day in the kitchen cooking and clean-
ing for the holiday. Many of the area’s res-
taurants are offering special “turkey day”
menus to make it easier on all of us.
BRABO (1600 King Street, Alexan-
dria) by Robert Wiedmaier will be open
on Thanksgiving between 2:30 and 7
p.m., offering patrons a Thanksgiving-
themed three-course dinner for $65, with
the regular children’s menu also avail-
able. The bar will be open during those
hours and the regular bar menu will be
available exclusively at the bar.
The three-course Thanksgiving menu
will include appetizers such as roasted
beets with arugula, pistachios and goat
cheese fondue and a squash soup with
duck conft ravioli. Entrees include a tra-
ditional turkey dinner with sweet potato
purée, Brussels sprouts, cranberry rel-
ish, chestnuts dressing and giblet gravy
and a pan-seared ribeye with Pennsylva-
nia mushrooms, potato purée and Borde-
laise sauce, among other offerings. Des-
sert selections include everything from a
pumpkin pie to a caramel walnut tart with
calvados ice cream. Reservations are
strongly recommended. (703-894-3440)
Commonwealth (1400 Irving St.
N.W.), Columbia Heights’ own British
gastropub, is offering a three-course,
family-style Thanksgiving dinner from 1
to 8 p.m. for $35 per person, as well as
its à la carte menu with snacks ranging in
price from $5 to $13, all boosted by U.K.
and American beers (202-265-1400).
If you want to indulge yourself on gour-
met food while giving to a worthy cause,
head out to Tyson’s Corner to partake in
the feast offered at Wildfre (1714 Chain
Bridge Rd, McLean). Serving a family-style
menu with spit-roasted turkey and classic
sides, a portion of the day’s proceeds will
be donated to feed the needy (11 a.m. to 8
p.m.; $36.95 per adult, $14.95 per child 12
and under; 703-442-9110).
Holiday traditions will be showcased with
style at West End dining room Blue Duck
Tavern (1201 24th St. N.W.), where diners
can gorge on a three-course brunch with tur-
key and trimmings, plus hors d’oeuvres and
dessert buffets (10:30 a.m. to 3 p.m.; $90 per
adult, $45 for children 6–12, complimentary
for children under 6; à la carte dinner avail-
able from 6–10:30 p.m.; 202-419-6755).
For those of us with a hankering for
higher brow cuisine, with a French fair,
check out 2941 (2941 Fairview Park Dr.) in
Falls Church. The kitchen is turning out a
three-course prix fxe with appetizers like
a mushroom feuille and lobster chowder
with Indonesian long pepper, and entree
choices ranging from turkey to bouilla-
baisse (noon to 8 p.m.; $65 per adult, $25
per child 12 and under; 703-270-1500).
Vidalia (1900 M St. N.W.) is going for a
more “stuff-your-face-and-go-home” South-
ern approach with its a la carte offerings
showcasing shrimp and grits, frogmore stew,
lamb and steak as well as a stuffed turkey
with all the fxings (seatings from noon to 3
p.m. and 5 to 8 p.m.; 202-659-1990).
Looking ahead into December, Urba-
na will host “Kimpton’s Red Hot Night in the
Nation’s Capital,” a cocktail party beneft-
ing Whitman-Walker Clinic. The event will
feature popular TV personality and beauty/
lifestyle expert Paul Wharton as co-host and
emcee, $5 “Cocktails for a Cure,” light bites
of Western Mediterranean cuisine from Ur-
bana’s kitchen, and a live/silent auction in-
cluding a weekend getaway to any Kimpton
hotel nationwide and two roundtrip jetBlue
tickets. A $10 admission fee includes one
drink ticket and all proceeds beneft Whit-
man-Walker Clinic. The event begins im-
mediately following the 5:30 pm candlelight
vigil in Dupont Circle. (Wednesday from 6 to
8:30 p.m.; Kimpton’s Urbana Restaurant &
Wine Bar, 2121 P St. N.W.)
Then on Thursday, get out to Palomar in
Arlington for “A Taste of Virginia’s Own,” a Vir-
ginia wine tasting event benefting the North-
ern Virginia AIDS Ministry (NOVAM). Guests
are invited to enjoy hors d’oeuvres while
sampling varietals from top Virginia wine-
makers, including Chateau O’Brien, Horton
Cellars, Pearmund Cellars, Tarara Winery,
Rappahannock Cellars and Boxwood Estate
Winery. Admission is $30 per person in ad-
vance and $35 at the door with all ticket pro-
ceeds to beneft NOVAM. Reservations are
recommended. (Thursday from 6:30 p.m. to
8:30 p.m.; Kimpton’s Palomar Arlington)
FOODISTCOLONY
Thankfully not cooking
november 26, 2010 • washingtonblade.com 41
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: CR ISSUE DATE: 100430 SALES REP: DJ
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-19-10 SALES REPRESENTATIVE: PHIL ROCKSTROH (prockstroh@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Today
DJs Will Eastman and Brian Bil-
lion bring their ‘90s dance party,
No Scrubs, to 9:30 Club tonight at 9
p.m. Featuring guilty pleasures by TLC,
Nirvana, C&C Music Factory, Marky Mark
and more, this started as a one-off con-
cept party that quickly grew. Tickets are
$15 and can be purchased at 930.com.
Nellie’s (900 U St., N.W.) will be host-
ing “Beat the Clock Happy Hour” tonight
from 5 to 8 p.m. Drink specials start at $1
for all bottles, Miller Light, and house vod-
ka drinks and increase a $1 every hour.
Neil Simon’s “The Odd Couple” will
be at Theater J (1529 16th St., N.W.)
today at 2 p.m., presented by the D.C.
Jewish Community Center.
The Hirshhorn Museum and Sculp-
ture Garden will have “Black Box: Su-
perfex” on display today. Hirshhorn is
open from 10 a.m. to 5:30 p.m
Workhouse Arts Center (9601 Ox
Rd.) in Lorton will have an art sale with
food and drink tasting today from 9 a.m.
to 7 p.m. with an evening performance
by the Potomac Jazz Project.
American Century Theater pres-
ents Chip Deffaa’s one-woman show
highlighting the music of the famous
comedienne, singer and actress, “One
Night with Fanny Brice” at Rosslyn
Spectrum Theatre (1611 N. Kent St.) in
Arlington. Tickets range from $27 to $32.
Saturday, Nov. 27
Cyndi Lauper will be at 9:30 Club for
the early show at 6 p.m. Mastermind
behind the gay-themed “True Colors
Tour,” Lauper has been an advocate for
LGBT rights for years. Her newest album,
“Memphis Blues,” was released June
22. KT Tunstall will follow Lauper with a
late show at 10 p.m. Tickets for Lauper’s
performance are $45 and Tunstall’s are
$25. Both can be purchased at 930.com.
Electrik, hosted by Timur Tugberk, will be
at Green Lantern (1335 Green Court, N.W.)
tonight at 10 p.m. featuring dance, electro,
deep and dirty house, trance and circuit mu-
sic. Open rail vodka bar and no cover from
10 to 11:30 p.m with a $5 cover starting at
11. A $17 “All-U-Can-Drink Bacardi” buffet
will be available from 10 p.m. to closing.
Apex (1415 22nd St., N.W.) presents
Dragapalooza tonight with special guest
performances by house divas and the D.C.
Kings throughout the night. Kristina Kelly
and her Girls of Glamour will perform at 11
p.m. DJ Gigi will be providing music in the
main hall starting at midnight with DJ Michael
Brandon in the East Wing Dance Lounge
playing latin sounds. There is a $10 cover
and attendees must be 18 or older to enter.
Lisa Lampanelli will be at the War-
ner Theatre (1299 Pennsylvania Ave.,
N.W.) tonight with her “Hot Off the Roast
Tour” tonight at 7 p.m. with Whitney
Cummings and Jeffrey Ross. Tickets are
$58.70, which includes fees, and can be
purchased at livenation.com.
Will Eastman’s dance party “Bliss”
returns to U Street Music Hall with
Gavin Royce of Boys and Girls and
Cam Jus at 10 p.m. Tickets are $10 and
can be purchased at ustreetmusicahall.
com. Attendees must be 18 or older.
Sunday, Nov. 28
The Imperial Court of Washington
presents “Dragging Out the Gospel”
hosting by Co Co L. Blackwell at Green
Lantern (1335 Green Court, N.W.). Drag
performers should check in with their music
45 minutes before showtime. Doors open at
6 p.m. and the show starts at 7. There is a
$3 cover for this event. For information, e-
mail emperorjohnrichard@gmail.com.
Marcus Gardley’s “Every Tongue
Confess,” directed by Kenny Leon, will
be at Arena Stage today at 2 and 7:30
p.m. Tickets are $110 and can be pur-
chased at arenastage.org.
Shi-Queeta-Lee hosts Drag Brunch
today from 11 a.m. to 4 p.m. at Nellie’s
(900 U St., N.W.) with a $20 brunch buffet,
Zing Zang Bloody Marys and Mimosas.
Monday, Nov. 29
Brandon Flowers, frontman of the
Killers, will be performing solo at 9:30
Club at 7 p.m. This is a sold out show.
Openly gay, Tony Award-winning
actor/singer Levi Kreis, will be at Jam-
min’ Java (227 Maple Ave. E.) in Vienna,
tonight at 7:30 p.m. with Eric Himan and
Jason Antone. Tickets are $15 and can
be purchased at www.jamminjava.com.
Tuesday, Nov. 30
Team LUNA Chix, a local girls ath-
letic group, is hosting Lunafest tonight
at Jammin’ Java in Vienna. Tickets are
$20 and help beneft the Breast Cancer
Fund. A silent auction will begin at 6 p.m.
and the flms will start at 7:30 p.m.
The Beltway Poetry Slam will be to-
night at the Fridge (516 8th St., S.E.) at 8
p.m. Poet sign-up begins when the doors
open at 7:30 p.m. The slam will start at
8. There is a $5 cover charge. For rules
on participating, visit thefridgedc.com.
Join Burgundy Crescent Volunteers
to help pack safer sex kits from 7 to 9 p.m.
tonight at FUK!T’s new packing location
Green Lantern, 1335 Green Ct., N.W.
Wednesday, Dec. 1
Bookmen D.C., an informal group of
men interested in gay literature, meets
tonight at 7:30 p.m. at the Charles Sum-
ner School and Archives (1201 17th St.,
N.W.) to discuss selections from “Bud-
dy’s: Meditations on Desire” by Stan Per-
sky. All are welcome.
The Tom Davaron Social Bridge Club
will meet at 7:30 tonight at the Dignity Cen-
ter, 721 8th St., S.E., (across from Marine
Barracks) for social bridge. No partner
is needed. Visit lambdabridge.com and
click on “Social Bridge in Washington.”
Thursday, Dec. 2
Hollaback DC! Will be having a dis-
cussion on street harassment in the
LGBT community at the D.C. Center
(1318 U St., N.W.) from 6:30 to 8:30 p.m.
The Art Gallery at the University of
Maryland presents the exhibition, “The
Very Queer Portraits of Heyd Fontenot”
by Austin, Texas-based artist Heyd
Fontenot.
Cyndi Lauper plays the 9:30 Club this weekend. Go to page 48 for an interview.
Photo by Ellen Von Unwerth
CALENDAR
42 washingtonblade.com • november 26, 2010
AIDS Day Calendar
Tuesday, Nov. 3
Roby Chavez hosts “Persistent Voices: A World AIDS Event” tonight at the Thur-
good Marshall Building (1816 12th St., N.W.) from 6:30 to 10:30 p.m. Presented by
Us Helping Us, the D.C. Center, Ganymede Arts and the Vaccine Research Center,
“Persistent Voices” is an anthology of poems by writers who died of AIDS. The
event will feature readings by local actors, poets and community members. The
editor of “Voices,” Philip Clark, will attend.
Wednesday, Dec. 1
Urbana (2121 P St., N.W.) will host Kimpton’s Red Hot Night in the Nation’s Capi-
tal, a cocktail party benefting the Whitman-Walker Clinic featuring TV personality
Paul Wharton as co-host and emcee tonight from 6 to 8:30 p.m. There will be a live
and silent auction for items such as a weekend getaway to any Kimpton hotel and
two roundtrip jetBlue tickets. A $10 admission covers one drink ticket and all the
proceeds go to Whitman-Walker.
Thursday, Dec. 2
Kimpton’s Palomar Arlington will host “A Taste of Virginia’s Own,” a wine tasting
to beneft Nothern Virginia AIDS Ministry, tonight from 6:30 to 8:30 p.m. Guests
will be given appetizers while sampling wines from places like Chateau O’Brien,
Horton Cellars and Boxwood Estate Winery. Admission is $30 per person and all
proceeds go to the Ministry.
Friday, Dec. 3
The D.C. Center (1318 U St., N.W.) will host an open mic night tonight at 8
p.m., with poems focusing on HIV/AIDS issues in conjunction with World AIDS
Day. Doors open at 7:30 p.m.
Rodrigo Santoro, left, and Jim Carrey as lovers in the long-delayed ‘I Love You, Philip Morris.’
Photo courtesy of Europa Corp.
‘We the People’ exhibit closes Sunday
Closing on Sunday is “We The People,” an exhibit by Scott Brooks at Long View
Gallery.
If you have a taste for pop sensibility framed with a dark vision of the current
American political scene and nude or nearly nude male physiques, see this exhibit,
“We The People,” 12 new oil paintings by D.C. artist Scott G. Brooks in the few
remaining days before it closes Sunday at Long View Gallery, 1234 9th St., N.W.
Drew Porterfeld, gay managing director of the gallery, says that Brooks’ work
“refects the political and economic turmoil that takes up the head space of those
who are paying attention.” One of his paintings even depicts Fox News commenta-
tor and Tea Party advocate Glenn Beck in the altogether, sporting only strategically
placed patriotic bunting. Brooks calls Beck “a fake messiah distracting people”
from the real issues that surround them.
But Brooks is not much more enthused with President Obama. In the title piece of
the show, “We The People,” a 48” x 38” oil on canvas, “Brooks’ disillusionment with
Washington is central,” says Porterfeld about the work depicting a snake-charmer
who distracts his followers as his head is illuminated by a Christ-like halo, a possible
comment on religion, as what Karl Marx once called “the opiate of the people.”
The gallery is open 11 a.m. to 6 p.m. Saturday and noon to 5 p.m. Saturday. Call
202-232-4788 or visit longviewgallery.com.
New gay-themed films to debut
Opening at area theaters on Dec. 3 is the long-delayed “I Love You, Philip Mor-
ris,” a comedy starring actors Jim Carrey and Ewan McGregor as gay lovers who
meet in prison and then are separated and reunited through a series of joke-flled
jail-breaks and impersonations.
“Mary Lou,” a modern-day fable by Israeli flmmaker Eytan Fox, featuring Tel Aviv’s fa-
mous drag queen Meir/Mary Lou, playing at 9:15 p.m. Dec. 4 as part of the 21st Washing-
ton Jewish Film Festival, at the 16th St., N.W., D.C. Jewish Community Center.
“Undertow,” a 2009 Peruvian blend of gay love story and ghost story by writer-
director Javier Fuentes-Leon, already selected as Peru’s entry for the 2010 Acad-
emy Awards — the “buzz-flm” at the San Francisco LGBT Film Festival — will be
shown at the DC JCC at 7 p.m. and 9:15 p.m. Dec. 10 as part of the Reel Affrma-
tions “R.A. Extra” monthly series of LGBT flms.
‘Cave of Crystals’
This is the frst time that Lia Halloran, photographer, painter and professor in Los
Angeles, has worked with Sarah Strauss, a Brooklyn-based architect, though they
bonded years ago as graduate students at Yale University over how nature and
science could sometimes intersect with art. Their joint exhibit — “Folding Unfold-
ing: Collider” — is on exhibit at the new Artisphere in Rosslyn’s repurposed old
Newseum Building, 1101 Wilson Blvd, through Jan 12.
Collider is the name of their new collaborative group whose work is “all built by
girls!” The exhibit includes what appears at frst to be large crystals though they are
in fact made out of a light-weight wood composite using 3D digital modeling tech-
niques. Their inspiration came from the discovery some 10 years ago in Mexico of
underground, half-a-million-year-old crystals, some of them as large as 37 feet long.
Another Halloran exhibit is also now at the Artisphere, a photographic series
called “Dark Skate” — photos she took while skateboarding in the dark.
For more information, call 703-875-1100 or visit artisphere.com.
Arlington is for all lovers
Also at the Artisphere in Rosslyn, the Arlington Gay and Lesbian Alliance
(AGLA) invites the public at no charge to be part of a video shoot on Dec. 4 from
11 a.m. to 1:30 p.m., hosted by drag entertainer Destiny B. Childs. The fnished
video, inspired by a video of LGBT people in Paris embracing, will premiere at the
Artisphere on Dec. 20. The tagline will be “Arlington is for all lovers.”
For more information or to volunteer, go to www.agla.org.
–DAVID J. HOFFMAN
ARTINBRIEF
november 26, 2010 • washingtonblade.com 43
Gay dancer Edwin Aparicio says he’d eventually like to explore aspects of being gay in his dancing.
Photo courtesy of GALA Hiapanic Theatre
Local gay dancer keeps
tradition alive with Latin
art form
By PATRICK FOLLIARD
Costumed like a bull fighter in short
jacket and tight pants, his heels passion-
ately striking the floor, the flamenco dancer
is an unmistakable classic image. Gay
choreographer and dancer Edwin Apari-
cio is doing his best not only to keep the
fiery tradition alive but also to ensure its rel-
evancy. Part of how he does this is by co-
ordinating Gala Hispanic Theatre’s annual
flamenco festival (through Dec 5).
Each year, Aparicio curates the pro-
gram and recruits first rate flamenco
artists (musicians, singers and danc-
ers) from throughout the Americas and
Europe. For the final weekend of Gala’s
“Fuego Flamenco VI,” Aparicio’s own
company — Flamenco Aparicio Dance
Company – will debut the world premiere
of “Alma Flamenco.”
“It’s a salute to Gala’s 35th anniversa-
ry,” says Aparicio, who is choreograph-
ing and performing his new work with
flamenco star Nélida Tirado and other fe-
male dancers from his company. “’Alma’
means ‘soul’ in Spanish, and I hope to
express how Gala has been the soul and
spirit of the Latino performing arts com-
munity for such a long time.”
“For me,” says Aparicion (also 35),
“the beauty of dance is its expressive-
ness. Flamenco allows the musician,
singer and dance to show both hap-
piness and pain. As a choreographer I
hope the audience picks up on the feel-
ings that I’m trying to express.”
Influenced by the gypsy, Arab, Jew-
ish and indigenous cultures of Andalu-
sia in southern Spain, flamenco’s roots
are centuries old. What began as songs
sung around the fire sometimes accom-
panied by guitar gained in popularity
and moved to cafes in the 19th century
where dancers were added to the mix.
Over the years, flamenco slowly earned
its niche in the pantheon of internation-
ally recognized and respected art forms.
“What’s so great about flamenco is
that it’s always evolving,” Aparcio says.
“My choreography employs traditional
and contemporary movement and makes
greater use of the space. And though our
female dancers wear skirts and I wear
a suit, we’ve relaxed the traditional cos-
tumes significantly.”
Aparicio, who was born in El Salvador
but grew up in D.C., began his dance
career as a student at Bell Multicultural
High School in Columbia Heights.
“Because our gym class was full,
some of us were offered to take a dance
class instead. And even though I’d never
been exposed to any formal dance train-
ing before, I, of course, accepted. The
class was very rudimentary — held in a
room without a mirror or bar — but I was
immediately hooked.”
Soon after, Aparicio transferred to
Duke Ellington School of the Arts in
Georgetown where he was able to more
seriously concentrate on dance. Eventu-
ally he began auditioning for profession-
al dance gigs. During this time, one of
the directors he encountered suggested
that Aparicio give flamenco a try. He did
and he loved it from the start. Shortly af-
ter graduating from high school, Aparicio
traveled to Spain where he studied fla-
menco and performed with the masters.
In addition to running his eponymous
dance company, he conducts flamenco
classes nationwide and is a faculty mem-
ber of the Washington School of Ballet.
Not long ago, only male flamenco
dancers were expected to execute rapid
fire footwork; the women typically tapped
lightly and swayed their ruffled, loud-
print skirts. While that is now changing
and female dancers are stomping hard
and competing with men in competitions,
flamenco remains primarily, a very mas-
culine-oriented art form.
“During tours with other flamenco
groups, I tend to keep to myself,” Apari-
cio says. “It’s not a particularly open en-
vironment for gay people. But more and
more dancers are coming out sometimes
shocking other artists and audiences.”
THEATERAGENDA
44 washingtonblade.com • november 26, 2010
Pink flamenco
‘Fuego Flamenco VI’
Through Dec. 5
Gala Hispanic Theatre
3333 14th Street, N.W.
202-234-7174
www.galatheatre.org
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Boditalk Escort Bullet is activated by calls made to or from your
cell phone when in close range. The cell triggers a unique 3
pattern vibrating sequence that lasts for the entire call.
1510 U Street NW • Washington, DC • (202) 664-1476
secretpleasuresboutique.com











Lost and Found
The Lesbian and Gay Presence in the Archives of American Art
through February 13, 2011



Join us for a FREE gallery talk with guest
curator
Jonathan Weinberg

November 30, 2 p.m.
meet in the exhibition
Donald W. Reynolds Center for
American Art and Portraiture, 8th and G Streets NW
202.633.7959 │www.aaa.si.edu

REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF # ISSUE DATE SALES REPRESENTATIVE
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
wanna
blade
in your gay-borhood?
call us!
202.747.2077
november 26, 2010 • washingtonblade.com 45
Center for the Arts
On the Fairfax campus, six miles west of Beltway exit 54 at the intersection of Braddock Road and Rt. 123.
888-945-2468 or cfa.gmu.edu
Visit us at cfa.gmu.edu
Chanticleer
A Chanticleer Christmas
Saturday, November 27 at 8 p.m.
These twelve singers have been a hallmark of the Christmas season for
more than 30 years and their elegant holiday concert is a delightful
tradition at the Center for the Arts. This season, Chanticleer performs
an enchanting program that features treasured traditional carols,
revered sacred works, and always-welcome holiday favorites. “No
one does a better choral Christmas than the virtuoso male voices of
Chanticleer.” (New Yorker)
$48, $40, $24
Celebrate the holidays at the Center for the arts
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #3 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: PHIL ROCKSTROH (prockstroh@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Alvaro Maldonado grew up in war-torn El Salvador and credits his life today to being enrolled
by his mother in the prestigious El Salvador National School of Ballet.
Photo courtesy of Maldonado
Maldonado brings unique
outlook to his studio
By PETER ROSENSTEIN
Alvaro Maldonado is the founder and
director of the Ballet Teatro Internacional
(BTI). Members of the BTI Troupe recently
performed at the Shakespeare Theatre’s
Harman Center for the Arts. Alvaro is a
gifted dancer who studied from a young
age and believes in using the power of
dance to transform young people’s lives.
He is an entrepreneur, producer, teacher,
choreographer, dancer and singer. But
above all he is dedicated to dance and
to what dance can do for people.
Alvaro grew up in war-torn El Salva-
dor and often credits his life today to
being enrolled by his mother at the age
of 8 in the prestigious El Salvador Na-
tional School of Ballet. At 14, he began
his professional career, which eventually
led to him performing in more than 30
countries. Along the way he received ad-
ditional training at the Washington Ballet,
School of Ballet and the Alvin Ailey Com-
pany in New York City.
Alvaro arrived in Washington, D.C., at
the age of 17, already a veteran dancer.
He met Michael Everts who became a
friend and they formed a business part-
nership. Everts opened FIT as a train-
ing gym in 2001 and Alvaro joined him
as a partner in the business in 2003.
FIT, located on the corner of 17th and Q
streets, N.W., is now one of the premier
training gyms in the Metro D.C. area.
Although Alvaro enjoys his work as a
trainer at FIT he has always wanted to
continue to dance before he ages out
(his words), and to bring the joy of dance
to the young people of the District and to
those that are just young at heart.
“I believe that we need arts program-
ming in our schools across the nation
and here in D.C.,” he said. “I want to
help to create such programming. I be-
lieve we need structured long term pro-
grams.” He added, “I have a desire to
give back to society what I was given as
a child in El Salvador; the opportunity to
participate in such programming which
ended up giving me my career.”
Alvaro says that dance can bring
structure and balance to a child’s life
even if they don’t go into it as a career.
His belief is that through the arts, and in
his case dance, these programs open
up new worlds to young people that they
may have never thought of or had the op-
portunity to explore.
To accomplish his dream he has
worked countless hours leading to the
opening of his dance studio. In July, BTI
Dance Institute Studio opened its doors
on the second floor at 1515 14th St.,
N.W., in the heart of Logan Circle. The
Institute will eventually combine Alvaro’s
three passions in its programming with
a Youth Dance Training Program, Com-
munity Outreach Program and the Adult
Dance and Fitness Program. BTI Dance
Institute is a non-profit training facility
that Alvaro created under the umbrella of
his BTI Dance Company.
The studio has a number of ongoing
classes and there are always new ones
in which you can enroll. One fun ongoing
one is the “Glee” class. Inspired by the
popular TV show the five-week class has
an instructor/choreographer and a vocal
coach teaching students two “Glee” num-
bers from the show after which students
are offered an informal performance op-
portunity at the BTI studios. There will also
be ongoing regular “Glee” classes, so
whether you want to live your inner Kurt
or Rachel, you can learn to perform as
you now only can in your dreams. Other
classes include ballet for those over 50,
an Argentine Tango class for beginners,
and a belly dance six-week series.
For anyone interested in dance,
whether it is for performance, health and
fitness or just for fun, contact the BTI
Dance Institute Studio, btidance.org.
DANCEAGENDA
46 washingtonblade.com • november 26, 2010
Sharing a passion for dance
Michael McCarthy conducts the
Cathedral Choir and Baroque orchestra
in this essential Christmas music
experience. With soloists:
• Gillian Keith, soprano
• Marietta Simpson, alto
• Rufus Müller, tenor
• Eric Downs, bass
Tickets start at $25—
purchase yours today:
(202) 537-2228 or
online at www.nationalcathedral.org
Massachusetts and Wisconsin Avenues, NW • Washington, D.C.
George Frideric Handel
Experience the exuberant Hallelujah Chorus—
at Washington national Cathedral
Friday, December 3, 7:30 pm
Saturday, December 4, 4 pm
Sunday, December 5, 4 pm
original file: Adobe InDesign CS2
PDF
[if circled]
Washington Blade
Fri, Nov 26, 2010
1/8H (4.75” x 2.6875”) Non-SAU CMYK
Landmark Theatres/CO
.
PRES E NTS
In space no one can hear you scream.
Fri & Sat, November 26 & 27 at Midnight!
Buy Advance Tickets Online tickets.landmarktheatres.com
THE
DIRECTOR

S
CUT!
A FILM BY RIDLEY SCOTT
SIGOURNEY WEAVER
HARRY DEAN STANTON
JOHN HURT
IAN HOLM
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF # 2 ISSUE DATE 101112 SALES REPRESENTATIVE Jeryl Parade jparade@washblade.com
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
1039 31
ST
STREET NW WASHINGTON, DC 20007 202 965 2684
Georgetown’s
Oldest French Bistro
Lunch, Dinner, Brunch
Daily Specials
Award Winning Pastries
Happy Hour
Monday - Friday, 4 pm - 7 pm
Half price appetizers, drink specials
november 26, 2010 • washingtonblade.com 47
Please check your ad copy
for accuracy. The ad will be
presumed correct if proof
corrections are not submitted
by 24 hrs. of receipt of this
copy of your ad.
PROOF#: 1 ISSUE DATE: 100514 SALES REP: BP
Revisions
Redesign
Text revisions
Image/Logo revisions
No revisions
Signature
washingtonblade
the lgbtq community’s news source
Come and see
what you’ve been
missing 24/7
BEST LUNCH EVER!!!
MONDAY - FRIDAY:
1/2 PRICE ROOMS 10 - 2PM
1/2 PRICE TUESDAYS
8AM - 12 Midnight
All Rooms & Lockers 1/2 Price
FRIDAY/SATURDAY/SUNDAY
Late Night Steams • Afternoon Workouts
Goodlooking Guys • Hot Showers • Videos
Big Steamroom • Sauna
Gym & Cardio • Lounges
Friendly Staff • Very Clean Facilities
Private Rooms & Lockers
Must have valid I.D.
www.inspot.org
All STD/HIV testing Information
Lauper’s swampy, moody
new album belies her sunny
frame of mind
Gays love La Lauper, ‘tis no secret. And the
feelings are mutual. In honor of her D.C. show
Saturday at the 9:30 Club, she e-mailed her
thoughts on the blues, her lesser-known al-
bums, her inspirations and how it feels to be
immortalized in Barbie doll form.
By JOEY DiGUGLIELMO
The new album is doing quite well
— do you think this might become a
regular genre for you (i.e. blues) where
you may do several projects in this
vein as Dolly Parton did with blue-
grass when her “Grass is Blue” album
sold solidly and spawned a trilogy?
I am not sure yet. Just living and en-
joying this release right now. I am flming
a live DVD in Memphis in a few weeks
that will come out Spring 2011. Basically
it’s the show we’ve been doing on the
road since “Memphis Blues” has come
out. It will include songs from “Memphis
Blues,” my hits and a few new songs. We
will see after that. Stay tuned.

You made some phenomenal al-
bums like “Hat Full of Stars” and “Sis-
ters of Avalon” that were largely over-
looked. Why do you think they failed to
catch on to the degree that your early
albums did?
I honestly don’t know. I am very proud
of those records and am often told by
fans that “Sisters” or “Hat Full of Stars” is
their favorite CD, so its nice to hear and
I continue to perform songs from those
CDs live so hopefully they can grow the
old fashioned way on the road.

Did you overcut tracks for any or
many of your ’80s and ’90s albums?
Are there outtakes and alternate ver-
sions from the “Unusual” or “Colors”
sessions just waiting for a box set
someday?
No I didn’t. We didn’t do things like
that back in the ’80s and ’90s. Sony has
put out so many, and in my opinion, too
many greatest hits packages, something
I have very little control over, and there
are too much “greatest hits” packages,
box sets, etc. out there already and I
don’t think my fans need more of that.
The only greatest hits I am proud of or
had anything to do with was “12 Deadly
Cyns.”

How would you summarize your
philosophy of set list building? What
makes an effective set list in your
opinion? Do you like doing covers or
deep album cuts in concert to surprise
the hardcore fans?
My set list is different with each
show. As you can see, I love to mix some
old into something new with each per-
formance. You should hear how “Girl”
sounds with this tour. I have to say it’s re-
ally good. Come to a show and you will
know what I am talking about.

You’ve been such an outspoken
proponent for gay rights in so many
ways — was there any sense that you
might come to be thought of largely
for that?
No, I never thought that ... I wanted to do
an album that spoke to the nation’s mood
right now, and blue defnitely sums it up.
From the economy to the wars to the fact that
people are still not treated equally on many
fronts. Blues music is a genre that the gay
community, for those who haven’t already,
should embrace because blues is about tell-
ing uplifting stories through overcoming the
obstacles in one’s life. It is a message that
everyone can connect to, but I think gay and
transgender people can beneft from it even
more given the times we still live in.

What did you think of the Cyndi Lau-
per Barbie doll that came out last year?
Do you think it looked like you? Did you
have to give permission for that?
I love it. They did a fab job, right? Yes as
I had a lot of creative input. Hope you like it.

There were some years where it
seemed like you went eons between re-
cords but now it feels like you’re back
in a pretty regular groove of writing,
recording and touring. There are prob-
ably a million reasons for that but any
overarching factors that led to that?
Nothing really. I get bored very eas-
ily. Love new challenges. Maybe that’s why
I am doing something different all the time.

You’ve made a lot of specialty re-
cords. Is it artistically or commercially
rewarding to go into a project with
some theme in mind versus doing a
straight-up studio project?
I just follow my spirit. I have no idea
what’s next. Maybe a new studio CD,
maybe a specialty record. Really the
ideas for all of my albums have kind of
come to me and then I focus and do the
best I can each time out.
Cyndi Lauper plays the 9:30 Club in Wash-
ington Saturday.
Photo by Ellen Von Unwerth
CONCERTAGENDA
48 washingtonblade.com • november 26, 2010
Hat full of the blues
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF # ISSUE DATE SALES REPRESENTATIVE
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
wanna
blade
in your gay-borhood?
call us!
202.747.2077
There, he says he outed himself in
confidence to his roommate who then
exposed him to school officials when he
was just a few short credits from gradu-
ation. After debating expelling him, they
decided not to, but he says he was
meanwhile “so embarrassed that it was
just more than I could handle.” He had
struggled with his sexual orientation
much earlier in secret, in seventh grade
entering what he calls “Christian coun-
seling” for so-called “reparative” or “re-
orientation therapy,” and he kept this up
for six years without telling his parents.
He left Belmont before completing his
degree, moving to Los Angeles to begin
a career in show business, and quickly
was picked to go on tour with the rock-
musical “Rent.” He also appeared in
several indie films while trying to make a
go of it as a singer, and he went through
more than a few record labels before
breaking with the last of them (Atlantic
Records) in 2004, and with only $200 in
his pocket he decided to go into a re-
cording studio. That independently pro-
duced album “One of the Ones” came
out in 2005 and it began to sell following
his appearance that year on the Donald
Trump reality-TV show, “The Apprentice.”
What made this album different was
that he was now open about his sexual-
ity. And not just his career but also his life
began to flourish.
“My life has been so affected in a pos-
itive way by coming out,” he says. “I’m
not very good at keeping secrets. I value
a peaceful life, being calm, and it’s im-
portant to live transparently. I just couldn’t
hold that level of grief, that weight inside
my body, any more, and now I can feel
truly perfect in the eyes of God.”
His next album, “The Gospel Accord-
ing to Levi,” was released in 2007, and
one of its songs, “We’re Okay,” was writ-
ten openly to his mother to try to recon-
cile the rift that had grown between them
after he came out. He says she refused
to listen to it for a long time but finally saw
the music video and then called him and
admitted that she had never allowed her-
self to just listen to the words.
That same year, he also took a break
from touring to join the original cast of
“Million Dollar Quartet,” at first in work-
shops in Seattle and then in regular per-
formance in Chicago, where it was co-di-
rected by Eric Schaeffer, the gay artistic
director of Arlington’s Signature Theatre.
Kreis laughs and says “me and Eric, we
were were the lone gays” in what he calls
for short “MDQ,” a production that he
says is highly “testosterone-filled.”
Under Schaeffer’s direction still, the show
moved to Broadway in April. From the show’s
beginning, Kreis’s enthusiasm to recreate the
combustible Jerry Lee Lewis on stage meant
he would vault over pianos to land standing-
up at the keyboard, especially in what he calls
“the show’s very exuberant encore, where
each of the four legends comes out for one
last song.” The strain of such showmanship
has since required reconstructive surgery on
both of his knees, he admits, and for a time he
wore a full leg brace, “and now I keep my feet
as close to the ground as I can.”
Kreis actually met Lewis, at 75 the
only “quartet” member still alive, in Sep-
tember when Lewis sat in for one show.
Kreis and Lewis met at his hotel room,
and he says that “Jerry Lee was so gra-
cious, so loving and supportive, so witty,
and so lively.”
After Kreis laid out his own South-
ern Baptist credentials, “soon I felt just
like family with him and an undeniable
bond.” Their duet, recorded separately
— a cover of the Motown song “Money
(That’s What I Want”) — will appear on
Lewis’ next album.
DCAGENDA
november 26, 2010 • washingtonblade.com 49
Levi Kreis and Eric Himan
Monday at 7:30 p.m.
Jammin’ Java
227 Maple Ave. East
Vienna, VA
703-255-1566
jamminjava.com
www.levikreis.com
Music and faith formed
early for Tenn.-born Kreis
Jerry Lee Lewis liked Levi Kreis, who played him on Broadway, so much he asked Kreis to sing a
duet with him.
Photo courtesy of LaFamos
Continued from page 33
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-26-10 SALES REPRESENTATIVE: JERYL PARADE (jparade@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
CANTOR JINNY MARSH
Offciates at Jewish, Interfaith
and LGBT Ceremonies
WEDDING DIRECTORY























































Celebrate Shabbat and Your Jewish Life


Bet Mishpachah
Erev Shabbat Services, Fridays, 8:30 PM
Followed by Oneg Shabbat Social
Shabbat Morning Services, 2nd & 4th Saturdays, 10 AM
Followed by Kiddush Luncheon

DC JCC, 16th & Q Streets NW

www.betmish.org

Rabbi Toby Manewith
BET MISHPACHAH ~ YOUR JEWISH HOME

An egalitarian synagogue serving the GLBT community and all who wish to participate
in an inclusive environment.

Erev Shabbat Services, Fridays, 8:30 PM
Followed by Oneg Shabbat Social
Shabbat Morning Services, 2nd & 4th Saturdays, 10 AM
Followed by Kiddush Luncheon

DCJCC 16th & Q Streets, NW



Rabbi Toby Manewith www.betmish.org
Let's Get Engaged...
in worship...in study...in social action...in community
Bet Mishpachah
An egalitarian synagogue serving the GLBT community and all who wish to
participate in an inclusive environment.

Rabbi Toby Manewith

Erev Shabbat Services, 8:30 pm, Fridays
Shabbat Morning Services, 10:00 am, 2nd & 4th Saturdays
DCJCC, 16th and Q Streets, NW
www.betmish.org
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF # ISSUE DATE SALES REPRESENTATIVE
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
wanna
blade
in your gay-borhood?
call us!
202.747.2077
50 washingtonblade.com • november 26, 2010
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 10.29.10 SALES REPRESENTATIVE: PHIL ROCKSTROH (prockstroh@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
LEGAL NOTICE
SUPERIOR COURT OF THE DISTRICT
OF COLUMBIA
CIVIL DIVISION IN RE: C.A. No.
0008544-10
David Washington, Jr.
ORDER OF PUBLICATION -
CHANGE OF NAME
David William Washington, Jr. having
fled complaint for judgment changing
David William Washington, Jr name
to Diana Rosetta Williams and having
applied to the court for an Order of
Publication of the notice required by
law in such cases; it is by the Court this
9th day of Nov 2010, ORDERED, that
all persons concerned show cause, if
any there be, on or before the 14th day
of December 2010, why the prayers of
said complaint should not be granted;
provided that a copy of this order
be published once a week for three
consecutive weeks before said day in
the Washington Blade. A True Test Copy.
MASSAGE
PROFESSIONAL MASSAGE THERAPIST
offering the best deep tissue massage
available. Stretching, Swedish & Sports
massage. Dupont, Special 1st time rates.
Mention this ad for $10 OFF. Marcio (202)
271-9440. www.MarcioMassage.com
CHECK IT OUT Only $55 per hour for
an awesome massage by Ron. Ask
about Monday & Wednesday special
discounts. 19 years experience. Call
now 202-641-1078 & treat yourself to
one of the best.
INDULGE YOURSELF WITH RELAXING,
deep tissue massage. Feel the stress
leave your body. CMT with 15 years
experience. Located in Logan/Dupont
Circle. www.DCMassageTherapist.
com. Visa, MC. David (202) 213-
9646 Lic#MT410
Excellent Deep Tissue Massage and
stretching by athletic CMT for neck/back
pain, sports recovery, injury rehab. All
ages/types, last minute welcome. 7dys/wk
‘til 11pm. 17th/Kalorama NW next to Harris
Teeter. Ask about the 4hand option! Tim
202.957.1559 www.dcpromassage.com
STRONG HANDS & GREAT
INSTINCTS with a combination of
deep tissue, sports and swedish
designed to provide a great all
round massage. open 7 days 10am
to 9pm, hr massage only $75 major
c/c. call 202 293 8484.
N. ARLINGTON CMT Male therapist
providing therapeutic Sports / Deep
Tissue & relaxing Swedish / Reiki
in private, home studio. Clean,
quiet & discreet. By appointment
@ mymassagebygary.com or call 301-
704-1158 Gary.
GREAT TOUCH! Full sensual body
massage by Latin Male. Swedish,
deep tissue. Relieve stress! Parking
available. In/out. 703-401-9093.
ITALIAN JOCK Give full body
massage. Masculine, muscular, VGL
masseur, offers, full-body, Swedish,
sports, deep tissue massage on a
table, including stretching, shower
available. See my photos on www.
massagem4m.com/jockguy. Located
downtown, parking available. Brian
312-961-7724.
PAMPER YOURSELF with a 60 or
90 min. massage. With 11 years
experience let me tailor a session
right for you. Ben 202.277.7097
www.benmassagedc.com
TIME TO RELAX, TAME YOUR
TENSION & improve your
health with a professional
massage! Swedish, Deep Tissue,
Athletic and Pain Management
massages really can improve
your outlook. J. David Starn,
Nationally Certifed, LMT. www.
expertlycraftedmassage.com
or call 202-257-9726. Ask about
weekday specials!
ASIAN MALE MASSAGE Swedish, Deep
Tissue, Sports, Shiatsu, Stretching
Techniques. Intuitive, Therapeutic.
Glebe Rd/395. $70/hr; $90/1.5 hrs.
Dant65@hotmail.com. (202) 425-5105.
RELAXING, SOOTHING MASSAGE
BY EXPERIENCED MASSAGE
THERAPIST. Convenient
Arlington location. Evenings
and weekends. $60/hr, $85/90
min. Visa/MC Errol (703) 525-4616.
www.goodhands2.biz
RELAX, REGENERATE,
REJUVENATE The 3 Rs to Health.
Experienced Certifed Massage
Therapist helps you with the 3
Rs: Swedish, Deep Tissue, Reiki,
Energetics. Call Bruce (202) 491-
8306. MT 0697.
THE MAGIC TOUCH: Swedish, Massage
or Deep Tissue. Appts 202-486-6183,
Low Rates, 24/7.
RESTORE BALANCE & RELIEVE
STRESS Handsome, young, licensed
massage therapist, comfortable,
private studio, heart of DC. Call for
packages & discounts. Sam 202-213-
0401, www.renacer-ftness.com.
WEDDINGS & SERVICES
Roman Catholic priest, licensed
DC marriage offciant. Many years
experience working with gay & straight
couples in civil & religious services.
No wedding too small. Want a private
signing? Outside or special site? Let me
help you make your special day simple,
elegant, memorable. Call Fr. Ed (202)
445-0366, ed.ingebretsen@gmail.com.
PHOTOGRAPHY
STEVE O’TOOLE PHOTOGRAPHY
Fine Art Photographer for portraits,
weddings & dating photos for the
internet. Call (703) 532-3031. www.
steveotoolephotography.com
Hot Intimate photos. Get intimate photos
of yourself or together with your lover
taken by professional photographer
at private studio. Call 703.981.4206 or
Email marigothouse@gmail.com. See
portfolio at www.intimatefneart.com.
LIMOUSINES / DRIVERS
KASPER’S LIVERY SERVICE Gay
and Veteran Owned since 1987
Hourly, Point to Point and Airport
Transfer Service. Call Today (202)-
554-2471 (800)-4552471 http://www.
KasperLivery.com click on rates!
CATERING
BARTENDERS WITH THAT PERSONAL
TOUCH Bartenders and wait staff ready
to assist you with your next private
affair. Contact us at 202-390-4018 for
more information. Our 20th year!
ENTERTAINMENT /
EVENT SERVICES
FABULOUS DRAGQUEENS AND
STRIPPERS AVAILABLE for your next
party or event. Various entertainers
to choose from, reasonable rates.
Celebrity impersonators also available
(240) 605-2912.
TRAVEL
SKI WITH US! Share home with two gay
men at Snowshoe, WV. 1-2 people:
$75pp/night. 3-8: $50pp/night. Call
304-572-5225 or 571-214-4495.
AFFORDABLE FORT LAUDERDALE
Perfect Winter Vacation Apartments.
Full Kitchens, minutes to Gay
attractions, NudeGay Beaches,
shopping. Clothing optional heated
pool, Internet. 954-927-0090,
LibertySuites.com.
COUNSELING
LGBTQ Affrming Therapy at Dupont
Metro. Individuals, couples, families,
adolescents. Over 15 years serving
the community. Mike Giordano,
LICSW. 202/460-6384, mike.
giordano.msw@gmail.com, www.
WhatIHearYouSaying.com
COUNSELING FOR GAY MEN.
Individual/couple counseling with
volunteer peer counselor. Gay Men’s
Counseling Community. 202-265-
6495. gaymenscounseling.org. No
fees, donation requested.
INDIVIDUAL THERAPY FOR the gay
& lesbian community. Relationships,
grief, anxiety, transitions,
careers. Jonathan Kirkendall (202)
550-3589. www.dclpc.com.
LEGAL SERVICES
FULL SERVICE LAW FIRM
Representing the GLBT community for
over 25 years. Family adoptions, estate
planning, real estate, immigration,
employment. (301) 891-2200. Silber,
Perlman, Sigman & Tilev, P.A. & Kirstin
Gulling, Of Counsel. www.SP-Law.com
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 11-12-10 SALES REPRESENTATIVE: PHIL ROCKSTROH (prockstroh@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
For a Great Massage
MATTHEW
(202) 247-0776
100% Professional
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE 11.26.10 SALES REPRESENTATIVE: PHIL ROCKSTROH prockstroh@washblade.com
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
DAVIS Construction is seeking certifed CBE
companies for their participation in the upcoming
opportunity CoStar Offces in Washington, DC.
Bids due by 12pm on Friday December 31, 2010.
At this time, we seek bidders in divisions 1-16.
Documents will be available
on or about December 16, 2010.
DAVIS Construction
12530 Parklawn Drive
Rockville, MD 20852
suboutreach@davisconstruction.com
Fax: 301-468-3918
WASHI NGTONBLADE. COM NOVEMBER 26, 2010 • 51
PLACE YOUR CLASSIFIED wAShIngtOnbLADE.COm
EMPLOYMENT LAW ATTORNEY
- Wrongful Discharge, Sexual
Harrassment, Contract Review,
Whitleblowers. The Law Office of Carl
Roller (202) 531-2777, www.carlroller.
com
ADOPTION & REPRODUCTIVE LAW
Jennifer Fairfax handles adoption,
donor, carrier & parenting matters
for LGBT families. Experienced.
Affordable. Maryland & D.C. 301-
221-9651. JFairfax@jenniferfairfax.
com. www.jenniferfairfax.com
LIPPMAN, SEMSKER & SALB. A full-
service law firm serving the GLBT
community. Protecting You. Protecting
Your Family. Since 1972. (301) 656-
6905 or www.LSSLawyers.com.
AUTOS
FAST CASH!!! Wanted Cars & Trucks.
Don t throw your money away, call
me! I will buy your vehicle. Call Marty
Salins, at Auto Plaza, in Rockville,
(301) 340-1390.
BUY/USED BOOKS
ALL GAY THEMES. G BOOKS. 1520 U St,
NW. 202-986-9697 Brandonchan99@
msn.com. 4pm-10pm. P.S. our lubes,
DVDs & gear cheaper than online.
PETS & SUPPLIES
ADOPT AN ADORABLE PUPPY OR
DOG All-breed, non-profit rescue. 100%
volunteer run. Donations welcome &
needed. www.aforeverhome.org.
Mid-Day Dog Walks/Vacation Pet Sits:
Becky s Pet Care provides Professional
Dog Walks, Pet Sits in NOVA since
1998. Save $20 Code LESS20. Call
703.822.0933,BeckysPetCare.com.
MOVING
John Henry Movers Since 1990, the
area’s favorite gay owned crew.
Expert packing, pianos. Experienced,
equipped & punctual as hell.
Cheapskates love us! 703-597-5561
GULLIVER’S MOVERS- Swift & gentle
relocation’s. Packing, pianos, antiques.
Local & long distance 202-483-9579
www.gulliversmovers.com
CLEANING
TOO NEAT GUYS INC. Residential &
commercial cleaning in DC & Northern
VA. Over 12 years experience, gay
owned, licensed, bonded & insured
(703) 622-5983.
A CLEANING SERVICE invites you to
relax while our team of experienced,
dependable & friendly professionals
provides top-quality cleaning service
to your home or office. Excellent refs,
satisfaction guaranteed. Licensed,
bonded & insured. Reasonable
rates. Call today for a free
estimate. (703) 892-8648. www.
acleaningserviceinc.com
FERNANDO S CLEANING: Residential
& Commercial Cleaning, Reasonable
Rates, Free Estimates, Routine, 1-Time,
Move-In/Move-Out. (202) 234-7050,
202-486-6183.
MAID TO CLEAN. Rated #1 in Metro
DC. Gay owned. Serving DC/VA/
MD. DC 202-270-2967, VA (703) 299-
0101. MD (301) 656-7171. Visit www.
maidtoclean.com
TREE CARE
Branches Tree Experts has certified
arborists with experience in Spraying,
Fertilizing, Tree Pruning, Root Pruning,
Construction Damage, Storm Damage,
Stump Grinding, Tree Protection Plans,
Planting and Consulting. 301-589-
6181, Expert Tree Care Service Since
1988, www.BranchesTreeExperts.com
HOME IMPROVEMENT
CROWN MOULDINGS & CHAIR RAILS -
All facets of interior trim, specializing in
crown moulding, chair rails & custom
moulding fabrication. Call Matt 571-
238-8366.
TIRED OF THAT DAMN DOOR?
Specializing in older doors, repairing,
modifying, weatherstrip, thresholds,
deadbolts and doorknobs. Call Matt
571-238-8366.
REAL ESTATE AGENTS
w w w. G a y R e a l E s t a t e . c o m
Free On-Line Directory of the
Top Gay & Lesbian Realtors in
Washington D.C., Maryland, Virginia
& the Nation Instantly on-line at
www.GayRealEstate.com.
RENT / DC
FURNISHED DUPONT STUDIO for rent,
Dupont Circle Metro, short term rent.
Available on Dec 1st to March 30. For
information call 202-239-9510.
FURNISHED HOUSING
/ DC
WASHINGTON DC FURNISHED
HOUSING APARTMENTS &
LODGING. 1 to 3 blocks to US Capitol
grounds, Supreme Court, LOC. (202)
544-4419. Veteran owned small
business www.capitolhillstay.com
SALE / MD
HISTORIC MOUNT RAINIER
2-3-4 Bedroom Homes! Great
Condition! $149,999 - $329,900
Handy-Dandy House needs Major
Renovation $149,995
LARRY PERRIN, Realtor
301.983.0601 LJPerrin@aol.com

GREENBELT CONDOMINIUM
EXTRAVAGANZA
1-2-3 BEDROOM Units + Separate
Family Room!
Walk to Safeway, CVS, Restaurants,
Shopping!
From $99,995
LARRY PERRIN, Realtor
301.983.601 LJPerrin@aol.com
RENT / VA
BLOCKS TO METRO IN ALEXANDRIA!
2BR, 2BA luxury condos for rent,
starting at $2450 per month including
parking, storage, wood floors, etc. Just
pay electric. Walk to 2 Metros, movies,
restaurants and shops. Enjoy 2 gyms,
pool, tennis, 24-hr security and more.
www.stonerealtyservices.com or Brenda
Stone, Keller Williams, 703-739-4663.
SHARE / VA
LAKE JACKSON, VA SHARE Gay
friendly community, waterfront lot,
convenient to VRE. Private bath, 2 rooms
(furnishing optional) Will share kitchen,
deck & laundry room. Lesbian; single
or couple. $750.00 incl. utilities. No
smoking inside. No pets. 571 643 3115
A D V E R T I S E
bladeclassifieds
BEST RATES
BEST RESULTS
CONTACT
PHIL ROCKSTROH
AT
prockstroh@washblade.com
202-747-2077 X8092
ENHANCE YOUR AD WITH
OUR UPGRADES LIKE
PICTURES
BOLD TEXT
LARGE TEXT
COLOR
AND MORE!
DEADLINES
all classified ads - including regular and adult - must be received by
mondays at 5pm so they can be included in that weeks edition of the
washington blade and washingtonblade.com
52 • NOVEMBER 26, 2010 WASHI NGTONBLADE. COM
ESCORTS
Never hired before? Get tips for
a good experience here: http://
beforeyoucome.blogspot.com
The Blacklist Site a tool for escorts.
http://blacklistednow.blogspot.com
SENSUOUS BOD 2 BOD Friendly,
creative, erotic massage& Your willing
body, for a toe curling experience!
Chad (202) 329-7097
THAI-AMERICAN NUDE BODY
MASSAGE, 27 yrs., 5’8”, 150 lbs.,
friendly, handsome, smooth, nice body.
In (Alexandria VA)/out 10AM - 10PM
Call Robert (703) 655-2130
THINKING MAN’S MASSAGE – A
quality massage by a nationally
certified, Irish/Italian US Navy
Swimmer/Gymnast. Exceptional
deep tissue and sensual bodywork
for total stress relief in private
studio. (Shower & parking
available, Metro 2.5 blocks) Call
Erik 202-544-7905 for one of the
best. In calls only.
ALL-AMERICAN BOY 24y/o, 5’9,
138lbs, 29w. Very cute & clean-cut,
w/a smooth lean build. Affectionate
& versatile, loves older guys.
HotDCkid@gmail.com
703-568-1560.
WHEN QUALITY COUNTS Male/TV/TS,
202-487-3660, www.tops69.com
ENASARIS 5’ 11”, 155lbs, 30yo, 9X6,
Versatile Top 202.271.0440
GREAT MASSEUR in DC. 24/7 to make
appts. 6.0 tall 180 lbs. mix latin. Call
me at (202) 413-5952 CESAR
“sexy latin boy” 21y/o, 5’6,130 lbs, 28w.
cute, young, w/a smooth thin/lean build.
give a try it! you won’t be disappointed
loves older guys in/out 202-710-2224
ANYTHINGS POSSIBLE FULL NUDE
EROTIC MASSAGE , BY VGL 30 YR
OLD 5’9 150 BL, BL GREAT RATES
IN/OUT. LOOKING TO RELAX AND
ENJOY YOU FOUND IT , MICK 703-
338-1860.
sexy latin strong big brazilian guy,
massage & more, 8 inches, out
calls only 24/7, Aldo 202.696.5161
http://aldobigstrong.jimdo.com
BODYWORK
DAVID EROTIC MASSAGE by certified
therapist. Deep tissue also available.
On table. Handsome man with class.
Thank you for your repeat business.
Days & evenings. Easy parking or
metro. Call 202-421-8900.
MALE MASSAGE by 32 yo, 5 9 ,
165 lbs, Hot Latino with a special
touch. Offering full body release
in a private atmosphere. In/out.
Parking Available, hotels welcome,
Silver Spring/DC area, 24/7.
240-462-8669
Stressed Out? Relax your
body, mind and spirit with
strong,skilled & caring hands.
Give it a try! No calls after 10
PM! Call Manuel at 202-251-
1652, Bodywork202@hotmail.com
“SATISFACTION GUARANTEED”
BLONDE GI 6 0 , 165LBS Good looking,
athletic, well-endowed. Sensual
Massage & More. Eli (703) 599-2668.
MASSAGE SILVER SPRING
Spanish/Irish, 160 lbs, 5’10” great
shape, beach tan, strong soothing
hands. Full-body erotic experience,
masculine energy. Stress release.
Comfortable studio, private
home. $70/hr. Days/evenings,
metro. BRUNO (301) 580-2716.
BEAR HUNTING Strong sensual paws
for your willing body. Tom (202) 289-
7367.
Erotic Swedish Massage - healthy clean
cut guy, 6’1”, 160lbs, Dupont Circle,
massage table, noon to 1:00 a.m.,
indulge your body. Bill 202-728-0238
ADULT
Get him on the line!
Try free with code 4617
Call 202-448-0112
InteractiveMale.com
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF # 1 ISSUE DATE 10.15.10 SALES REPRESENTATIVE: BRIAN PITTS bpitts@washblade.com
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
A D V E R T I S E
bladeclassifieds
BEST RATES
BEST RESULTS
LOOK NO FURTHER
CONTACT PHIL ROCKSTROH AT
prockstroh@washblade.com
202-747-2077 X8092
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of proof.
Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of the date
of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts omnimedia
llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is responsible
for any legal liability arising out of or relating to the advertisement, and/or any material to which users can link through
the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or any rgihts of third
parties, including, but not limited to, such violations as infringement or misapporpriation of any copyright, patent,
trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair competition,
defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation, or any other right
of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the washington blade) and
to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all liability, loss, damages,
claims, or causes of action, including reasonable legal fees and expenses that may be incurred by brown naff pitts
omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations and warranties.
A D V E R T I S I N G P R O O F
PROOF #1 ISSUE DATE: 101015 SALES REPRESENTATIVE: Phil Rockstroh (prockstroh@washblade.com)
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS
ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
Discretion assured.
For an extraordinary, tender, personal
experience with a masculine man
call 202-495-1091
Beau knows what feels good!
More info at DCBeau.blogspot.com
Incalls or
outcalls
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF # 1 ISSUE DATE 10.15.10 SALES REPRESENTATIVE: PHIL ROCKSTROH prockstroh@washblade.com
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
TOPS Referrals TOPS Referrals
DC’S OLDEST
& FINEST
REFERRAL
SERVICE
College Boys
Mature & Masculine Men
TV/TS
SERVING
METROPOLITAN
WASHINGTON DC
TOPS69.COM
202.487.3660
TOPS69.COM
202.487.3660
WASHI NGTONBLADE. COM NOVEMBER 26, 2010 • 53
54 washingtonblade.com • november 26, 2010
202.448.0112
Find your local number: 1.800.777.8000
18+ www.interactivemale.com
FREE TRIAL CODE 7349
GET HIM
ON THE LINE
REVIEW AD FOR COPY AND DESIGN ACCURACY. Revisions must be submitted within 24 hours of the date of
proof. Proof will be considered fnal and will be submitted for publication if revision is not submitted within 24 hours of
the date of proof. Revisions will not be accepted after 12:01 pm wednesday, the week of publication.Brown naff pitts
omnimedia llc (dba the washington blade) is not responsible for the content and/or design of your ad. Advertiser is
responsible for any legal liability arising out of or relating to the advertisement, and/or any material to which users
can link through the advertisement. Advertiser represents that its advertisement will not violate any criminal laws or
any rgihts of third parties, including, but not limited to, such violations as infringement or misapporpriation of any
copyright, patent, trademark, trade secret, music, image, or other proprietary or propety right, false advertising, unfair
competition, defamation, invasion of privacy or rights of celebrity, violation of anti-discrimination law or regulation,
or any other right of any person or entity. Advertiser agrees to idemnify brown naff pitts omnimedia llc (dba the
washington blade) and to hold brown naff pitts omnimedia llc (dba the washington blade) harmless from any and all
liability, loss, damages, claims, or causes of action, including reasonable legal fees and expenses that may be incurred
by brown naff pitts omnimedia llc, arising out of or related to advertiser’s breach of any of the foregoing representations
and warranties.
A D V E R T I S I N G P R O O F
PROOF ISSUE DATE: SALES REPRESENTATIVE:
REVISIONS
REDESIGN
TEXT REVISIONS
IMAGE/LOGO REVISIONS
NO REVISIONS ADVERTISER SIGNATURE
By signing this proof you are agreeing to your contract obligations with the
washington blade newspaper. This includes but is not limited to placement,
payment and insertion schedule.
DEADLINES
all classifed ads - including regular and adult - must be received by mondays at 5pm so they can be
included in that week’s edition of the washington blade and washingtonblade.com
A D V E R T I S E
bladeclassifieds
BEST RATES
BEST RESULTS
CONTACT
PHIL ROCKSTROH
AT
prockstroh@washblade.com
202-747-2077 X8092
ENHANCE YOUR AD WITH
OUR UPGRADES LIKE
PICTURES
BOLD TEXT
LARGE TEXT
COLOR
AND MORE!
november 26, 2010 • washingtonblade.com 55

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->